id	sid	tid	token	lemma	pos
aiua-10431	1	1	stesura	stesura	PROPN
aiua-10431	1	2	seveso	seveso	PROPN
aiua-10431	1	3	archivio	archivio	PROPN
aiua-10431	1	4	italiano	italiano	X
aiua-10431	1	5	di	di	X
aiua-10431	1	6	urologia	urologia	PROPN
aiua-10431	1	7	e	e	PROPN
aiua-10431	1	8	andrologia	andrologia	PROPN
aiua-10431	1	9	2022	2022	NUM
aiua-10431	1	10	;	;	PUNCT
aiua-10431	1	11	94	94	NUM
aiua-10431	1	12	,	,	PUNCT
aiua-10431	1	13	4464	4464	NUM
aiua-10431	1	14	original	original	ADJ
aiua-10431	1	15	paper	paper	NOUN
aiua-10431	1	16	no	no	DET
aiua-10431	1	17	conflict	conflict	NOUN
aiua-10431	1	18	of	of	ADP
aiua-10431	1	19	interest	interest	NOUN
aiua-10431	1	20	declared	declare	VERB
aiua-10431	1	21	.	.	PUNCT
aiua-10431	2	1	comorbidities	comorbiditie	NOUN
aiua-10431	2	2	such	such	ADJ
aiua-10431	2	3	as	as	ADP
aiua-10431	2	4	chronic	chronic	ADJ
aiua-10431	2	5	fatigue	fatigue	NOUN
aiua-10431	2	6	,	,	PUNCT
aiua-10431	2	7	loss	loss	NOUN
aiua-10431	2	8	of	of	ADP
aiua-10431	2	9	libido	libido	NOUN
aiua-10431	2	10	,	,	PUNCT
aiua-10431	2	11	erectile	erectile	ADJ
aiua-10431	2	12	dysfunction	dysfunction	NOUN
aiua-10431	2	13	,	,	PUNCT
aiua-10431	2	14	low	low	ADJ
aiua-10431	2	15	haematocrit	haematocrit	PROPN
aiua-10431	2	16	level	level	NOUN
aiua-10431	2	17	,	,	PUNCT
aiua-10431	2	18	cardiovascular	cardiovascular	ADJ
aiua-10431	2	19	events	event	NOUN
aiua-10431	2	20	,	,	PUNCT
aiua-10431	2	21	and	and	CCONJ
aiua-10431	2	22	decreased	decrease	VERB
aiua-10431	2	23	bone	bone	NOUN
aiua-10431	2	24	density	density	NOUN
aiua-10431	2	25	(	(	PUNCT
aiua-10431	2	26	3	3	NUM
aiua-10431	2	27	)	)	PUNCT
aiua-10431	2	28	.	.	PUNCT
aiua-10431	3	1	several	several	ADJ
aiua-10431	3	2	studies	study	NOUN
aiua-10431	3	3	consistently	consistently	ADV
aiua-10431	3	4	show	show	VERB
aiua-10431	3	5	significant	significant	ADJ
aiua-10431	3	6	relationships	relationship	NOUN
aiua-10431	3	7	between	between	ADP
aiua-10431	3	8	serum	serum	NOUN
aiua-10431	3	9	testosterone	testosterone	NOUN
aiua-10431	3	10	and	and	CCONJ
aiua-10431	3	11	t2	t2	NOUN
aiua-10431	3	12	dm	dm	X
aiua-10431	3	13	(	(	PUNCT
aiua-10431	3	14	4	4	NUM
aiua-10431	3	15	)	)	PUNCT
aiua-10431	3	16	.	.	PUNCT
aiua-10431	4	1	many	many	ADJ
aiua-10431	4	2	studies	study	NOUN
aiua-10431	4	3	reported	report	VERB
aiua-10431	4	4	that	that	SCONJ
aiua-10431	4	5	25	25	NUM
aiua-10431	4	6	%	%	NOUN
aiua-10431	4	7	to	to	PART
aiua-10431	4	8	50	50	NUM
aiua-10431	4	9	%	%	NOUN
aiua-10431	4	10	of	of	ADP
aiua-10431	4	11	type	type	NOUN
aiua-10431	4	12	2	2	NUM
aiua-10431	4	13	diabetic	diabetic	ADJ
aiua-10431	4	14	males	male	NOUN
aiua-10431	4	15	have	have	AUX
aiua-10431	4	16	lowered	lower	VERB
aiua-10431	4	17	testosterone	testosterone	NOUN
aiua-10431	4	18	levels	level	NOUN
aiua-10431	4	19	(	(	PUNCT
aiua-10431	4	20	5	5	NUM
aiua-10431	4	21	)	)	PUNCT
aiua-10431	4	22	.	.	PUNCT
aiua-10431	5	1	hence	hence	ADV
aiua-10431	5	2	,	,	PUNCT
aiua-10431	5	3	testosterone	testosterone	NOUN
aiua-10431	5	4	deficiency	deficiency	NOUN
aiua-10431	5	5	in	in	ADP
aiua-10431	5	6	t2	t2	NOUN
aiua-10431	5	7	dm	dm	NUM
aiua-10431	5	8	has	have	VERB
aiua-10431	5	9	high	high	ADJ
aiua-10431	5	10	clinical	clinical	ADJ
aiua-10431	5	11	importance	importance	NOUN
aiua-10431	5	12	.	.	PUNCT
aiua-10431	6	1	although	although	SCONJ
aiua-10431	6	2	male	male	ADJ
aiua-10431	6	3	hypogonadism	hypogonadism	NOUN
aiua-10431	6	4	(	(	PUNCT
aiua-10431	6	5	mhg	mhg	PROPN
aiua-10431	6	6	)	)	PUNCT
aiua-10431	6	7	in	in	ADP
aiua-10431	6	8	t2	t2	NOUN
aiua-10431	6	9	dm	dm	NUM
aiua-10431	6	10	has	have	AUX
aiua-10431	6	11	been	be	AUX
aiua-10431	6	12	investigated	investigate	VERB
aiua-10431	6	13	in	in	ADP
aiua-10431	6	14	many	many	ADJ
aiua-10431	6	15	researches	research	NOUN
aiua-10431	6	16	,	,	PUNCT
aiua-10431	6	17	the	the	DET
aiua-10431	6	18	mechanism	mechanism	NOUN
aiua-10431	6	19	underlying	underlie	VERB
aiua-10431	6	20	the	the	DET
aiua-10431	6	21	pathogenesis	pathogenesis	NOUN
aiua-10431	6	22	of	of	ADP
aiua-10431	6	23	testosterone	testosterone	NOUN
aiua-10431	6	24	deficiency	deficiency	NOUN
aiua-10431	6	25	in	in	ADP
aiua-10431	6	26	diabetes	diabetes	NOUN
aiua-10431	6	27	is	be	AUX
aiua-10431	6	28	still	still	ADV
aiua-10431	6	29	not	not	PART
aiua-10431	6	30	fully	fully	ADV
aiua-10431	6	31	understood	understand	VERB
aiua-10431	6	32	yet	yet	ADV
aiua-10431	6	33	(	(	PUNCT
aiua-10431	6	34	6	6	NUM
aiua-10431	6	35	)	)	PUNCT
aiua-10431	6	36	.	.	PUNCT
aiua-10431	7	1	the	the	DET
aiua-10431	7	2	majority	majority	NOUN
aiua-10431	7	3	of	of	ADP
aiua-10431	7	4	previous	previous	ADJ
aiua-10431	7	5	studies	study	NOUN
aiua-10431	7	6	have	have	AUX
aiua-10431	7	7	assessed	assess	VERB
aiua-10431	7	8	testosterone	testosterone	NOUN
aiua-10431	7	9	levels	level	NOUN
aiua-10431	7	10	in	in	ADP
aiua-10431	7	11	elderly	elderly	ADJ
aiua-10431	7	12	,	,	PUNCT
aiua-10431	7	13	obese	obese	ADJ
aiua-10431	7	14	males	male	NOUN
aiua-10431	7	15	with	with	ADP
aiua-10431	7	16	t2	t2	NOUN
aiua-10431	7	17	dm	dm	X
aiua-10431	7	18	(	(	PUNCT
aiua-10431	7	19	7	7	NUM
aiua-10431	7	20	)	)	PUNCT
aiua-10431	7	21	.	.	PUNCT
aiua-10431	8	1	on	on	ADP
aiua-10431	8	2	other	other	ADJ
aiua-10431	8	3	hand	hand	NOUN
aiua-10431	8	4	,	,	PUNCT
aiua-10431	8	5	it	it	PRON
aiua-10431	8	6	is	be	AUX
aiua-10431	8	7	well	well	ADV
aiua-10431	8	8	established	establish	VERB
aiua-10431	8	9	that	that	SCONJ
aiua-10431	8	10	obesity	obesity	NOUN
aiua-10431	8	11	is	be	AUX
aiua-10431	8	12	a	a	DET
aiua-10431	8	13	major	major	ADJ
aiua-10431	8	14	risk	risk	NOUN
aiua-10431	8	15	factor	factor	NOUN
aiua-10431	8	16	for	for	ADP
aiua-10431	8	17	type	type	NOUN
aiua-10431	8	18	2	2	NUM
aiua-10431	8	19	diabetes	diabetes	NOUN
aiua-10431	8	20	and	and	CCONJ
aiua-10431	8	21	cardiovascular	cardiovascular	ADJ
aiua-10431	8	22	disease	disease	NOUN
aiua-10431	8	23	(	(	PUNCT
aiua-10431	8	24	8)	8)	NUM
aiua-10431	8	25	.	.	PUNCT
aiua-10431	9	1	several	several	ADJ
aiua-10431	9	2	studies	study	NOUN
aiua-10431	9	3	have	have	AUX
aiua-10431	9	4	linked	link	VERB
aiua-10431	9	5	male	male	ADJ
aiua-10431	9	6	hypogonadism	hypogonadism	NOUN
aiua-10431	9	7	with	with	ADP
aiua-10431	9	8	being	be	AUX
aiua-10431	9	9	overweight	overweight	ADJ
aiua-10431	9	10	or	or	CCONJ
aiua-10431	9	11	obese	obese	ADJ
aiua-10431	9	12	(	(	PUNCT
aiua-10431	9	13	9	9	NUM
aiua-10431	9	14	)	)	PUNCT
aiua-10431	9	15	.	.	PUNCT
aiua-10431	10	1	large	large	ADJ
aiua-10431	10	2	population	population	NOUN
aiua-10431	10	3	-	-	PUNCT
aiua-10431	10	4	based	base	VERB
aiua-10431	10	5	studies	study	NOUN
aiua-10431	10	6	have	have	AUX
aiua-10431	10	7	confirmed	confirm	VERB
aiua-10431	10	8	that	that	SCONJ
aiua-10431	10	9	obesity	obesity	NOUN
aiua-10431	10	10	is	be	AUX
aiua-10431	10	11	the	the	DET
aiua-10431	10	12	single	single	ADJ
aiua-10431	10	13	most	most	ADV
aiua-10431	10	14	important	important	ADJ
aiua-10431	10	15	factor	factor	NOUN
aiua-10431	10	16	associated	associate	VERB
aiua-10431	10	17	with	with	ADP
aiua-10431	10	18	low	low	ADJ
aiua-10431	10	19	testosterone	testosterone	NOUN
aiua-10431	10	20	,	,	PUNCT
aiua-10431	10	21	overriding	override	VERB
aiua-10431	10	22	the	the	DET
aiua-10431	10	23	effects	effect	NOUN
aiua-10431	10	24	of	of	ADP
aiua-10431	10	25	age	age	NOUN
aiua-10431	10	26	and	and	CCONJ
aiua-10431	10	27	comorbidities	comorbiditie	NOUN
aiua-10431	10	28	(	(	PUNCT
aiua-10431	10	29	10	10	NUM
aiua-10431	10	30	)	)	PUNCT
aiua-10431	10	31	.	.	PUNCT
aiua-10431	11	1	therefore	therefore	ADV
aiua-10431	11	2	,	,	PUNCT
aiua-10431	11	3	it	it	PRON
aiua-10431	11	4	is	be	AUX
aiua-10431	11	5	unclear	unclear	ADJ
aiua-10431	11	6	whether	whether	SCONJ
aiua-10431	11	7	this	this	PRON
aiua-10431	11	8	is	be	AUX
aiua-10431	11	9	ascribable	ascribable	ADJ
aiua-10431	11	10	to	to	ADP
aiua-10431	11	11	the	the	DET
aiua-10431	11	12	diabetic	diabetic	ADJ
aiua-10431	11	13	state	state	NOUN
aiua-10431	11	14	per	per	ADP
aiua-10431	11	15	se	se	X
aiua-10431	11	16	,	,	PUNCT
aiua-10431	11	17	or	or	CCONJ
aiua-10431	11	18	because	because	SCONJ
aiua-10431	11	19	of	of	ADP
aiua-10431	11	20	other	other	ADJ
aiua-10431	11	21	factors	factor	NOUN
aiua-10431	11	22	,	,	PUNCT
aiua-10431	11	23	such	such	ADJ
aiua-10431	11	24	as	as	ADP
aiua-10431	11	25	obesity	obesity	NOUN
aiua-10431	11	26	or	or	CCONJ
aiua-10431	11	27	age	age	NOUN
aiua-10431	11	28	.	.	PUNCT
aiua-10431	12	1	hence	hence	ADV
aiua-10431	12	2	,	,	PUNCT
aiua-10431	12	3	the	the	DET
aiua-10431	12	4	role	role	NOUN
aiua-10431	12	5	of	of	ADP
aiua-10431	12	6	the	the	DET
aiua-10431	12	7	diabetic	diabetic	ADJ
aiua-10431	12	8	state	state	NOUN
aiua-10431	12	9	in	in	ADP
aiua-10431	12	10	relation	relation	NOUN
aiua-10431	12	11	to	to	ADP
aiua-10431	12	12	the	the	DET
aiua-10431	12	13	effects	effect	NOUN
aiua-10431	12	14	of	of	ADP
aiua-10431	12	15	obesity	obesity	NOUN
aiua-10431	12	16	and	and	CCONJ
aiua-10431	12	17	comorbidities	comorbiditie	NOUN
aiua-10431	12	18	on	on	ADP
aiua-10431	12	19	testosterone	testosterone	NOUN
aiua-10431	12	20	levels	level	NOUN
aiua-10431	12	21	in	in	ADP
aiua-10431	12	22	diabetic	diabetic	ADJ
aiua-10431	12	23	men	man	NOUN
aiua-10431	12	24	is	be	AUX
aiua-10431	12	25	debatable	debatable	ADJ
aiua-10431	12	26	(	(	PUNCT
aiua-10431	12	27	11	11	NUM
aiua-10431	12	28	)	)	PUNCT
aiua-10431	12	29	.	.	PUNCT
aiua-10431	13	1	in	in	ADP
aiua-10431	13	2	this	this	DET
aiua-10431	13	3	study	study	NOUN
aiua-10431	13	4	,	,	PUNCT
aiua-10431	13	5	we	we	PRON
aiua-10431	13	6	tried	try	VERB
aiua-10431	13	7	to	to	PART
aiua-10431	13	8	limit	limit	VERB
aiua-10431	13	9	the	the	DET
aiua-10431	13	10	confounding	confound	VERB
aiua-10431	13	11	factor	factor	NOUN
aiua-10431	13	12	that	that	PRON
aiua-10431	13	13	affects	affect	VERB
aiua-10431	13	14	the	the	DET
aiua-10431	13	15	testosterone	testosterone	NOUN
aiua-10431	13	16	levels	level	NOUN
aiua-10431	13	17	in	in	ADP
aiua-10431	13	18	diabetic	diabetic	ADJ
aiua-10431	13	19	males	male	NOUN
aiua-10431	13	20	such	such	ADJ
aiua-10431	13	21	as	as	ADP
aiua-10431	13	22	obesity	obesity	NOUN
aiua-10431	13	23	.	.	PUNCT
aiua-10431	14	1	therefore	therefore	ADV
aiua-10431	14	2	,	,	PUNCT
aiua-10431	14	3	we	we	PRON
aiua-10431	14	4	aimed	aim	VERB
aiua-10431	14	5	to	to	PART
aiua-10431	14	6	investigate	investigate	VERB
aiua-10431	14	7	the	the	DET
aiua-10431	14	8	prevalence	prevalence	NOUN
aiua-10431	14	9	and	and	CCONJ
aiua-10431	14	10	identify	identify	VERB
aiua-10431	14	11	the	the	DET
aiua-10431	14	12	predictors	predictor	NOUN
aiua-10431	14	13	for	for	ADP
aiua-10431	14	14	testosterone	testosterone	NOUN
aiua-10431	14	15	deficiency	deficiency	NOUN
aiua-10431	14	16	among	among	ADP
aiua-10431	14	17	non	non	ADJ
aiua-10431	14	18	-	-	ADJ
aiua-10431	14	19	obese	obese	ADJ
aiua-10431	14	20	type	type	NOUN
aiua-10431	14	21	2	2	NUM
aiua-10431	14	22	male	male	ADJ
aiua-10431	14	23	diabetic	diabetic	ADJ
aiua-10431	14	24	patients	patient	NOUN
aiua-10431	14	25	.	.	PUNCT
aiua-10431	15	1	patients	patient	NOUN
aiua-10431	15	2	and	and	CCONJ
aiua-10431	15	3	methods	method	NOUN
aiua-10431	15	4	study	study	VERB
aiua-10431	15	5	population	population	NOUN
aiua-10431	15	6	this	this	DET
aiua-10431	15	7	cross	cross	ADJ
aiua-10431	15	8	-	-	ADJ
aiua-10431	15	9	sectional	sectional	ADJ
aiua-10431	15	10	study	study	NOUN
aiua-10431	15	11	was	be	AUX
aiua-10431	15	12	conducted	conduct	VERB
aiua-10431	15	13	at	at	ADP
aiua-10431	15	14	mansoura	mansoura	PROPN
aiua-10431	15	15	university	university	NOUN
aiua-10431	15	16	's	's	PART
aiua-10431	15	17	endocrinology	endocrinology	NOUN
aiua-10431	15	18	,	,	PUNCT
aiua-10431	15	19	diabetes	diabetes	NOUN
aiua-10431	15	20	,	,	PUNCT
aiua-10431	15	21	and	and	CCONJ
aiua-10431	15	22	metabolism	metabolism	NOUN
aiua-10431	15	23	unit	unit	NOUN
aiua-10431	15	24	,	,	PUNCT
aiua-10431	15	25	specialized	specialized	ADJ
aiua-10431	15	26	medical	medical	ADJ
aiua-10431	15	27	hospital	hospital	NOUN
aiua-10431	15	28	,	,	PUNCT
aiua-10431	15	29	between	between	ADP
aiua-10431	15	30	march	march	PROPN
aiua-10431	15	31	2021	2021	NUM
aiua-10431	15	32	and	and	CCONJ
aiua-10431	15	33	august	august	PROPN
aiua-10431	15	34	2021	2021	NUM
aiua-10431	15	35	.	.	PUNCT
aiua-10431	16	1	the	the	DET
aiua-10431	16	2	mansoura	mansoura	ADJ
aiua-10431	16	3	faculty	faculty	NOUN
aiua-10431	16	4	of	of	ADP
aiua-10431	16	5	medicine	medicine	NOUN
aiua-10431	16	6	's	's	PART
aiua-10431	16	7	institutional	institutional	ADJ
aiua-10431	16	8	research	research	NOUN
aiua-10431	16	9	board	board	NOUN
aiua-10431	16	10	approved	approve	VERB
aiua-10431	16	11	the	the	DET
aiua-10431	16	12	study	study	NOUN
aiua-10431	16	13	design	design	NOUN
aiua-10431	16	14	.	.	PUNCT
aiua-10431	17	1	all	all	DET
aiua-10431	17	2	study	study	NOUN
aiua-10431	17	3	participants	participant	NOUN
aiua-10431	17	4	provided	provide	VERB
aiua-10431	17	5	written	write	VERB
aiua-10431	17	6	informed	inform	VERB
aiua-10431	17	7	consent	consent	NOUN
aiua-10431	17	8	.	.	PUNCT
aiua-10431	18	1	we	we	PRON
aiua-10431	18	2	enrolled	enrol	VERB
aiua-10431	18	3	95	95	NUM
aiua-10431	18	4	patients	patient	NOUN
aiua-10431	18	5	aged	age	VERB
aiua-10431	18	6	25	25	NUM
aiua-10431	18	7	to	to	PART
aiua-10431	18	8	65	65	NUM
aiua-10431	18	9	who	who	PRON
aiua-10431	18	10	had	have	AUX
aiua-10431	18	11	been	be	AUX
aiua-10431	18	12	diagnosed	diagnose	VERB
aiua-10431	18	13	with	with	ADP
aiua-10431	18	14	t2	t2	NOUN
aiua-10431	18	15	dm	dm	NOUN
aiua-10431	18	16	using	use	VERB
aiua-10431	18	17	the	the	DET
aiua-10431	18	18	american	american	ADJ
aiua-10431	18	19	diabetes	diabetes	PROPN
aiua-10431	18	20	association	association	PROPN
aiua-10431	18	21	's	's	PART
aiua-10431	18	22	diabetes	diabetes	NOUN
aiua-10431	18	23	diagnosis	diagnosis	NOUN
aiua-10431	18	24	criteria	criterion	NOUN
aiua-10431	18	25	.	.	PUNCT
aiua-10431	19	1	inclusion	inclusion	NOUN
aiua-10431	19	2	criteria	criterion	NOUN
aiua-10431	19	3	were	be	AUX
aiua-10431	19	4	set	set	VERB
aiua-10431	19	5	as	as	SCONJ
aiua-10431	19	6	follows	follow	VERB
aiua-10431	19	7	:	:	PUNCT
aiua-10431	19	8	males	male	NOUN
aiua-10431	19	9	with	with	ADP
aiua-10431	19	10	type	type	NOUN
aiua-10431	19	11	2	2	NUM
aiua-10431	19	12	background	background	NOUN
aiua-10431	19	13	and	and	CCONJ
aiua-10431	19	14	aims	aim	VERB
aiua-10431	19	15	:	:	PUNCT
aiua-10431	19	16	it	it	PRON
aiua-10431	19	17	is	be	AUX
aiua-10431	19	18	unclear	unclear	ADJ
aiua-10431	19	19	whether	whether	SCONJ
aiua-10431	19	20	male	male	ADJ
aiua-10431	19	21	hypogonadism	hypogonadism	NOUN
aiua-10431	19	22	is	be	AUX
aiua-10431	19	23	ascribable	ascribable	ADJ
aiua-10431	19	24	to	to	ADP
aiua-10431	19	25	the	the	DET
aiua-10431	19	26	diabetic	diabetic	ADJ
aiua-10431	19	27	state	state	NOUN
aiua-10431	19	28	per	per	ADP
aiua-10431	19	29	se	se	X
aiua-10431	19	30	,	,	PUNCT
aiua-10431	19	31	or	or	CCONJ
aiua-10431	19	32	because	because	SCONJ
aiua-10431	19	33	of	of	ADP
aiua-10431	19	34	other	other	ADJ
aiua-10431	19	35	factors	factor	NOUN
aiua-10431	19	36	,	,	PUNCT
aiua-10431	19	37	such	such	ADJ
aiua-10431	19	38	as	as	ADP
aiua-10431	19	39	obesity	obesity	NOUN
aiua-10431	19	40	or	or	CCONJ
aiua-10431	19	41	age	age	NOUN
aiua-10431	19	42	.	.	PUNCT
aiua-10431	20	1	we	we	PRON
aiua-10431	20	2	aimed	aim	VERB
aiua-10431	20	3	to	to	PART
aiua-10431	20	4	investigate	investigate	VERB
aiua-10431	20	5	the	the	DET
aiua-10431	20	6	prevalence	prevalence	NOUN
aiua-10431	20	7	and	and	CCONJ
aiua-10431	20	8	identify	identify	VERB
aiua-10431	20	9	the	the	DET
aiua-10431	20	10	predictors	predictor	NOUN
aiua-10431	20	11	for	for	ADP
aiua-10431	20	12	testosterone	testosterone	NOUN
aiua-10431	20	13	deficiency	deficiency	NOUN
aiua-10431	20	14	among	among	ADP
aiua-10431	20	15	non	non	ADJ
aiua-10431	20	16	-	-	ADJ
aiua-10431	20	17	obese	obese	ADJ
aiua-10431	20	18	type	type	NOUN
aiua-10431	20	19	2	2	NUM
aiua-10431	20	20	diabetic	diabetic	ADJ
aiua-10431	20	21	males	male	NOUN
aiua-10431	20	22	.	.	PUNCT
aiua-10431	21	1	methods	method	NOUN
aiua-10431	21	2	:	:	PUNCT
aiua-10431	21	3	this	this	DET
aiua-10431	21	4	cross	cross	ADJ
aiua-10431	21	5	-	-	ADJ
aiua-10431	21	6	sectional	sectional	ADJ
aiua-10431	21	7	study	study	NOUN
aiua-10431	21	8	was	be	AUX
aiua-10431	21	9	conducted	conduct	VERB
aiua-10431	21	10	on	on	ADP
aiua-10431	21	11	95	95	NUM
aiua-10431	21	12	nonobese	nonobese	ADJ
aiua-10431	21	13	type	type	NOUN
aiua-10431	21	14	2	2	NUM
aiua-10431	21	15	diabetic	diabetic	ADJ
aiua-10431	21	16	males	male	NOUN
aiua-10431	21	17	with	with	ADP
aiua-10431	21	18	bmi	bmi	NOUN
aiua-10431	21	19	below	below	ADP
aiua-10431	21	20	30	30	NUM
aiua-10431	21	21	.	.	PUNCT
aiua-10431	22	1	we	we	PRON
aiua-10431	22	2	evaluated	evaluate	VERB
aiua-10431	22	3	the	the	DET
aiua-10431	22	4	total	total	ADJ
aiua-10431	22	5	testosterone	testosterone	NOUN
aiua-10431	22	6	(	(	PUNCT
aiua-10431	22	7	tt	tt	PROPN
aiua-10431	22	8	)	)	PUNCT
aiua-10431	22	9	levels	level	NOUN
aiua-10431	22	10	to	to	PART
aiua-10431	22	11	determine	determine	VERB
aiua-10431	22	12	prevalence	prevalence	NOUN
aiua-10431	22	13	and	and	CCONJ
aiua-10431	22	14	risk	risk	NOUN
aiua-10431	22	15	factors	factor	NOUN
aiua-10431	22	16	of	of	ADP
aiua-10431	22	17	testosterone	testosterone	NOUN
aiua-10431	22	18	deficiency	deficiency	NOUN
aiua-10431	22	19	.	.	PUNCT
aiua-10431	23	1	serum	serum	VERB
aiua-10431	23	2	tt	tt	PROPN
aiua-10431	23	3	≤	≤	PROPN
aiua-10431	23	4	300	300	NUM
aiua-10431	23	5	ng	ng	PROPN
aiua-10431	23	6	/	/	SYM
aiua-10431	23	7	dl	dl	PROPN
aiua-10431	23	8	defined	define	VERB
aiua-10431	23	9	testosterone	testosterone	NOUN
aiua-10431	23	10	deficiency	deficiency	NOUN
aiua-10431	23	11	.	.	PUNCT
aiua-10431	24	1	results	result	NOUN
aiua-10431	24	2	:	:	PUNCT
aiua-10431	24	3	the	the	DET
aiua-10431	24	4	prevalence	prevalence	NOUN
aiua-10431	24	5	of	of	ADP
aiua-10431	24	6	testosterone	testosterone	NOUN
aiua-10431	24	7	deficiency	deficiency	NOUN
aiua-10431	24	8	was	be	AUX
aiua-10431	24	9	29.1	29.1	NUM
aiua-10431	24	10	%	%	NOUN
aiua-10431	24	11	.	.	PUNCT
aiua-10431	25	1	testosterone	testosterone	NOUN
aiua-10431	25	2	deficient	deficient	ADJ
aiua-10431	25	3	patients	patient	NOUN
aiua-10431	25	4	had	have	VERB
aiua-10431	25	5	statistically	statistically	ADV
aiua-10431	25	6	significantly	significantly	ADV
aiua-10431	25	7	higher	high	ADJ
aiua-10431	25	8	visceral	visceral	ADJ
aiua-10431	25	9	adiposity	adiposity	NOUN
aiua-10431	25	10	index	index	NOUN
aiua-10431	25	11	(	(	PUNCT
aiua-10431	25	12	vai	vai	NOUN
aiua-10431	25	13	)	)	PUNCT
aiua-10431	25	14	,	,	PUNCT
aiua-10431	25	15	waist	waist	NOUN
aiua-10431	25	16	,	,	PUNCT
aiua-10431	25	17	and	and	CCONJ
aiua-10431	25	18	triglyceride	triglyceride	ADP
aiua-10431	25	19	in	in	ADP
aiua-10431	25	20	comparison	comparison	NOUN
aiua-10431	25	21	with	with	ADP
aiua-10431	25	22	normal	normal	ADJ
aiua-10431	25	23	testosterone	testosterone	NOUN
aiua-10431	25	24	patients	patient	NOUN
aiua-10431	25	25	.	.	PUNCT
aiua-10431	26	1	tt	tt	PROPN
aiua-10431	26	2	level	level	NOUN
aiua-10431	26	3	correlated	correlate	VERB
aiua-10431	26	4	with	with	ADP
aiua-10431	26	5	vai	vai	ADJ
aiua-10431	26	6	,	,	PUNCT
aiua-10431	26	7	waist	waist	NOUN
aiua-10431	26	8	,	,	PUNCT
aiua-10431	26	9	bmi	bmi	PROPN
aiua-10431	26	10	,	,	PUNCT
aiua-10431	26	11	lh	lh	PROPN
aiua-10431	26	12	,	,	PUNCT
aiua-10431	26	13	and	and	CCONJ
aiua-10431	26	14	age	age	NOUN
aiua-10431	26	15	.	.	PUNCT
aiua-10431	27	1	vai	vai	PROPN
aiua-10431	27	2	was	be	AUX
aiua-10431	27	3	the	the	DET
aiua-10431	27	4	only	only	ADJ
aiua-10431	27	5	significant	significant	ADJ
aiua-10431	27	6	predictor	predictor	NOUN
aiua-10431	27	7	of	of	ADP
aiua-10431	27	8	tt	tt	PROPN
aiua-10431	27	9	levels	level	NOUN
aiua-10431	27	10	even	even	ADV
aiua-10431	27	11	after	after	ADP
aiua-10431	27	12	adjustment	adjustment	NOUN
aiua-10431	27	13	for	for	ADP
aiua-10431	27	14	age	age	NOUN
aiua-10431	27	15	and	and	CCONJ
aiua-10431	27	16	bmi	bmi	NOUN
aiua-10431	27	17	in	in	ADP
aiua-10431	27	18	regression	regression	NOUN
aiua-10431	27	19	analysis	analysis	NOUN
aiua-10431	27	20	.	.	PUNCT
aiua-10431	28	1	furthermore	furthermore	ADV
aiua-10431	28	2	,	,	PUNCT
aiua-10431	28	3	vai	vai	PROPN
aiua-10431	28	4	was	be	AUX
aiua-10431	28	5	a	a	DET
aiua-10431	28	6	statistically	statistically	ADV
aiua-10431	28	7	significant	significant	ADJ
aiua-10431	28	8	risk	risk	NOUN
aiua-10431	28	9	factor	factor	NOUN
aiua-10431	28	10	for	for	ADP
aiua-10431	28	11	testosterone	testosterone	NOUN
aiua-10431	28	12	deficiency	deficiency	NOUN
aiua-10431	28	13	in	in	ADP
aiua-10431	28	14	binary	binary	ADJ
aiua-10431	28	15	logistic	logistic	ADJ
aiua-10431	28	16	analysis	analysis	NOUN
aiua-10431	28	17	.	.	PUNCT
aiua-10431	29	1	conclusions	conclusion	NOUN
aiua-10431	29	2	:	:	PUNCT
aiua-10431	29	3	testosterone	testosterone	NOUN
aiua-10431	29	4	deficient	deficient	ADJ
aiua-10431	29	5	non	non	ADJ
aiua-10431	29	6	-	-	ADJ
aiua-10431	29	7	obese	obese	ADJ
aiua-10431	29	8	type	type	NOUN
aiua-10431	29	9	2	2	NUM
aiua-10431	29	10	diabetic	diabetic	ADJ
aiua-10431	29	11	male	male	ADJ
aiua-10431	29	12	patients	patient	NOUN
aiua-10431	29	13	had	have	VERB
aiua-10431	29	14	elevated	elevate	VERB
aiua-10431	29	15	vai	vai	ADJ
aiua-10431	29	16	,	,	PUNCT
aiua-10431	29	17	waist	waist	NOUN
aiua-10431	29	18	,	,	PUNCT
aiua-10431	29	19	and	and	CCONJ
aiua-10431	29	20	triglyceride	triglyceride	ADJ
aiua-10431	29	21	.	.	PUNCT
aiua-10431	30	1	moreover	moreover	ADV
aiua-10431	30	2	,	,	PUNCT
aiua-10431	30	3	elevated	elevated	ADJ
aiua-10431	30	4	vai	vai	NOUN
aiua-10431	30	5	was	be	AUX
aiua-10431	30	6	a	a	DET
aiua-10431	30	7	risk	risk	NOUN
aiua-10431	30	8	factor	factor	NOUN
aiua-10431	30	9	for	for	ADP
aiua-10431	30	10	testosterone	testosterone	NOUN
aiua-10431	30	11	deficiency	deficiency	NOUN
aiua-10431	30	12	.	.	PUNCT
aiua-10431	31	1	vai	vai	NOUN
aiua-10431	31	2	could	could	AUX
aiua-10431	31	3	be	be	AUX
aiua-10431	31	4	an	an	DET
aiua-10431	31	5	easily	easily	ADV
aiua-10431	31	6	applicable	applicable	ADJ
aiua-10431	31	7	and	and	CCONJ
aiua-10431	31	8	reliable	reliable	ADJ
aiua-10431	31	9	index	index	NOUN
aiua-10431	31	10	for	for	ADP
aiua-10431	31	11	the	the	DET
aiua-10431	31	12	evaluation	evaluation	NOUN
aiua-10431	31	13	and	and	CCONJ
aiua-10431	31	14	prediction	prediction	NOUN
aiua-10431	31	15	in	in	ADP
aiua-10431	31	16	type	type	NOUN
aiua-10431	31	17	2	2	NUM
aiua-10431	31	18	non	non	ADJ
aiua-10431	31	19	-	-	ADJ
aiua-10431	31	20	obese	obese	ADJ
aiua-10431	31	21	diabetic	diabetic	ADJ
aiua-10431	31	22	males	male	NOUN
aiua-10431	31	23	.	.	PUNCT
aiua-10431	32	1	key	key	ADJ
aiua-10431	32	2	words	word	NOUN
aiua-10431	32	3	:	:	PUNCT
aiua-10431	32	4	non	non	ADJ
aiua-10431	32	5	-	-	ADJ
aiua-10431	32	6	obese	obese	ADJ
aiua-10431	32	7	;	;	PUNCT
aiua-10431	32	8	t2	t2	PROPN
aiua-10431	32	9	dm	dm	NOUN
aiua-10431	32	10	;	;	PUNCT
aiua-10431	32	11	visceral	visceral	ADJ
aiua-10431	32	12	obesity	obesity	NOUN
aiua-10431	32	13	;	;	PUNCT
aiua-10431	32	14	testosterone	testosterone	NOUN
aiua-10431	32	15	;	;	PUNCT
aiua-10431	32	16	vai	vai	ADJ
aiua-10431	32	17	;	;	PUNCT
aiua-10431	32	18	males	male	NOUN
aiua-10431	32	19	.	.	PUNCT
aiua-10431	32	20	submitted	submit	VERB
aiua-10431	32	21	5	5	NUM
aiua-10431	32	22	march	march	NOUN
aiua-10431	32	23	2022	2022	NUM
aiua-10431	32	24	;	;	PUNCT
aiua-10431	32	25	accepted	accept	VERB
aiua-10431	32	26	2	2	NUM
aiua-10431	32	27	april	april	PROPN
aiua-10431	32	28	2022	2022	NUM
aiua-10431	32	29	introduction	introduction	NOUN
aiua-10431	32	30	diabetes	diabetes	NOUN
aiua-10431	32	31	mellitus	mellitus	NOUN
aiua-10431	32	32	(	(	PUNCT
aiua-10431	32	33	dm	dm	PROPN
aiua-10431	32	34	)	)	PUNCT
aiua-10431	32	35	is	be	AUX
aiua-10431	32	36	a	a	DET
aiua-10431	32	37	major	major	ADJ
aiua-10431	32	38	cause	cause	NOUN
aiua-10431	32	39	of	of	ADP
aiua-10431	32	40	health	health	NOUN
aiua-10431	32	41	concern	concern	NOUN
aiua-10431	32	42	due	due	ADP
aiua-10431	32	43	to	to	ADP
aiua-10431	32	44	its	its	PRON
aiua-10431	32	45	increasing	increase	VERB
aiua-10431	32	46	prevalence	prevalence	NOUN
aiua-10431	32	47	rate	rate	NOUN
aiua-10431	32	48	worldwide	worldwide	ADV
aiua-10431	32	49	.	.	PUNCT
aiua-10431	33	1	by	by	ADP
aiua-10431	33	2	the	the	DET
aiua-10431	33	3	turn	turn	NOUN
aiua-10431	33	4	of	of	ADP
aiua-10431	33	5	the	the	DET
aiua-10431	33	6	last	last	ADJ
aiua-10431	33	7	decade	decade	NOUN
aiua-10431	33	8	,	,	PUNCT
aiua-10431	33	9	the	the	DET
aiua-10431	33	10	international	international	ADJ
aiua-10431	33	11	diabetes	diabetes	PROPN
aiua-10431	33	12	federation	federation	PROPN
aiua-10431	33	13	(	(	PUNCT
aiua-10431	33	14	idf	idf	PROPN
aiua-10431	33	15	)	)	PUNCT
aiua-10431	33	16	estimated	estimate	VERB
aiua-10431	33	17	that	that	SCONJ
aiua-10431	33	18	404.7	404.7	NUM
aiua-10431	33	19	million	million	NUM
aiua-10431	33	20	people	people	NOUN
aiua-10431	33	21	worldwide	worldwide	ADV
aiua-10431	33	22	had	have	VERB
aiua-10431	33	23	type	type	NOUN
aiua-10431	33	24	2	2	NUM
aiua-10431	33	25	diabetes	diabetes	NOUN
aiua-10431	33	26	mellitus	mellitus	NOUN
aiua-10431	33	27	(	(	PUNCT
aiua-10431	33	28	t2	t2	NOUN
aiua-10431	33	29	dm	dm	PROPN
aiua-10431	33	30	)	)	PUNCT
aiua-10431	33	31	,	,	PUNCT
aiua-10431	33	32	with	with	SCONJ
aiua-10431	33	33	the	the	DET
aiua-10431	33	34	total	total	ADJ
aiua-10431	33	35	number	number	NOUN
aiua-10431	33	36	of	of	ADP
aiua-10431	33	37	diabetic	diabetic	ADJ
aiua-10431	33	38	patients	patient	NOUN
aiua-10431	33	39	expected	expect	VERB
aiua-10431	33	40	to	to	PART
aiua-10431	33	41	rise	rise	VERB
aiua-10431	33	42	to	to	ADP
aiua-10431	33	43	679.7	679.7	NUM
aiua-10431	33	44	million	million	NUM
aiua-10431	33	45	by	by	ADP
aiua-10431	33	46	2045	2045	NUM
aiua-10431	33	47	(	(	PUNCT
aiua-10431	33	48	1	1	NUM
aiua-10431	33	49	)	)	PUNCT
aiua-10431	33	50	.	.	PUNCT
aiua-10431	34	1	one	one	NUM
aiua-10431	34	2	complication	complication	NOUN
aiua-10431	34	3	of	of	ADP
aiua-10431	34	4	type	type	NOUN
aiua-10431	34	5	2	2	NUM
aiua-10431	34	6	diabetes	diabetes	NOUN
aiua-10431	34	7	(	(	PUNCT
aiua-10431	34	8	t2	t2	NOUN
aiua-10431	34	9	dm	dm	NOUN
aiua-10431	34	10	)	)	PUNCT
aiua-10431	34	11	is	be	AUX
aiua-10431	34	12	hypothalamic	hypothalamic	ADJ
aiua-10431	34	13	-	-	PUNCT
aiua-10431	34	14	pituitary	pituitary	ADJ
aiua-10431	34	15	-	-	PUNCT
aiua-10431	34	16	testicular	testicular	NOUN
aiua-10431	34	17	axis	axis	NOUN
aiua-10431	34	18	(	(	PUNCT
aiua-10431	34	19	hpt	hpt	NOUN
aiua-10431	34	20	axis	axis	NOUN
aiua-10431	34	21	)	)	PUNCT
aiua-10431	34	22	dysfunction	dysfunction	NOUN
aiua-10431	34	23	.	.	PUNCT
aiua-10431	35	1	the	the	DET
aiua-10431	35	2	hallmark	hallmark	NOUN
aiua-10431	35	3	of	of	ADP
aiua-10431	35	4	hpt	hpt	NOUN
aiua-10431	35	5	axis	axis	NOUN
aiua-10431	35	6	dysfunction	dysfunction	NOUN
aiua-10431	35	7	is	be	AUX
aiua-10431	35	8	characterized	characterize	VERB
aiua-10431	35	9	by	by	ADP
aiua-10431	35	10	subnormal	subnormal	ADJ
aiua-10431	35	11	testosterone	testosterone	NOUN
aiua-10431	35	12	levels	level	NOUN
aiua-10431	35	13	in	in	ADP
aiua-10431	35	14	association	association	NOUN
aiua-10431	35	15	with	with	ADP
aiua-10431	35	16	non	non	ADJ
aiua-10431	35	17	-	-	ADJ
aiua-10431	35	18	elevated	elevated	ADJ
aiua-10431	35	19	luteinizing	luteinizing	NOUN
aiua-10431	35	20	hormone	hormone	NOUN
aiua-10431	35	21	concentrations	concentration	NOUN
aiua-10431	35	22	.	.	PUNCT
aiua-10431	36	1	these	these	DET
aiua-10431	36	2	abnormalities	abnormality	NOUN
aiua-10431	36	3	were	be	AUX
aiua-10431	36	4	not	not	PART
aiua-10431	36	5	affected	affect	VERB
aiua-10431	36	6	by	by	ADP
aiua-10431	36	7	the	the	DET
aiua-10431	36	8	duration	duration	NOUN
aiua-10431	36	9	or	or	CCONJ
aiua-10431	36	10	severity	severity	NOUN
aiua-10431	36	11	of	of	ADP
aiua-10431	36	12	diabetes	diabetes	NOUN
aiua-10431	36	13	(	(	PUNCT
aiua-10431	36	14	2	2	NUM
aiua-10431	36	15	)	)	PUNCT
aiua-10431	36	16	.	.	PUNCT
aiua-10431	37	1	testosterone	testosterone	NOUN
aiua-10431	37	2	deficiency	deficiency	NOUN
aiua-10431	37	3	is	be	AUX
aiua-10431	37	4	associated	associate	VERB
aiua-10431	37	5	with	with	ADP
aiua-10431	37	6	many	many	ADJ
aiua-10431	37	7	testosterone	testosterone	NOUN
aiua-10431	37	8	deficiency	deficiency	NOUN
aiua-10431	37	9	in	in	ADP
aiua-10431	37	10	non	non	ADJ
aiua-10431	37	11	-	-	ADJ
aiua-10431	37	12	obese	obese	ADJ
aiua-10431	37	13	type	type	NOUN
aiua-10431	37	14	2	2	NUM
aiua-10431	37	15	diabetic	diabetic	ADJ
aiua-10431	37	16	male	male	ADJ
aiua-10431	37	17	patients	patient	NOUN
aiua-10431	37	18	sherihan	sherihan	ADV
aiua-10431	37	19	i.	i.	PROPN
aiua-10431	37	20	gouda	gouda	PROPN
aiua-10431	37	21	1	1	NUM
aiua-10431	37	22	,	,	PUNCT
aiua-10431	37	23	mohamed	mohamed	PROPN
aiua-10431	37	24	m.	m.	PROPN
aiua-10431	37	25	aboelnaga	aboelnaga	PROPN
aiua-10431	37	26	1	1	NUM
aiua-10431	37	27	,	,	PUNCT
aiua-10431	37	28	ahmed	ahmed	PROPN
aiua-10431	37	29	m.g	m.g	PROPN
aiua-10431	37	30	.	.	PROPN
aiua-10431	37	31	elbeltagy	elbeltagy	PROPN
aiua-10431	37	32	2	2	NUM
aiua-10431	37	33	,	,	PUNCT
aiua-10431	37	34	amro	amro	X
aiua-10431	37	35	elbaz	elbaz	PROPN
aiua-10431	37	36	1	1	NUM
aiua-10431	37	37	1	1	NUM
aiua-10431	37	38	endocrinology	endocrinology	NOUN
aiua-10431	37	39	and	and	CCONJ
aiua-10431	37	40	diabetes	diabetes	NOUN
aiua-10431	37	41	unit	unit	NOUN
aiua-10431	37	42	,	,	PUNCT
aiua-10431	37	43	faculty	faculty	NOUN
aiua-10431	37	44	of	of	ADP
aiua-10431	37	45	medicine	medicine	NOUN
aiua-10431	37	46	,	,	PUNCT
aiua-10431	37	47	mansoura	mansoura	PROPN
aiua-10431	37	48	university	university	NOUN
aiua-10431	37	49	,	,	PUNCT
aiua-10431	37	50	mansoura	mansoura	PROPN
aiua-10431	37	51	,	,	PUNCT
aiua-10431	37	52	egypt	egypt	PROPN
aiua-10431	37	53	;	;	PUNCT
aiua-10431	37	54	2	2	NUM
aiua-10431	37	55	clinical	clinical	ADJ
aiua-10431	37	56	pathology	pathology	NOUN
aiua-10431	37	57	department	department	NOUN
aiua-10431	37	58	,	,	PUNCT
aiua-10431	37	59	faculty	faculty	NOUN
aiua-10431	37	60	of	of	ADP
aiua-10431	37	61	medicine	medicine	NOUN
aiua-10431	37	62	,	,	PUNCT
aiua-10431	37	63	mansoura	mansoura	PROPN
aiua-10431	37	64	university	university	NOUN
aiua-10431	37	65	,	,	PUNCT
aiua-10431	37	66	mansoura	mansoura	PROPN
aiua-10431	37	67	,	,	PUNCT
aiua-10431	37	68	egypt	egypt	PROPN
aiua-10431	37	69	.	.	PUNCT
aiua-10431	38	1	doi	doi	PROPN
aiua-10431	38	2	:	:	PUNCT
aiua-10431	38	3	10.4081	10.4081	NUM
aiua-10431	38	4	/	/	SYM
aiua-10431	38	5	aiua.2022.4.464	aiua.2022.4.464	ADP
aiua-10431	38	6	summary	summary	NOUN
aiua-10431	38	7	465archivio	465archivio	PROPN
aiua-10431	38	8	italiano	italiano	NOUN
aiua-10431	38	9	di	di	NOUN
aiua-10431	38	10	urologia	urologia	PROPN
aiua-10431	38	11	e	e	PROPN
aiua-10431	38	12	andrologia	andrologia	PROPN
aiua-10431	38	13	2022	2022	NUM
aiua-10431	38	14	;	;	PUNCT
aiua-10431	38	15	94	94	NUM
aiua-10431	38	16	,	,	PUNCT
aiua-10431	38	17	4	4	NUM
aiua-10431	38	18	testosterone	testosterone	NOUN
aiua-10431	38	19	deficiency	deficiency	NOUN
aiua-10431	38	20	in	in	ADP
aiua-10431	38	21	non	non	ADJ
aiua-10431	38	22	-	-	ADJ
aiua-10431	38	23	obese	obese	ADJ
aiua-10431	38	24	type	type	NOUN
aiua-10431	38	25	2	2	NUM
aiua-10431	38	26	diabetic	diabetic	ADJ
aiua-10431	38	27	male	male	ADJ
aiua-10431	38	28	patients	patient	NOUN
aiua-10431	38	29	diabetes	diabete	NOUN
aiua-10431	38	30	;	;	PUNCT
aiua-10431	38	31	body	body	NOUN
aiua-10431	38	32	mass	mass	NOUN
aiua-10431	38	33	index	index	NOUN
aiua-10431	38	34	below	below	ADP
aiua-10431	38	35	30	30	NUM
aiua-10431	38	36	;	;	PUNCT
aiua-10431	38	37	history	history	NOUN
aiua-10431	38	38	of	of	ADP
aiua-10431	38	39	normal	normal	ADJ
aiua-10431	38	40	pubertal	pubertal	ADJ
aiua-10431	38	41	development	development	NOUN
aiua-10431	38	42	;	;	PUNCT
aiua-10431	38	43	a	a	DET
aiua-10431	38	44	normal	normal	ADJ
aiua-10431	38	45	sense	sense	NOUN
aiua-10431	38	46	of	of	ADP
aiua-10431	38	47	smell	smell	NOUN
aiua-10431	38	48	for	for	ADP
aiua-10431	38	49	exclusion	exclusion	NOUN
aiua-10431	38	50	of	of	ADP
aiua-10431	38	51	kallman	kallman	NOUN
aiua-10431	38	52	syndrome	syndrome	NOUN
aiua-10431	38	53	;	;	PUNCT
aiua-10431	38	54	age	age	NOUN
aiua-10431	38	55	between	between	ADP
aiua-10431	38	56	18	18	NUM
aiua-10431	38	57	and	and	CCONJ
aiua-10431	38	58	65	65	NUM
aiua-10431	38	59	.	.	PUNCT
aiua-10431	39	1	in	in	ADP
aiua-10431	39	2	contrast	contrast	NOUN
aiua-10431	39	3	,	,	PUNCT
aiua-10431	39	4	patients	patient	NOUN
aiua-10431	39	5	were	be	AUX
aiua-10431	39	6	excluded	exclude	VERB
aiua-10431	39	7	from	from	ADP
aiua-10431	39	8	this	this	DET
aiua-10431	39	9	study	study	NOUN
aiua-10431	39	10	in	in	ADP
aiua-10431	39	11	case	case	NOUN
aiua-10431	39	12	of	of	ADP
aiua-10431	39	13	:	:	PUNCT
aiua-10431	39	14	female	female	ADJ
aiua-10431	39	15	sex	sex	NOUN
aiua-10431	39	16	;	;	PUNCT
aiua-10431	39	17	abnormal	abnormal	ADJ
aiua-10431	39	18	renal	renal	ADJ
aiua-10431	39	19	function	function	NOUN
aiua-10431	39	20	;	;	PUNCT
aiua-10431	39	21	abnormal	abnormal	ADJ
aiua-10431	39	22	albumin	albumin	ADJ
aiua-10431	39	23	levels	level	NOUN
aiua-10431	39	24	;	;	PUNCT
aiua-10431	39	25	diabetes	diabete	NOUN
aiua-10431	39	26	with	with	ADP
aiua-10431	39	27	macro	macro	ADJ
aiua-10431	39	28	albuminuria	albuminuria	NOUN
aiua-10431	39	29	;	;	PUNCT
aiua-10431	39	30	liver	liver	NOUN
aiua-10431	39	31	disorders	disorder	NOUN
aiua-10431	39	32	;	;	PUNCT
aiua-10431	39	33	heart	heart	NOUN
aiua-10431	39	34	failure	failure	NOUN
aiua-10431	39	35	;	;	PUNCT
aiua-10431	39	36	usea	usea	NOUN
aiua-10431	39	37	of	of	ADP
aiua-10431	39	38	drugs	drug	NOUN
aiua-10431	39	39	that	that	PRON
aiua-10431	39	40	may	may	AUX
aiua-10431	39	41	affect	affect	VERB
aiua-10431	39	42	testosterone	testosterone	NOUN
aiua-10431	39	43	levels	level	NOUN
aiua-10431	39	44	,	,	PUNCT
aiua-10431	39	45	such	such	ADJ
aiua-10431	39	46	as	as	ADP
aiua-10431	39	47	replacement	replacement	NOUN
aiua-10431	39	48	therapy	therapy	NOUN
aiua-10431	39	49	and	and	CCONJ
aiua-10431	39	50	anabolic	anabolic	NOUN
aiua-10431	39	51	steroids	steroid	NOUN
aiua-10431	39	52	;	;	PUNCT
aiua-10431	39	53	patients	patient	NOUN
aiua-10431	39	54	with	with	ADP
aiua-10431	39	55	known	know	VERB
aiua-10431	39	56	causes	cause	NOUN
aiua-10431	39	57	of	of	ADP
aiua-10431	39	58	hypogonadism	hypogonadism	NOUN
aiua-10431	39	59	;	;	PUNCT
aiua-10431	39	60	history	history	NOUN
aiua-10431	39	61	of	of	ADP
aiua-10431	39	62	malignancy	malignancy	NOUN
aiua-10431	39	63	;	;	PUNCT
aiua-10431	39	64	autoimmune	autoimmune	ADJ
aiua-10431	39	65	diseases	disease	NOUN
aiua-10431	39	66	;	;	PUNCT
aiua-10431	39	67	diseases	disease	NOUN
aiua-10431	39	68	of	of	ADP
aiua-10431	39	69	the	the	DET
aiua-10431	39	70	endocrine	endocrine	ADJ
aiua-10431	39	71	system	system	NOUN
aiua-10431	39	72	other	other	ADJ
aiua-10431	39	73	than	than	ADP
aiua-10431	39	74	type	type	NOUN
aiua-10431	39	75	2	2	NUM
aiua-10431	39	76	dm	dm	NOUN
aiua-10431	39	77	,	,	PUNCT
aiua-10431	39	78	including	include	VERB
aiua-10431	39	79	type	type	NOUN
aiua-10431	39	80	1	1	NUM
aiua-10431	39	81	dm	dm	NOUN
aiua-10431	39	82	,	,	PUNCT
aiua-10431	39	83	pituitary	pituitary	ADJ
aiua-10431	39	84	disorders	disorder	NOUN
aiua-10431	39	85	,	,	PUNCT
aiua-10431	39	86	and	and	CCONJ
aiua-10431	39	87	abnormal	abnormal	ADJ
aiua-10431	39	88	thyroid	thyroid	NOUN
aiua-10431	39	89	functions	function	NOUN
aiua-10431	39	90	.	.	PUNCT
aiua-10431	40	1	all	all	DET
aiua-10431	40	2	patients	patient	NOUN
aiua-10431	40	3	were	be	AUX
aiua-10431	40	4	divided	divide	VERB
aiua-10431	40	5	into	into	ADP
aiua-10431	40	6	either	either	CCONJ
aiua-10431	40	7	a	a	DET
aiua-10431	40	8	low	low	ADJ
aiua-10431	40	9	testosterone	testosterone	NOUN
aiua-10431	40	10	group	group	NOUN
aiua-10431	40	11	(	(	PUNCT
aiua-10431	40	12	tt	tt	PROPN
aiua-10431	40	13	≤	≤	PROPN
aiua-10431	40	14	300	300	NUM
aiua-10431	40	15	ng	ng	PROPN
aiua-10431	40	16	/	/	SYM
aiua-10431	40	17	dl	dl	PROPN
aiua-10431	40	18	)	)	PUNCT
aiua-10431	40	19	or	or	CCONJ
aiua-10431	40	20	a	a	DET
aiua-10431	40	21	normal	normal	ADJ
aiua-10431	40	22	testosterone	testosterone	NOUN
aiua-10431	40	23	group	group	NOUN
aiua-10431	40	24	(	(	PUNCT
aiua-10431	40	25	tt	tt	PROPN
aiua-10431	40	26	>	>	PROPN
aiua-10431	40	27	300	300	NUM
aiua-10431	40	28	ng	ng	PROPN
aiua-10431	40	29	/	/	SYM
aiua-10431	40	30	dl	dl	PROPN
aiua-10431	40	31	)	)	PUNCT
aiua-10431	40	32	.	.	PUNCT
aiua-10431	41	1	clinical	clinical	ADJ
aiua-10431	41	2	assessment	assessment	NOUN
aiua-10431	41	3	and	and	CCONJ
aiua-10431	41	4	anthropometric	anthropometric	ADJ
aiua-10431	41	5	measurements	measurement	NOUN
aiua-10431	41	6	all	all	DET
aiua-10431	41	7	subjects	subject	NOUN
aiua-10431	41	8	underwent	undergo	VERB
aiua-10431	41	9	a	a	DET
aiua-10431	41	10	comprehensive	comprehensive	ADJ
aiua-10431	41	11	medical	medical	ADJ
aiua-10431	41	12	evaluation	evaluation	NOUN
aiua-10431	41	13	including	include	VERB
aiua-10431	41	14	medical	medical	ADJ
aiua-10431	41	15	history	history	NOUN
aiua-10431	41	16	with	with	ADP
aiua-10431	41	17	special	special	ADJ
aiua-10431	41	18	emphasis	emphasis	NOUN
aiua-10431	41	19	on	on	ADP
aiua-10431	41	20	diabetes	diabetes	NOUN
aiua-10431	41	21	duration	duration	NOUN
aiua-10431	41	22	,	,	PUNCT
aiua-10431	41	23	medication	medication	NOUN
aiua-10431	41	24	,	,	PUNCT
aiua-10431	41	25	smoking	smoking	NOUN
aiua-10431	41	26	history	history	NOUN
aiua-10431	41	27	,	,	PUNCT
aiua-10431	41	28	and	and	CCONJ
aiua-10431	41	29	diabetic	diabetic	ADJ
aiua-10431	41	30	complications	complication	NOUN
aiua-10431	41	31	history	history	NOUN
aiua-10431	41	32	;	;	PUNCT
aiua-10431	41	33	physical	physical	ADJ
aiua-10431	41	34	examination	examination	NOUN
aiua-10431	41	35	and	and	CCONJ
aiua-10431	41	36	measurement	measurement	NOUN
aiua-10431	41	37	of	of	ADP
aiua-10431	41	38	anthropometric	anthropometric	ADJ
aiua-10431	41	39	parameters	parameter	NOUN
aiua-10431	41	40	.	.	PUNCT
aiua-10431	42	1	the	the	DET
aiua-10431	42	2	patient	patient	NOUN
aiua-10431	42	3	's	's	PART
aiua-10431	42	4	height	height	NOUN
aiua-10431	42	5	and	and	CCONJ
aiua-10431	42	6	weight	weight	NOUN
aiua-10431	42	7	were	be	AUX
aiua-10431	42	8	measured	measure	VERB
aiua-10431	42	9	while	while	SCONJ
aiua-10431	42	10	they	they	PRON
aiua-10431	42	11	were	be	AUX
aiua-10431	42	12	dressed	dress	VERB
aiua-10431	42	13	casually	casually	ADV
aiua-10431	42	14	and	and	CCONJ
aiua-10431	42	15	were	be	AUX
aiua-10431	42	16	not	not	PART
aiua-10431	42	17	wearing	wear	VERB
aiua-10431	42	18	shoes	shoe	NOUN
aiua-10431	42	19	.	.	PUNCT
aiua-10431	43	1	bmi	bmi	PROPN
aiua-10431	43	2	was	be	AUX
aiua-10431	43	3	calculated	calculate	VERB
aiua-10431	43	4	by	by	ADP
aiua-10431	43	5	dividing	divide	VERB
aiua-10431	43	6	weight	weight	NOUN
aiua-10431	43	7	(	(	PUNCT
aiua-10431	43	8	kg	kg	NOUN
aiua-10431	43	9	)	)	PUNCT
aiua-10431	43	10	by	by	ADP
aiua-10431	43	11	height	height	PROPN
aiua-10431	43	12	square	square	PROPN
aiua-10431	43	13	(	(	PUNCT
aiua-10431	43	14	m2	m2	PROPN
aiua-10431	43	15	)	)	PUNCT
aiua-10431	43	16	.	.	PUNCT
aiua-10431	44	1	waist	waist	NOUN
aiua-10431	44	2	circumference	circumference	NOUN
aiua-10431	44	3	(	(	PUNCT
aiua-10431	44	4	wc	wc	PROPN
aiua-10431	44	5	)	)	PUNCT
aiua-10431	44	6	was	be	AUX
aiua-10431	44	7	measured	measure	VERB
aiua-10431	44	8	halfway	halfway	ADV
aiua-10431	44	9	between	between	ADP
aiua-10431	44	10	the	the	DET
aiua-10431	44	11	inferior	inferior	ADJ
aiua-10431	44	12	border	border	NOUN
aiua-10431	44	13	of	of	ADP
aiua-10431	44	14	the	the	DET
aiua-10431	44	15	last	last	ADJ
aiua-10431	44	16	rib	rib	NOUN
aiua-10431	44	17	and	and	CCONJ
aiua-10431	44	18	the	the	DET
aiua-10431	44	19	crest	crest	NOUN
aiua-10431	44	20	of	of	ADP
aiua-10431	44	21	the	the	DET
aiua-10431	44	22	ilium	ilium	NOUN
aiua-10431	44	23	at	at	ADP
aiua-10431	44	24	the	the	DET
aiua-10431	44	25	end	end	NOUN
aiua-10431	44	26	of	of	ADP
aiua-10431	44	27	expiration	expiration	NOUN
aiua-10431	44	28	.	.	PUNCT
aiua-10431	45	1	following	follow	VERB
aiua-10431	45	2	standard	standard	ADJ
aiua-10431	45	3	procedure	procedure	NOUN
aiua-10431	45	4	,	,	PUNCT
aiua-10431	45	5	blood	blood	NOUN
aiua-10431	45	6	pressure	pressure	NOUN
aiua-10431	45	7	was	be	AUX
aiua-10431	45	8	measured	measure	VERB
aiua-10431	45	9	with	with	ADP
aiua-10431	45	10	a	a	DET
aiua-10431	45	11	sphygmomanometer	sphygmomanometer	NOUN
aiua-10431	45	12	.	.	PUNCT
aiua-10431	46	1	vai	vai	PROPN
aiua-10431	46	2	was	be	AUX
aiua-10431	46	3	calculated	calculate	VERB
aiua-10431	46	4	for	for	ADP
aiua-10431	46	5	all	all	DET
aiua-10431	46	6	participants	participant	NOUN
aiua-10431	46	7	using	use	VERB
aiua-10431	46	8	the	the	DET
aiua-10431	46	9	following	follow	VERB
aiua-10431	46	10	formula	formula	NOUN
aiua-10431	46	11	for	for	ADP
aiua-10431	46	12	males	male	NOUN
aiua-10431	46	13	(	(	PUNCT
aiua-10431	46	14	12	12	NUM
aiua-10431	46	15	):	):	PUNCT
aiua-10431	46	16	vai	vai	NOUN
aiua-10431	46	17	:	:	PUNCT
aiua-10431	46	18	wc	wc	PROPN
aiua-10431	46	19	/	/	PUNCT
aiua-10431	47	1	[	[	X
aiua-10431	47	2	39:68	39:68	NUM
aiua-10431	47	3	+	+	CCONJ
aiua-10431	47	4	(	(	PUNCT
aiua-10431	47	5	1.88	1.88	NUM
aiua-10431	47	6	×	×	NOUN
aiua-10431	47	7	bmi	bmi	NOUN
aiua-10431	47	8	)	)	PUNCT
aiua-10431	47	9	]	]	PUNCT
aiua-10431	48	1	×	×	NOUN
aiua-10431	48	2	tg/1:03	tg/1:03	PROPN
aiua-10431	48	3	×	×	NOUN
aiua-10431	48	4	1:31	1:31	NUM
aiua-10431	48	5	/	/	SYM
aiua-10431	48	6	hdl	hdl	PROPN
aiua-10431	48	7	.	.	PUNCT
aiua-10431	49	1	biochemical	biochemical	ADJ
aiua-10431	49	2	parameters	parameter	NOUN
aiua-10431	49	3	after	after	ADP
aiua-10431	49	4	a	a	DET
aiua-10431	49	5	12	12	NUM
aiua-10431	49	6	-	-	PUNCT
aiua-10431	49	7	hour	hour	NOUN
aiua-10431	49	8	overnight	overnight	ADV
aiua-10431	49	9	fast	fast	ADV
aiua-10431	49	10	,	,	PUNCT
aiua-10431	49	11	venous	venous	ADJ
aiua-10431	49	12	blood	blood	NOUN
aiua-10431	49	13	samples	sample	NOUN
aiua-10431	49	14	were	be	AUX
aiua-10431	49	15	collected	collect	VERB
aiua-10431	49	16	from	from	ADP
aiua-10431	49	17	all	all	DET
aiua-10431	49	18	patients	patient	NOUN
aiua-10431	49	19	between	between	ADP
aiua-10431	49	20	8	8	NUM
aiua-10431	49	21	a.m.	a.m.	NOUN
aiua-10431	49	22	and	and	CCONJ
aiua-10431	49	23	10	10	NUM
aiua-10431	49	24	a.m.	a.m.	NOUN
aiua-10431	49	25	including	include	VERB
aiua-10431	49	26	:	:	PUNCT
aiua-10431	49	27	complete	complete	ADJ
aiua-10431	49	28	blood	blood	NOUN
aiua-10431	49	29	count	count	NOUN
aiua-10431	49	30	(	(	PUNCT
aiua-10431	49	31	cbc	cbc	PROPN
aiua-10431	49	32	)	)	PUNCT
aiua-10431	49	33	,	,	PUNCT
aiua-10431	49	34	fasting	fast	VERB
aiua-10431	49	35	lipid	lipid	NOUN
aiua-10431	49	36	profile	profile	NOUN
aiua-10431	49	37	that	that	PRON
aiua-10431	49	38	included	include	VERB
aiua-10431	49	39	triglycerides	triglyceride	NOUN
aiua-10431	49	40	(	(	PUNCT
aiua-10431	49	41	tg	tg	NOUN
aiua-10431	49	42	)	)	PUNCT
aiua-10431	49	43	,	,	PUNCT
aiua-10431	49	44	total	total	ADJ
aiua-10431	49	45	cholesterol	cholesterol	NOUN
aiua-10431	49	46	(	(	PUNCT
aiua-10431	49	47	tc	tc	NOUN
aiua-10431	49	48	)	)	PUNCT
aiua-10431	49	49	,	,	PUNCT
aiua-10431	49	50	low	low	ADJ
aiua-10431	49	51	-	-	PUNCT
aiua-10431	49	52	density	density	NOUN
aiua-10431	49	53	lipoprotein	lipoprotein	ADJ
aiua-10431	49	54	(	(	PUNCT
aiua-10431	49	55	ldl	ldl	NOUN
aiua-10431	49	56	)	)	PUNCT
aiua-10431	49	57	,	,	PUNCT
aiua-10431	49	58	and	and	CCONJ
aiua-10431	49	59	high	high	ADJ
aiua-10431	49	60	-	-	PUNCT
aiua-10431	49	61	density	density	NOUN
aiua-10431	49	62	lipoprotein	lipoprotein	ADJ
aiua-10431	49	63	(	(	PUNCT
aiua-10431	49	64	hdl	hdl	PROPN
aiua-10431	49	65	)	)	PUNCT
aiua-10431	49	66	;	;	PUNCT
aiua-10431	49	67	serum	serum	NOUN
aiua-10431	49	68	creatinine	creatinine	NOUN
aiua-10431	49	69	;	;	PUNCT
aiua-10431	49	70	glycosylated	glycosylated	ADJ
aiua-10431	49	71	haemoglobin	haemoglobin	NOUN
aiua-10431	49	72	(	(	PUNCT
aiua-10431	49	73	hba1c	hba1c	PROPN
aiua-10431	49	74	)	)	PUNCT
aiua-10431	49	75	;	;	PUNCT
aiua-10431	49	76	fasting	fast	VERB
aiua-10431	49	77	blood	blood	NOUN
aiua-10431	49	78	sugar	sugar	NOUN
aiua-10431	49	79	;	;	PUNCT
aiua-10431	49	80	albumin	albumin	NOUN
aiua-10431	49	81	;	;	PUNCT
aiua-10431	49	82	luteinizing	luteinize	VERB
aiua-10431	49	83	hormone	hormone	NOUN
aiua-10431	49	84	(	(	PUNCT
aiua-10431	49	85	lh	lh	PROPN
aiua-10431	49	86	)	)	PUNCT
aiua-10431	49	87	;	;	PUNCT
aiua-10431	49	88	serum	serum	NOUN
aiua-10431	49	89	total	total	ADJ
aiua-10431	49	90	testosterone	testosterone	NOUN
aiua-10431	49	91	.	.	PUNCT
aiua-10431	50	1	ldl	ldl	NOUN
aiua-10431	50	2	-	-	PUNCT
aiua-10431	50	3	cholesterol	cholesterol	NOUN
aiua-10431	50	4	was	be	AUX
aiua-10431	50	5	estimated	estimate	VERB
aiua-10431	50	6	according	accord	VERB
aiua-10431	50	7	to	to	ADP
aiua-10431	50	8	the	the	DET
aiua-10431	50	9	friedewald	friedewald	ADJ
aiua-10431	50	10	formula	formula	NOUN
aiua-10431	50	11	(	(	PUNCT
aiua-10431	50	12	tc	tc	NOUN
aiua-10431	50	13	minus	minus	CCONJ
aiua-10431	50	14	hdl	hdl	PROPN
aiua-10431	50	15	-	-	PUNCT
aiua-10431	50	16	cholesterol	cholesterol	PROPN
aiua-10431	50	17	minus	minus	CCONJ
aiua-10431	50	18	tgs/5	tgs/5	PROPN
aiua-10431	50	19	in	in	ADP
aiua-10431	50	20	mg	mg	PROPN
aiua-10431	50	21	/	/	SYM
aiua-10431	50	22	dl	dl	PROPN
aiua-10431	50	23	)	)	PUNCT
aiua-10431	50	24	.	.	PUNCT
aiua-10431	51	1	visceral	visceral	ADJ
aiua-10431	51	2	adiposity	adiposity	NOUN
aiua-10431	51	3	index	index	NOUN
aiua-10431	51	4	(	(	PUNCT
aiua-10431	51	5	vai	vai	NOUN
aiua-10431	51	6	)	)	PUNCT
aiua-10431	51	7	was	be	AUX
aiua-10431	51	8	calculated	calculate	VERB
aiua-10431	51	9	for	for	ADP
aiua-10431	51	10	women	woman	NOUN
aiua-10431	51	11	and	and	CCONJ
aiua-10431	51	12	men	man	NOUN
aiua-10431	51	13	according	accord	VERB
aiua-10431	51	14	to	to	ADP
aiua-10431	51	15	the	the	DET
aiua-10431	51	16	formulas	formula	NOUN
aiua-10431	51	17	.	.	PUNCT
aiua-10431	52	1	definition	definition	NOUN
aiua-10431	52	2	diabetes	diabetes	NOUN
aiua-10431	52	3	was	be	AUX
aiua-10431	52	4	defined	define	VERB
aiua-10431	52	5	as	as	ADP
aiua-10431	52	6	a	a	DET
aiua-10431	52	7	fasting	fast	VERB
aiua-10431	52	8	plasma	plasma	NOUN
aiua-10431	52	9	glucose	glucose	NOUN
aiua-10431	52	10	of	of	ADP
aiua-10431	52	11	100	100	NUM
aiua-10431	52	12	mg	mg	PROPN
aiua-10431	52	13	/	/	SYM
aiua-10431	52	14	dl	dl	PROPN
aiua-10431	52	15	or	or	CCONJ
aiua-10431	52	16	higher	high	ADJ
aiua-10431	52	17	,	,	PUNCT
aiua-10431	52	18	hba1c	hba1c	PROPN
aiua-10431	52	19	of	of	ADP
aiua-10431	52	20	6.5	6.5	NUM
aiua-10431	52	21	%	%	NOUN
aiua-10431	52	22	or	or	CCONJ
aiua-10431	52	23	higher	high	ADJ
aiua-10431	52	24	,	,	PUNCT
aiua-10431	52	25	or	or	CCONJ
aiua-10431	52	26	a	a	DET
aiua-10431	52	27	previous	previous	ADJ
aiua-10431	52	28	diagnosis	diagnosis	NOUN
aiua-10431	52	29	of	of	ADP
aiua-10431	52	30	type	type	NOUN
aiua-10431	52	31	2	2	NUM
aiua-10431	52	32	diabetes	diabetes	NOUN
aiua-10431	52	33	.	.	PUNCT
aiua-10431	53	1	hypertension	hypertension	NOUN
aiua-10431	53	2	was	be	AUX
aiua-10431	53	3	defined	define	VERB
aiua-10431	53	4	as	as	ADP
aiua-10431	53	5	systolic	systolic	ADJ
aiua-10431	53	6	blood	blood	NOUN
aiua-10431	53	7	pressure	pressure	NOUN
aiua-10431	53	8	≥	≥	NOUN
aiua-10431	53	9	140	140	NUM
aiua-10431	53	10	mmhg	mmhg	NOUN
aiua-10431	53	11	,	,	PUNCT
aiua-10431	53	12	diastolic	diastolic	ADJ
aiua-10431	53	13	blood	blood	NOUN
aiua-10431	53	14	pressure	pressure	NOUN
aiua-10431	53	15	≥	≥	NOUN
aiua-10431	53	16	90	90	NUM
aiua-10431	53	17	mmhg	mmhg	NOUN
aiua-10431	53	18	,	,	PUNCT
aiua-10431	53	19	current	current	ADJ
aiua-10431	53	20	use	use	NOUN
aiua-10431	53	21	of	of	ADP
aiua-10431	53	22	the	the	DET
aiua-10431	53	23	antihypertensive	antihypertensive	ADJ
aiua-10431	53	24	drug	drug	NOUN
aiua-10431	53	25	.	.	PUNCT
aiua-10431	54	1	overweight	overweight	PROPN
aiua-10431	54	2	was	be	AUX
aiua-10431	54	3	defined	define	VERB
aiua-10431	54	4	by	by	ADP
aiua-10431	54	5	a	a	DET
aiua-10431	54	6	body	body	NOUN
aiua-10431	54	7	mass	mass	NOUN
aiua-10431	54	8	index	index	NOUN
aiua-10431	54	9	of	of	ADP
aiua-10431	54	10	at	at	ADV
aiua-10431	54	11	least	least	ADV
aiua-10431	54	12	25	25	NUM
aiua-10431	54	13	kg	kg	NOUN
aiua-10431	54	14	/	/	SYM
aiua-10431	54	15	m2	m2	PROPN
aiua-10431	54	16	.	.	PUNCT
aiua-10431	54	17	testosterone	testosterone	NOUN
aiua-10431	54	18	deficiency	deficiency	NOUN
aiua-10431	54	19	was	be	AUX
aiua-10431	54	20	defined	define	VERB
aiua-10431	54	21	as	as	ADP
aiua-10431	54	22	serum	serum	NOUN
aiua-10431	54	23	tt	tt	PROPN
aiua-10431	54	24	less	less	ADJ
aiua-10431	54	25	than	than	ADP
aiua-10431	54	26	300	300	NUM
aiua-10431	54	27	ng	ng	PROPN
aiua-10431	54	28	/	/	SYM
aiua-10431	54	29	dl	dl	PROPN
aiua-10431	55	1	that	that	PRON
aiua-10431	55	2	is	be	AUX
aiua-10431	55	3	the	the	DET
aiua-10431	55	4	lower	low	ADJ
aiua-10431	55	5	limit	limit	NOUN
aiua-10431	55	6	of	of	ADP
aiua-10431	55	7	the	the	DET
aiua-10431	55	8	normal	normal	ADJ
aiua-10431	55	9	range	range	NOUN
aiua-10431	55	10	according	accord	VERB
aiua-10431	55	11	to	to	ADP
aiua-10431	55	12	the	the	DET
aiua-10431	55	13	american	american	PROPN
aiua-10431	55	14	urological	urological	PROPN
aiua-10431	55	15	association	association	PROPN
aiua-10431	55	16	guidelines	guideline	NOUN
aiua-10431	55	17	(	(	PUNCT
aiua-10431	55	18	13	13	NUM
aiua-10431	55	19	)	)	PUNCT
aiua-10431	55	20	.	.	PUNCT
aiua-10431	56	1	lh	lh	PROPN
aiua-10431	56	2	level	level	NOUN
aiua-10431	56	3	above	above	ADP
aiua-10431	56	4	9.4	9.4	NUM
aiua-10431	56	5	iu	iu	NOUN
aiua-10431	56	6	/	/	SYM
aiua-10431	56	7	l	l	NOUN
aiua-10431	56	8	was	be	AUX
aiua-10431	56	9	defined	define	VERB
aiua-10431	56	10	as	as	ADP
aiua-10431	56	11	hypergonadotropic	hypergonadotropic	NOUN
aiua-10431	56	12	hypogonadism	hypogonadism	NOUN
aiua-10431	56	13	,	,	PUNCT
aiua-10431	56	14	while	while	SCONJ
aiua-10431	56	15	lh	lh	PROPN
aiua-10431	56	16	levels	level	NOUN
aiua-10431	56	17	below	below	ADP
aiua-10431	56	18	9.4	9.4	NUM
aiua-10431	56	19	iu	iu	NOUN
aiua-10431	56	20	/	/	SYM
aiua-10431	56	21	l	l	NOUN
aiua-10431	56	22	were	be	AUX
aiua-10431	56	23	defined	define	VERB
aiua-10431	56	24	as	as	ADP
aiua-10431	56	25	hypogonadotropic	hypogonadotropic	ADJ
aiua-10431	56	26	hypogonadism	hypogonadism	NOUN
aiua-10431	56	27	(	(	PUNCT
aiua-10431	56	28	14	14	NUM
aiua-10431	56	29	)	)	PUNCT
aiua-10431	56	30	.	.	PUNCT
aiua-10431	57	1	statistical	statistical	ADJ
aiua-10431	57	2	analysis	analysis	NOUN
aiua-10431	57	3	the	the	DET
aiua-10431	57	4	statistical	statistical	ADJ
aiua-10431	57	5	package	package	NOUN
aiua-10431	57	6	for	for	ADP
aiua-10431	57	7	the	the	DET
aiua-10431	57	8	social	social	ADJ
aiua-10431	57	9	sciences	sciences	PROPN
aiua-10431	57	10	(	(	PUNCT
aiua-10431	57	11	spss	spss	PROPN
aiua-10431	57	12	)	)	PUNCT
aiua-10431	57	13	,	,	PUNCT
aiua-10431	57	14	version	version	NOUN
aiua-10431	57	15	23	23	NUM
aiua-10431	57	16	was	be	AUX
aiua-10431	57	17	used	use	VERB
aiua-10431	57	18	to	to	PART
aiua-10431	57	19	analyze	analyze	VERB
aiua-10431	57	20	the	the	DET
aiua-10431	57	21	statistical	statistical	ADJ
aiua-10431	57	22	data	datum	NOUN
aiua-10431	57	23	.	.	PUNCT
aiua-10431	58	1	continuous	continuous	ADJ
aiua-10431	58	2	variables	variable	NOUN
aiua-10431	58	3	were	be	AUX
aiua-10431	58	4	presented	present	VERB
aiua-10431	58	5	as	as	ADP
aiua-10431	58	6	the	the	DET
aiua-10431	58	7	mean	mean	ADJ
aiua-10431	58	8	±standard	±standard	ADJ
aiua-10431	58	9	deviation	deviation	NOUN
aiua-10431	58	10	,	,	PUNCT
aiua-10431	58	11	and	and	CCONJ
aiua-10431	58	12	categorical	categorical	ADJ
aiua-10431	58	13	variables	variable	NOUN
aiua-10431	58	14	were	be	AUX
aiua-10431	58	15	expressed	express	VERB
aiua-10431	58	16	as	as	ADP
aiua-10431	58	17	a	a	DET
aiua-10431	58	18	proportion	proportion	NOUN
aiua-10431	58	19	(	(	PUNCT
aiua-10431	58	20	%	%	INTJ
aiua-10431	58	21	)	)	PUNCT
aiua-10431	58	22	whereas	whereas	SCONJ
aiua-10431	58	23	non	non	ADJ
aiua-10431	58	24	-	-	ADJ
aiua-10431	58	25	normally	normally	ADV
aiua-10431	58	26	distributed	distribute	VERB
aiua-10431	58	27	data	datum	NOUN
aiua-10431	58	28	are	be	AUX
aiua-10431	58	29	expressed	express	VERB
aiua-10431	58	30	as	as	ADP
aiua-10431	58	31	the	the	DET
aiua-10431	58	32	median	median	NOUN
aiua-10431	58	33	(	(	PUNCT
aiua-10431	58	34	interquartile	interquartile	NOUN
aiua-10431	58	35	range	range	NOUN
aiua-10431	58	36	)	)	PUNCT
aiua-10431	58	37	.	.	PUNCT
aiua-10431	59	1	differences	difference	NOUN
aiua-10431	59	2	between	between	ADP
aiua-10431	59	3	groups	group	NOUN
aiua-10431	59	4	of	of	ADP
aiua-10431	59	5	patients	patient	NOUN
aiua-10431	59	6	were	be	AUX
aiua-10431	59	7	compared	compare	VERB
aiua-10431	59	8	by	by	ADP
aiua-10431	59	9	the	the	DET
aiua-10431	59	10	mann	mann	PROPN
aiua-10431	59	11	-	-	PUNCT
aiua-10431	59	12	whitney	whitney	PROPN
aiua-10431	59	13	u	u	NOUN
aiua-10431	59	14	or	or	CCONJ
aiua-10431	59	15	student	student	NOUN
aiua-10431	59	16	t	t	PROPN
aiua-10431	59	17	-	-	PUNCT
aiua-10431	59	18	test	test	NOUN
aiua-10431	59	19	for	for	ADP
aiua-10431	59	20	continuous	continuous	ADJ
aiua-10431	59	21	variables	variable	NOUN
aiua-10431	59	22	and	and	CCONJ
aiua-10431	59	23	the	the	DET
aiua-10431	59	24	chi	chi	ADJ
aiua-10431	59	25	-	-	PUNCT
aiua-10431	59	26	square	square	ADJ
aiua-10431	59	27	test	test	NOUN
aiua-10431	59	28	for	for	ADP
aiua-10431	59	29	categorical	categorical	ADJ
aiua-10431	59	30	variables	variable	NOUN
aiua-10431	59	31	.	.	PUNCT
aiua-10431	60	1	the	the	DET
aiua-10431	60	2	relationship	relationship	NOUN
aiua-10431	60	3	between	between	ADP
aiua-10431	60	4	testosterone	testosterone	NOUN
aiua-10431	60	5	(	(	PUNCT
aiua-10431	60	6	the	the	DET
aiua-10431	60	7	dependent	dependent	ADJ
aiua-10431	60	8	variable	variable	NOUN
aiua-10431	60	9	)	)	PUNCT
aiua-10431	60	10	and	and	CCONJ
aiua-10431	60	11	other	other	ADJ
aiua-10431	60	12	statistically	statistically	ADV
aiua-10431	60	13	significant	significant	ADJ
aiua-10431	60	14	correlated	correlate	VERB
aiua-10431	60	15	parameters	parameter	NOUN
aiua-10431	60	16	in	in	ADP
aiua-10431	60	17	pearson	pearson	PROPN
aiua-10431	60	18	correlation	correlation	NOUN
aiua-10431	60	19	(	(	PUNCT
aiua-10431	60	20	the	the	DET
aiua-10431	60	21	independent	independent	ADJ
aiua-10431	60	22	variables	variable	NOUN
aiua-10431	60	23	)	)	PUNCT
aiua-10431	60	24	was	be	AUX
aiua-10431	60	25	investigated	investigate	VERB
aiua-10431	60	26	using	use	VERB
aiua-10431	60	27	linear	linear	PROPN
aiua-10431	60	28	regression	regression	NOUN
aiua-10431	60	29	.	.	PUNCT
aiua-10431	61	1	the	the	DET
aiua-10431	61	2	risk	risk	NOUN
aiua-10431	61	3	factors	factor	NOUN
aiua-10431	61	4	associated	associate	VERB
aiua-10431	61	5	with	with	ADP
aiua-10431	61	6	testosterone	testosterone	NOUN
aiua-10431	61	7	deficiency	deficiency	NOUN
aiua-10431	61	8	were	be	AUX
aiua-10431	61	9	assessed	assess	VERB
aiua-10431	61	10	using	use	VERB
aiua-10431	61	11	binary	binary	ADJ
aiua-10431	61	12	logistic	logistic	ADJ
aiua-10431	61	13	regression	regression	NOUN
aiua-10431	61	14	,	,	PUNCT
aiua-10431	61	15	and	and	CCONJ
aiua-10431	61	16	the	the	DET
aiua-10431	61	17	odds	odd	NOUN
aiua-10431	61	18	ratio	ratio	NOUN
aiua-10431	61	19	(	(	PUNCT
aiua-10431	61	20	or	or	CCONJ
aiua-10431	61	21	)	)	PUNCT
aiua-10431	61	22	and	and	CCONJ
aiua-10431	61	23	95	95	NUM
aiua-10431	61	24	per	per	ADP
aiua-10431	61	25	cent	cent	NOUN
aiua-10431	61	26	confidence	confidence	NOUN
aiua-10431	61	27	interval	interval	NOUN
aiua-10431	61	28	(	(	PUNCT
aiua-10431	61	29	ci	ci	NOUN
aiua-10431	61	30	)	)	PUNCT
aiua-10431	61	31	were	be	AUX
aiua-10431	61	32	calculated	calculate	VERB
aiua-10431	61	33	.	.	PUNCT
aiua-10431	62	1	p	p	NOUN
aiua-10431	62	2	values	value	NOUN
aiua-10431	62	3	less	less	ADJ
aiua-10431	62	4	than	than	ADP
aiua-10431	62	5	0.05	0.05	NUM
aiua-10431	62	6	were	be	AUX
aiua-10431	62	7	considered	consider	VERB
aiua-10431	62	8	statistically	statistically	ADV
aiua-10431	62	9	significant	significant	ADJ
aiua-10431	62	10	.	.	PUNCT
aiua-10431	63	1	results	result	NOUN
aiua-10431	63	2	we	we	PRON
aiua-10431	63	3	enrolled	enrol	VERB
aiua-10431	63	4	ninety	ninety	NUM
aiua-10431	63	5	-	-	PUNCT
aiua-10431	63	6	six	six	NUM
aiua-10431	63	7	non	non	ADJ
aiua-10431	63	8	-	-	ADJ
aiua-10431	63	9	obese	obese	ADJ
aiua-10431	63	10	patients	patient	NOUN
aiua-10431	63	11	with	with	ADP
aiua-10431	63	12	type	type	NOUN
aiua-10431	63	13	2	2	NUM
aiua-10431	63	14	dm	dm	NOUN
aiua-10431	63	15	in	in	ADP
aiua-10431	63	16	this	this	DET
aiua-10431	63	17	cross	cross	ADJ
aiua-10431	63	18	-	-	ADJ
aiua-10431	63	19	sectional	sectional	ADJ
aiua-10431	63	20	study	study	NOUN
aiua-10431	63	21	.	.	PUNCT
aiua-10431	64	1	among	among	ADP
aiua-10431	64	2	those	those	DET
aiua-10431	64	3	diabetic	diabetic	ADJ
aiua-10431	64	4	patients	patient	NOUN
aiua-10431	64	5	,	,	PUNCT
aiua-10431	64	6	27	27	NUM
aiua-10431	64	7	(	(	PUNCT
aiua-10431	64	8	28.4	28.4	NUM
aiua-10431	64	9	%	%	NOUN
aiua-10431	64	10	)	)	PUNCT
aiua-10431	64	11	were	be	AUX
aiua-10431	64	12	of	of	ADP
aiua-10431	64	13	normal	normal	ADJ
aiua-10431	64	14	weight	weight	NOUN
aiua-10431	64	15	,	,	PUNCT
aiua-10431	64	16	while	while	SCONJ
aiua-10431	64	17	68	68	NUM
aiua-10431	64	18	(	(	PUNCT
aiua-10431	64	19	71.6	71.6	NUM
aiua-10431	64	20	%	%	NOUN
aiua-10431	64	21	)	)	PUNCT
aiua-10431	64	22	were	be	AUX
aiua-10431	64	23	overweight	overweight	ADJ
aiua-10431	64	24	.	.	PUNCT
aiua-10431	65	1	their	their	PRON
aiua-10431	65	2	age	age	NOUN
aiua-10431	65	3	ranged	range	VERB
aiua-10431	65	4	between	between	ADP
aiua-10431	65	5	34	34	NUM
aiua-10431	65	6	and	and	CCONJ
aiua-10431	65	7	65	65	NUM
aiua-10431	65	8	years	year	NOUN
aiua-10431	65	9	.	.	PUNCT
aiua-10431	66	1	we	we	PRON
aiua-10431	66	2	observed	observe	VERB
aiua-10431	66	3	that	that	SCONJ
aiua-10431	66	4	the	the	DET
aiua-10431	66	5	prevalence	prevalence	NOUN
aiua-10431	66	6	of	of	ADP
aiua-10431	66	7	testosterone	testosterone	NOUN
aiua-10431	66	8	deficiency	deficiency	NOUN
aiua-10431	66	9	was	be	AUX
aiua-10431	66	10	29.1	29.1	NUM
aiua-10431	66	11	%	%	NOUN
aiua-10431	66	12	(	(	PUNCT
aiua-10431	66	13	28	28	NUM
aiua-10431	66	14	patients	patient	NOUN
aiua-10431	66	15	)	)	PUNCT
aiua-10431	66	16	.	.	PUNCT
aiua-10431	67	1	we	we	PRON
aiua-10431	67	2	observed	observe	VERB
aiua-10431	67	3	high	high	ADJ
aiua-10431	67	4	abnormal	abnormal	ADJ
aiua-10431	67	5	level	level	NOUN
aiua-10431	67	6	of	of	ADP
aiua-10431	67	7	lh	lh	PROPN
aiua-10431	67	8	in	in	ADP
aiua-10431	67	9	14	14	NUM
aiua-10431	67	10	patients	patient	NOUN
aiua-10431	67	11	with	with	ADP
aiua-10431	67	12	low	low	ADJ
aiua-10431	67	13	testosterone	testosterone	NOUN
aiua-10431	67	14	levels	level	NOUN
aiua-10431	67	15	.	.	PUNCT
aiua-10431	68	1	the	the	DET
aiua-10431	68	2	prevalence	prevalence	NOUN
aiua-10431	68	3	of	of	ADP
aiua-10431	68	4	hypergonadotropic	hypergonadotropic	NOUN
aiua-10431	68	5	hypogonadism	hypogonadism	NOUN
aiua-10431	68	6	was	be	AUX
aiua-10431	68	7	50	50	NUM
aiua-10431	68	8	%	%	NOUN
aiua-10431	68	9	of	of	ADP
aiua-10431	68	10	testosterone	testosterone	NOUN
aiua-10431	68	11	deficient	deficient	ADJ
aiua-10431	68	12	patients	patient	NOUN
aiua-10431	68	13	.	.	PUNCT
aiua-10431	69	1	other	other	ADJ
aiua-10431	69	2	clinical	clinical	ADJ
aiua-10431	69	3	,	,	PUNCT
aiua-10431	69	4	anthropometric	anthropometric	ADJ
aiua-10431	69	5	,	,	PUNCT
aiua-10431	69	6	and	and	CCONJ
aiua-10431	69	7	laboratory	laboratory	NOUN
aiua-10431	69	8	details	detail	NOUN
aiua-10431	69	9	of	of	ADP
aiua-10431	69	10	the	the	DET
aiua-10431	69	11	patient	patient	NOUN
aiua-10431	69	12	were	be	AUX
aiua-10431	69	13	presented	present	VERB
aiua-10431	69	14	in	in	ADP
aiua-10431	69	15	table	table	NOUN
aiua-10431	69	16	1	1	NUM
aiua-10431	69	17	.	.	PUNCT
aiua-10431	69	18	table	table	NOUN
aiua-10431	69	19	1	1	NUM
aiua-10431	69	20	.	.	PUNCT
aiua-10431	69	21	general	general	ADJ
aiua-10431	69	22	characteristics	characteristic	NOUN
aiua-10431	69	23	of	of	ADP
aiua-10431	69	24	the	the	DET
aiua-10431	69	25	study	study	NOUN
aiua-10431	69	26	population	population	NOUN
aiua-10431	69	27	.	.	PUNCT
aiua-10431	70	1	n	n	NOUN
aiua-10431	70	2	=	=	SYM
aiua-10431	70	3	96	96	NUM
aiua-10431	70	4	age	age	NOUN
aiua-10431	70	5	(	(	PUNCT
aiua-10431	70	6	year	year	NOUN
aiua-10431	70	7	)	)	PUNCT
aiua-10431	70	8	51.41	51.41	NUM
aiua-10431	70	9	±	±	NUM
aiua-10431	70	10	7.17	7.17	NUM
aiua-10431	70	11	diabetic	diabetic	NOUN
aiua-10431	70	12	duration(year	duration(year	PROPN
aiua-10431	70	13	)	)	PUNCT
aiua-10431	70	14	9.59	9.59	NUM
aiua-10431	70	15	±	±	NUM
aiua-10431	70	16	4.18	4.18	NUM
aiua-10431	70	17	smoker	smoker	NOUN
aiua-10431	70	18	ratio	ratio	NOUN
aiua-10431	70	19	66	66	NUM
aiua-10431	70	20	(	(	PUNCT
aiua-10431	70	21	47.1	47.1	NUM
aiua-10431	70	22	%	%	NOUN
aiua-10431	70	23	)	)	PUNCT
aiua-10431	70	24	insulin	insulin	NOUN
aiua-10431	70	25	therapy	therapy	NOUN
aiua-10431	70	26	52	52	NUM
aiua-10431	70	27	(	(	PUNCT
aiua-10431	70	28	37.1	37.1	NUM
aiua-10431	70	29	%	%	NOUN
aiua-10431	70	30	)	)	PUNCT
aiua-10431	70	31	body	body	NOUN
aiua-10431	70	32	weight	weight	NOUN
aiua-10431	70	33	(	(	PUNCT
aiua-10431	70	34	kg	kg	NOUN
aiua-10431	70	35	)	)	PUNCT
aiua-10431	70	36	86.69	86.69	NUM
aiua-10431	70	37	±	±	NUM
aiua-10431	70	38	7.96	7.96	NUM
aiua-10431	70	39	height	height	NOUN
aiua-10431	70	40	(	(	PUNCT
aiua-10431	70	41	m	m	NOUN
aiua-10431	70	42	)	)	PUNCT
aiua-10431	70	43	1.78	1.78	NUM
aiua-10431	70	44	±	±	NOUN
aiua-10431	70	45	.058	.058	NUM
aiua-10431	70	46	bmi	bmi	PROPN
aiua-10431	70	47	(	(	PUNCT
aiua-10431	70	48	kg	kg	NOUN
aiua-10431	70	49	/	/	SYM
aiua-10431	70	50	m2	m2	PROPN
aiua-10431	70	51	)	)	PUNCT
aiua-10431	70	52	28.245	28.245	NUM
aiua-10431	70	53	(	(	PUNCT
aiua-10431	70	54	3.05	3.05	NUM
aiua-10431	70	55	)	)	PUNCT
aiua-10431	70	56	waist	waist	NOUN
aiua-10431	70	57	circumference(cm	circumference(cm	NOUN
aiua-10431	70	58	)	)	PUNCT
aiua-10431	70	59	99.48	99.48	NUM
aiua-10431	70	60	±	±	NUM
aiua-10431	70	61	9.68	9.68	NUM
aiua-10431	70	62	systolic	systolic	ADJ
aiua-10431	70	63	bp	bp	PROPN
aiua-10431	70	64	(	(	PUNCT
aiua-10431	70	65	mmhg	mmhg	PROPN
aiua-10431	70	66	)	)	PUNCT
aiua-10431	70	67	135.00	135.00	NUM
aiua-10431	70	68	(	(	PUNCT
aiua-10431	70	69	15	15	NUM
aiua-10431	70	70	)	)	PUNCT
aiua-10431	70	71	diastolic	diastolic	ADJ
aiua-10431	70	72	bp	bp	PROPN
aiua-10431	70	73	(	(	PUNCT
aiua-10431	70	74	mmhg	mmhg	PROPN
aiua-10431	70	75	)	)	PUNCT
aiua-10431	70	76	85.00	85.00	NUM
aiua-10431	70	77	(	(	PUNCT
aiua-10431	70	78	15	15	NUM
aiua-10431	70	79	)	)	PUNCT
aiua-10431	70	80	total	total	ADJ
aiua-10431	70	81	cholesterol	cholesterol	NOUN
aiua-10431	70	82	mg	mg	PROPN
aiua-10431	70	83	/	/	SYM
aiua-10431	70	84	dl	dl	PROPN
aiua-10431	70	85	248.54	248.54	NUM
aiua-10431	70	86	±	±	NUM
aiua-10431	70	87	43.29	43.29	NUM
aiua-10431	70	88	ldl	ldl	PROPN
aiua-10431	70	89	-	-	PUNCT
aiua-10431	70	90	c	c	NOUN
aiua-10431	70	91	mg	mg	PROPN
aiua-10431	70	92	/	/	SYM
aiua-10431	70	93	dl	dl	PROPN
aiua-10431	71	1	155.88	155.88	NUM
aiua-10431	71	2	±	±	NUM
aiua-10431	71	3	47.98	47.98	NUM
aiua-10431	71	4	hdl	hdl	PROPN
aiua-10431	71	5	-	-	PUNCT
aiua-10431	71	6	c	c	NOUN
aiua-10431	71	7	mg	mg	PROPN
aiua-10431	71	8	/	/	SYM
aiua-10431	71	9	dl	dl	PROPN
aiua-10431	71	10	43.83	43.83	NUM
aiua-10431	71	11	±	±	NUM
aiua-10431	71	12	6.85	6.85	NUM
aiua-10431	71	13	triglycerides	triglyceride	NOUN
aiua-10431	71	14	mg	mg	PROPN
aiua-10431	71	15	/	/	SYM
aiua-10431	71	16	dl	dl	PROPN
aiua-10431	71	17	244.14±74.48	244.14±74.48	NUM
aiua-10431	71	18	uacr	uacr	NOUN
aiua-10431	71	19	mg	mg	PROPN
aiua-10431	71	20	/	/	SYM
aiua-10431	71	21	gm	gm	PROPN
aiua-10431	71	22	28	28	NUM
aiua-10431	71	23	(	(	PUNCT
aiua-10431	71	24	62	62	NUM
aiua-10431	71	25	)	)	PUNCT
aiua-10431	71	26	retinopathy	retinopathy	ADJ
aiua-10431	71	27	29	29	NUM
aiua-10431	71	28	(	(	PUNCT
aiua-10431	71	29	30.2	30.2	NUM
aiua-10431	71	30	%	%	NOUN
aiua-10431	71	31	)	)	PUNCT
aiua-10431	72	1	hba1c	hba1c	NOUN
aiua-10431	72	2	%	%	NOUN
aiua-10431	72	3	8.5	8.5	NUM
aiua-10431	72	4	±	±	NUM
aiua-10431	72	5	1.613	1.613	NUM
aiua-10431	72	6	total	total	ADJ
aiua-10431	72	7	testosterone	testosterone	NOUN
aiua-10431	72	8	ng	ng	PROPN
aiua-10431	72	9	/	/	SYM
aiua-10431	72	10	dl	dl	PROPN
aiua-10431	72	11	405.71	405.71	NUM
aiua-10431	72	12	±	±	NUM
aiua-10431	72	13	133.78	133.78	NUM
aiua-10431	72	14	testosterone	testosterone	NOUN
aiua-10431	72	15	deficiency	deficiency	NOUN
aiua-10431	72	16	28	28	NUM
aiua-10431	72	17	(	(	PUNCT
aiua-10431	72	18	29.1	29.1	NUM
aiua-10431	72	19	%	%	NOUN
aiua-10431	72	20	)	)	PUNCT
aiua-10431	72	21	lh	lh	PROPN
aiua-10431	72	22	miu	miu	PROPN
aiua-10431	72	23	/	/	SYM
aiua-10431	72	24	l	l	PROPN
aiua-10431	72	25	7.44	7.44	NUM
aiua-10431	72	26	±	±	NUM
aiua-10431	72	27	2.67	2.67	NUM
aiua-10431	72	28	vai	vai	NOUN
aiua-10431	72	29	3.25	3.25	NUM
aiua-10431	72	30	(	(	PUNCT
aiua-10431	72	31	1.58	1.58	NUM
aiua-10431	72	32	)	)	PUNCT
aiua-10431	72	33	data	datum	NOUN
aiua-10431	72	34	expressed	express	VERB
aiua-10431	72	35	as	as	ADP
aiua-10431	72	36	mean	mean	NOUN
aiua-10431	72	37	(	(	PUNCT
aiua-10431	72	38	interquartile	interquartile	NOUN
aiua-10431	72	39	range	range	NOUN
aiua-10431	72	40	)	)	PUNCT
aiua-10431	72	41	according	accord	VERB
aiua-10431	72	42	normality	normality	NOUN
aiua-10431	72	43	of	of	ADP
aiua-10431	72	44	distribution	distribution	NOUN
aiua-10431	72	45	,	,	PUNCT
aiua-10431	72	46	data	datum	NOUN
aiua-10431	72	47	expressed	express	VERB
aiua-10431	72	48	as	as	ADP
aiua-10431	72	49	mean	mean	NOUN
aiua-10431	72	50	±	±	NUM
aiua-10431	72	51	standard	standard	ADJ
aiua-10431	72	52	deviation	deviation	NOUN
aiua-10431	72	53	or	or	CCONJ
aiua-10431	72	54	data	datum	NOUN
aiua-10431	72	55	expressed	express	VERB
aiua-10431	72	56	in	in	ADP
aiua-10431	72	57	parenthesis	parenthesis	NOUN
aiua-10431	72	58	are	be	AUX
aiua-10431	72	59	percentage	percentage	NOUN
aiua-10431	72	60	.	.	PUNCT
aiua-10431	73	1	bm	bm	PROPN
aiua-10431	73	2	:	:	PUNCT
aiua-10431	73	3	body	body	NOUN
aiua-10431	73	4	mass	mass	PROPN
aiua-10431	73	5	index	index	NOUN
aiua-10431	73	6	;	;	PUNCT
aiua-10431	73	7	wc	wc	PROPN
aiua-10431	73	8	:	:	PUNCT
aiua-10431	73	9	waist	waist	NOUN
aiua-10431	73	10	circumference	circumference	NOUN
aiua-10431	73	11	;	;	PUNCT
aiua-10431	73	12	sbp	sbp	NOUN
aiua-10431	73	13	:	:	PUNCT
aiua-10431	73	14	systolic	systolic	ADJ
aiua-10431	73	15	blood	blood	NOUN
aiua-10431	73	16	pressure	pressure	NOUN
aiua-10431	73	17	;	;	PUNCT
aiua-10431	73	18	dbp	dbp	PROPN
aiua-10431	73	19	:	:	PUNCT
aiua-10431	73	20	diastolic	diastolic	ADJ
aiua-10431	73	21	blood	blood	NOUN
aiua-10431	73	22	pressure	pressure	NOUN
aiua-10431	73	23	;	;	PUNCT
aiua-10431	73	24	ldl	ldl	NOUN
aiua-10431	73	25	:	:	PUNCT
aiua-10431	73	26	low	low	ADJ
aiua-10431	73	27	-	-	PUNCT
aiua-10431	73	28	density	density	NOUN
aiua-10431	73	29	lipoprotein	lipoprotein	NOUN
aiua-10431	73	30	;	;	PUNCT
aiua-10431	73	31	hdl	hdl	NOUN
aiua-10431	73	32	:	:	PUNCT
aiua-10431	73	33	high	high	ADJ
aiua-10431	73	34	-	-	PUNCT
aiua-10431	73	35	density	density	NOUN
aiua-10431	73	36	lipoprotein	lipoprotein	NOUN
aiua-10431	73	37	;	;	PUNCT
aiua-10431	73	38	uacr	uacr	ADJ
aiua-10431	73	39	:	:	PUNCT
aiua-10431	73	40	urinary	urinary	ADJ
aiua-10431	73	41	albumin	albumin	ADJ
aiua-10431	73	42	creatinine	creatinine	NOUN
aiua-10431	73	43	ratio	ratio	NOUN
aiua-10431	73	44	;	;	PUNCT
aiua-10431	73	45	hba1c	hba1c	PROPN
aiua-10431	73	46	:	:	PUNCT
aiua-10431	73	47	glycated	glycate	VERB
aiua-10431	73	48	hemoglobin	hemoglobin	NOUN
aiua-10431	73	49	;	;	PUNCT
aiua-10431	73	50	lh	lh	PROPN
aiua-10431	73	51	:	:	PUNCT
aiua-10431	73	52	luteinizing	luteinize	VERB
aiua-10431	73	53	hormone	hormone	NOUN
aiua-10431	73	54	;	;	PUNCT
aiua-10431	73	55	vai	vai	ADJ
aiua-10431	73	56	:	:	PUNCT
aiua-10431	73	57	visceral	visceral	ADJ
aiua-10431	73	58	adiposity	adiposity	NOUN
aiua-10431	73	59	index	index	NOUN
aiua-10431	73	60	.	.	PUNCT
aiua-10431	74	1	archivio	archivio	NOUN
aiua-10431	74	2	italiano	italiano	PROPN
aiua-10431	74	3	di	di	PROPN
aiua-10431	74	4	urologia	urologia	PROPN
aiua-10431	74	5	e	e	PROPN
aiua-10431	74	6	andrologia	andrologia	PROPN
aiua-10431	74	7	2022	2022	NUM
aiua-10431	74	8	;	;	PUNCT
aiua-10431	74	9	94	94	NUM
aiua-10431	74	10	,	,	PUNCT
aiua-10431	74	11	4	4	NUM
aiua-10431	74	12	s.i	s.i	PROPN
aiua-10431	74	13	.	.	PROPN
aiua-10431	74	14	gouda	gouda	PROPN
aiua-10431	74	15	,	,	PUNCT
aiua-10431	74	16	m.m	m.m	PROPN
aiua-10431	74	17	.	.	PROPN
aiua-10431	74	18	aboelnaga	aboelnaga	PROPN
aiua-10431	74	19	,	,	PUNCT
aiua-10431	74	20	a.m.g	a.m.g	NOUN
aiua-10431	74	21	.	.	PUNCT
aiua-10431	74	22	elbeltagy	elbeltagy	NOUN
aiua-10431	74	23	,	,	PUNCT
aiua-10431	74	24	a.	a.	PROPN
aiua-10431	74	25	elbaz	elbaz	PROPN
aiua-10431	74	26	466	466	NUM
aiua-10431	74	27	in	in	ADP
aiua-10431	74	28	the	the	DET
aiua-10431	74	29	comparison	comparison	NOUN
aiua-10431	74	30	between	between	ADP
aiua-10431	74	31	28	28	NUM
aiua-10431	74	32	patients	patient	NOUN
aiua-10431	74	33	in	in	ADP
aiua-10431	74	34	the	the	DET
aiua-10431	74	35	low	low	ADJ
aiua-10431	74	36	testosterone	testosterone	NOUN
aiua-10431	74	37	group	group	NOUN
aiua-10431	74	38	(	(	PUNCT
aiua-10431	74	39	tt	tt	PROPN
aiua-10431	74	40	≤	≤	PROPN
aiua-10431	74	41	300	300	NUM
aiua-10431	74	42	ng	ng	PROPN
aiua-10431	74	43	/	/	SYM
aiua-10431	74	44	dl	dl	PROPN
aiua-10431	74	45	)	)	PUNCT
aiua-10431	74	46	and	and	CCONJ
aiua-10431	74	47	68	68	NUM
aiua-10431	74	48	patients	patient	NOUN
aiua-10431	74	49	in	in	ADP
aiua-10431	74	50	the	the	DET
aiua-10431	74	51	normal	normal	ADJ
aiua-10431	74	52	testosterone	testosterone	NOUN
aiua-10431	74	53	group	group	NOUN
aiua-10431	74	54	(	(	PUNCT
aiua-10431	74	55	tt	tt	PROPN
aiua-10431	74	56	>	>	PROPN
aiua-10431	74	57	300	300	NUM
aiua-10431	74	58	ng	ng	PROPN
aiua-10431	74	59	/	/	SYM
aiua-10431	74	60	dl	dl	PROPN
aiua-10431	74	61	)	)	PUNCT
aiua-10431	74	62	,	,	PUNCT
aiua-10431	74	63	we	we	PRON
aiua-10431	74	64	found	find	VERB
aiua-10431	74	65	that	that	SCONJ
aiua-10431	74	66	the	the	DET
aiua-10431	74	67	low	low	ADJ
aiua-10431	74	68	testosterone	testosterone	NOUN
aiua-10431	74	69	group	group	NOUN
aiua-10431	74	70	had	have	VERB
aiua-10431	74	71	a	a	DET
aiua-10431	74	72	statistically	statistically	ADV
aiua-10431	74	73	significant	significant	ADJ
aiua-10431	74	74	higher	high	ADJ
aiua-10431	74	75	mean	mean	NOUN
aiua-10431	74	76	or	or	CCONJ
aiua-10431	74	77	median	median	NOUN
aiua-10431	74	78	of	of	ADP
aiua-10431	74	79	vai	vai	PROPN
aiua-10431	74	80	,	,	PUNCT
aiua-10431	74	81	wc	wc	NOUN
aiua-10431	74	82	,	,	PUNCT
aiua-10431	74	83	and	and	CCONJ
aiua-10431	74	84	triglyceride	triglyceride	ADP
aiua-10431	74	85	in	in	ADP
aiua-10431	74	86	comparison	comparison	NOUN
aiua-10431	74	87	with	with	ADP
aiua-10431	74	88	normal	normal	ADJ
aiua-10431	74	89	testosterone	testosterone	NOUN
aiua-10431	74	90	group	group	NOUN
aiua-10431	74	91	.	.	PUNCT
aiua-10431	75	1	moreover	moreover	ADV
aiua-10431	75	2	,	,	PUNCT
aiua-10431	75	3	a	a	DET
aiua-10431	75	4	higher	high	ADJ
aiua-10431	75	5	percentage	percentage	NOUN
aiua-10431	75	6	of	of	ADP
aiua-10431	75	7	patients	patient	NOUN
aiua-10431	75	8	complicated	complicate	VERB
aiua-10431	75	9	with	with	ADP
aiua-10431	75	10	retinopathy	retinopathy	ADJ
aiua-10431	75	11	was	be	AUX
aiua-10431	75	12	observed	observe	VERB
aiua-10431	75	13	in	in	ADP
aiua-10431	75	14	low	low	ADJ
aiua-10431	75	15	testosterone	testosterone	NOUN
aiua-10431	75	16	groups	group	NOUN
aiua-10431	75	17	.	.	PUNCT
aiua-10431	76	1	other	other	ADJ
aiua-10431	76	2	differences	difference	NOUN
aiua-10431	76	3	between	between	ADP
aiua-10431	76	4	the	the	DET
aiua-10431	76	5	two	two	NUM
aiua-10431	76	6	groups	group	NOUN
aiua-10431	76	7	were	be	AUX
aiua-10431	76	8	shown	show	VERB
aiua-10431	76	9	in	in	ADP
aiua-10431	76	10	table	table	NOUN
aiua-10431	76	11	2	2	NUM
aiua-10431	76	12	.	.	PUNCT
aiua-10431	77	1	according	accord	VERB
aiua-10431	77	2	to	to	ADP
aiua-10431	77	3	pearson	pearson	PROPN
aiua-10431	77	4	correlations	correlation	NOUN
aiua-10431	77	5	,	,	PUNCT
aiua-10431	77	6	tt	tt	PROPN
aiua-10431	77	7	was	be	AUX
aiua-10431	77	8	negatively	negatively	ADV
aiua-10431	77	9	correlated	correlate	VERB
aiua-10431	77	10	with	with	ADP
aiua-10431	77	11	vai	vai	PROPN
aiua-10431	77	12	(	(	PUNCT
aiua-10431	77	13	log	log	PROPN
aiua-10431	77	14	)	)	PUNCT
aiua-10431	77	15	,	,	PUNCT
aiua-10431	77	16	wc	wc	PROPN
aiua-10431	77	17	,	,	PUNCT
aiua-10431	77	18	bmi	bmi	PROPN
aiua-10431	77	19	(	(	PUNCT
aiua-10431	77	20	log	log	NOUN
aiua-10431	77	21	)	)	PUNCT
aiua-10431	77	22	,	,	PUNCT
aiua-10431	77	23	and	and	CCONJ
aiua-10431	77	24	lh	lh	PROPN
aiua-10431	77	25	.	.	PUNCT
aiua-10431	78	1	on	on	ADP
aiua-10431	78	2	the	the	DET
aiua-10431	78	3	other	other	ADJ
aiua-10431	78	4	hand	hand	NOUN
aiua-10431	78	5	,	,	PUNCT
aiua-10431	78	6	tt	tt	PROPN
aiua-10431	78	7	was	be	AUX
aiua-10431	78	8	positively	positively	ADV
aiua-10431	78	9	correlated	correlate	VERB
aiua-10431	78	10	to	to	ADP
aiua-10431	78	11	age	age	NOUN
aiua-10431	78	12	.	.	PUNCT
aiua-10431	79	1	however	however	ADV
aiua-10431	79	2	,	,	PUNCT
aiua-10431	79	3	tt	tt	PROPN
aiua-10431	79	4	was	be	AUX
aiua-10431	79	5	not	not	PART
aiua-10431	79	6	correlated	correlate	VERB
aiua-10431	79	7	with	with	ADP
aiua-10431	79	8	duration	duration	NOUN
aiua-10431	79	9	of	of	ADP
aiua-10431	79	10	diabetes	diabetes	NOUN
aiua-10431	79	11	,	,	PUNCT
aiua-10431	79	12	hba1c	hba1c	PROPN
aiua-10431	79	13	,	,	PUNCT
aiua-10431	79	14	or	or	CCONJ
aiua-10431	79	15	lipid	lipid	NOUN
aiua-10431	79	16	parameters	parameter	NOUN
aiua-10431	79	17	.	.	PUNCT
aiua-10431	80	1	we	we	PRON
aiua-10431	80	2	conducted	conduct	VERB
aiua-10431	80	3	a	a	DET
aiua-10431	80	4	regression	regression	NOUN
aiua-10431	80	5	analysis	analysis	NOUN
aiua-10431	80	6	to	to	PART
aiua-10431	80	7	determine	determine	VERB
aiua-10431	80	8	predictors	predictor	NOUN
aiua-10431	80	9	of	of	ADP
aiua-10431	80	10	total	total	ADJ
aiua-10431	80	11	testosterone	testosterone	NOUN
aiua-10431	80	12	levels	level	NOUN
aiua-10431	80	13	as	as	ADP
aiua-10431	80	14	the	the	DET
aiua-10431	80	15	dependent	dependent	ADJ
aiua-10431	80	16	variable	variable	NOUN
aiua-10431	80	17	and	and	CCONJ
aiua-10431	80	18	age	age	NOUN
aiua-10431	80	19	,	,	PUNCT
aiua-10431	80	20	bmi	bmi	NOUN
aiua-10431	80	21	(	(	PUNCT
aiua-10431	80	22	log	log	PROPN
aiua-10431	80	23	)	)	PUNCT
aiua-10431	80	24	,	,	PUNCT
aiua-10431	80	25	lh	lh	PROPN
aiua-10431	80	26	,	,	PUNCT
aiua-10431	80	27	and	and	CCONJ
aiua-10431	80	28	vai	vai	INTJ
aiua-10431	80	29	(	(	PUNCT
aiua-10431	80	30	log	log	NOUN
aiua-10431	80	31	)	)	PUNCT
aiua-10431	80	32	as	as	ADP
aiua-10431	80	33	the	the	DET
aiua-10431	80	34	independent	independent	ADJ
aiua-10431	80	35	variables	variable	NOUN
aiua-10431	80	36	in	in	ADP
aiua-10431	80	37	our	our	PRON
aiua-10431	80	38	study	study	NOUN
aiua-10431	80	39	patients	patient	NOUN
aiua-10431	80	40	.	.	PUNCT
aiua-10431	81	1	we	we	PRON
aiua-10431	81	2	observed	observe	VERB
aiua-10431	81	3	that	that	SCONJ
aiua-10431	81	4	vai	vai	PROPN
aiua-10431	81	5	was	be	AUX
aiua-10431	81	6	the	the	DET
aiua-10431	81	7	only	only	ADJ
aiua-10431	81	8	significant	significant	ADJ
aiua-10431	81	9	predictor	predictor	NOUN
aiua-10431	81	10	of	of	ADP
aiua-10431	81	11	tt	tt	PROPN
aiua-10431	81	12	levels	level	NOUN
aiua-10431	81	13	(	(	PUNCT
aiua-10431	81	14	p	p	NOUN
aiua-10431	81	15	-	-	PUNCT
aiua-10431	81	16	value	value	NOUN
aiua-10431	81	17	=	=	NOUN
aiua-10431	81	18	0.41	0.41	NUM
aiua-10431	81	19	)	)	PUNCT
aiua-10431	81	20	.	.	PUNCT
aiua-10431	82	1	furthermore	furthermore	ADV
aiua-10431	82	2	,	,	PUNCT
aiua-10431	82	3	vai	vai	PROPN
aiua-10431	82	4	was	be	AUX
aiua-10431	82	5	a	a	DET
aiua-10431	82	6	statistically	statistically	ADV
aiua-10431	82	7	significant	significant	ADJ
aiua-10431	82	8	predictor	predictor	NOUN
aiua-10431	82	9	of	of	ADP
aiua-10431	82	10	tt	tt	PROPN
aiua-10431	82	11	levels	level	NOUN
aiua-10431	82	12	even	even	ADV
aiua-10431	82	13	after	after	ADP
aiua-10431	82	14	adjustment	adjustment	NOUN
aiua-10431	82	15	for	for	ADP
aiua-10431	82	16	age	age	NOUN
aiua-10431	82	17	and	and	CCONJ
aiua-10431	82	18	bmi	bmi	NOUN
aiua-10431	82	19	as	as	SCONJ
aiua-10431	82	20	shown	show	VERB
aiua-10431	82	21	in	in	ADP
aiua-10431	82	22	tables	table	NOUN
aiua-10431	82	23	3	3	NUM
aiua-10431	82	24	,	,	PUNCT
aiua-10431	82	25	4	4	NUM
aiua-10431	82	26	.	.	PUNCT
aiua-10431	83	1	the	the	DET
aiua-10431	83	2	binary	binary	PROPN
aiua-10431	83	3	logistic	logistic	PROPN
aiua-10431	83	4	regression	regression	NOUN
aiua-10431	83	5	was	be	AUX
aiua-10431	83	6	performed	perform	VERB
aiua-10431	83	7	with	with	ADP
aiua-10431	83	8	hypogonadism	hypogonadism	NOUN
aiua-10431	83	9	as	as	ADP
aiua-10431	83	10	the	the	DET
aiua-10431	83	11	dependent	dependent	ADJ
aiua-10431	83	12	variable	variable	NOUN
aiua-10431	83	13	and	and	CCONJ
aiua-10431	83	14	age	age	NOUN
aiua-10431	83	15	,	,	PUNCT
aiua-10431	83	16	overweight	overweight	ADJ
aiua-10431	83	17	(	(	PUNCT
aiua-10431	83	18	defined	define	VERB
aiua-10431	83	19	by	by	ADP
aiua-10431	83	20	bmi	bmi	NOUN
aiua-10431	83	21	more	more	ADJ
aiua-10431	83	22	than	than	ADP
aiua-10431	83	23	30	30	NUM
aiua-10431	83	24	)	)	PUNCT
aiua-10431	83	25	,	,	PUNCT
aiua-10431	83	26	wc	wc	PROPN
aiua-10431	83	27	,	,	PUNCT
aiua-10431	83	28	lh	lh	PROPN
aiua-10431	83	29	,	,	PUNCT
aiua-10431	83	30	retinopathy	retinopathy	ADJ
aiua-10431	83	31	,	,	PUNCT
aiua-10431	83	32	and	and	CCONJ
aiua-10431	83	33	vai	vai	INTJ
aiua-10431	83	34	(	(	PUNCT
aiua-10431	83	35	log	log	NOUN
aiua-10431	83	36	)	)	PUNCT
aiua-10431	83	37	as	as	ADP
aiua-10431	83	38	the	the	DET
aiua-10431	83	39	independent	independent	ADJ
aiua-10431	83	40	variables	variable	NOUN
aiua-10431	83	41	.	.	PUNCT
aiua-10431	84	1	we	we	PRON
aiua-10431	84	2	observed	observe	VERB
aiua-10431	84	3	that	that	SCONJ
aiua-10431	84	4	the	the	DET
aiua-10431	84	5	visceral	visceral	ADJ
aiua-10431	84	6	adiposity	adiposity	NOUN
aiua-10431	84	7	index	index	NOUN
aiua-10431	84	8	was	be	AUX
aiua-10431	84	9	a	a	DET
aiua-10431	84	10	statistically	statistically	ADV
aiua-10431	84	11	significant	significant	ADJ
aiua-10431	84	12	risk	risk	NOUN
aiua-10431	84	13	factor	factor	NOUN
aiua-10431	84	14	for	for	ADP
aiua-10431	84	15	testosterone	testosterone	NOUN
aiua-10431	84	16	deficiency	deficiency	NOUN
aiua-10431	84	17	among	among	ADP
aiua-10431	84	18	nonobese	nonobese	ADJ
aiua-10431	84	19	type	type	NOUN
aiua-10431	84	20	2	2	NUM
aiua-10431	84	21	diabetic	diabetic	ADJ
aiua-10431	84	22	males	male	NOUN
aiua-10431	84	23	(	(	PUNCT
aiua-10431	84	24	p	p	NOUN
aiua-10431	84	25	-	-	PUNCT
aiua-10431	84	26	value	value	NOUN
aiua-10431	84	27	=	=	NOUN
aiua-10431	84	28	0.46	0.46	NUM
aiua-10431	84	29	)	)	PUNCT
aiua-10431	84	30	.	.	PUNCT
aiua-10431	85	1	more	more	ADJ
aiua-10431	85	2	data	datum	NOUN
aiua-10431	85	3	are	be	AUX
aiua-10431	85	4	available	available	ADJ
aiua-10431	85	5	in	in	ADP
aiua-10431	85	6	table	table	NOUN
aiua-10431	85	7	5	5	NUM
aiua-10431	85	8	.	.	PUNCT
aiua-10431	86	1	discussion	discussion	NOUN
aiua-10431	86	2	despite	despite	SCONJ
aiua-10431	86	3	the	the	DET
aiua-10431	86	4	high	high	ADJ
aiua-10431	86	5	prevalence	prevalence	NOUN
aiua-10431	86	6	of	of	ADP
aiua-10431	86	7	male	male	ADJ
aiua-10431	86	8	hypogonadism	hypogonadism	NOUN
aiua-10431	86	9	in	in	ADP
aiua-10431	86	10	type	type	NOUN
aiua-10431	86	11	2	2	NUM
aiua-10431	86	12	diabetic	diabetic	NOUN
aiua-10431	86	13	,	,	PUNCT
aiua-10431	86	14	regardless	regardless	ADV
aiua-10431	86	15	of	of	ADP
aiua-10431	86	16	diabetic	diabetic	ADJ
aiua-10431	86	17	control	control	NOUN
aiua-10431	86	18	status	status	NOUN
aiua-10431	86	19	,	,	PUNCT
aiua-10431	86	20	the	the	DET
aiua-10431	86	21	underlying	underlying	ADJ
aiua-10431	86	22	mechanisms	mechanism	NOUN
aiua-10431	86	23	of	of	ADP
aiua-10431	86	24	hypogonadism	hypogonadism	NOUN
aiua-10431	86	25	pathogenesis	pathogenesis	NOUN
aiua-10431	86	26	in	in	ADP
aiua-10431	86	27	type	type	NOUN
aiua-10431	86	28	2	2	NUM
aiua-10431	86	29	diabetes	diabetes	NOUN
aiua-10431	86	30	mellitus	mellitus	NOUN
aiua-10431	86	31	have	have	AUX
aiua-10431	86	32	not	not	PART
aiua-10431	86	33	been	be	AUX
aiua-10431	86	34	fully	fully	ADV
aiua-10431	86	35	clarified	clarify	VERB
aiua-10431	86	36	yet	yet	ADV
aiua-10431	86	37	(	(	PUNCT
aiua-10431	86	38	15	15	NUM
aiua-10431	86	39	)	)	PUNCT
aiua-10431	86	40	.	.	PUNCT
aiua-10431	87	1	in	in	ADP
aiua-10431	87	2	the	the	DET
aiua-10431	87	3	same	same	ADJ
aiua-10431	87	4	consent	consent	NOUN
aiua-10431	87	5	,	,	PUNCT
aiua-10431	87	6	the	the	DET
aiua-10431	87	7	contribution	contribution	NOUN
aiua-10431	87	8	of	of	ADP
aiua-10431	87	9	the	the	DET
aiua-10431	87	10	diabetic	diabetic	ADJ
aiua-10431	87	11	status	status	NOUN
aiua-10431	87	12	or	or	CCONJ
aiua-10431	87	13	hyperglycaemia	hyperglycaemia	NOUN
aiua-10431	87	14	on	on	ADP
aiua-10431	87	15	androgen	androgen	NOUN
aiua-10431	87	16	levels	level	NOUN
aiua-10431	87	17	in	in	ADP
aiua-10431	87	18	males	male	NOUN
aiua-10431	87	19	is	be	AUX
aiua-10431	87	20	still	still	ADV
aiua-10431	87	21	debated	debate	VERB
aiua-10431	87	22	.	.	PUNCT
aiua-10431	88	1	the	the	DET
aiua-10431	88	2	strong	strong	ADJ
aiua-10431	88	3	association	association	NOUN
aiua-10431	88	4	between	between	ADP
aiua-10431	88	5	type	type	NOUN
aiua-10431	88	6	2	2	NUM
aiua-10431	88	7	diabetes	diabetes	NOUN
aiua-10431	88	8	with	with	ADP
aiua-10431	88	9	obesity	obesity	NOUN
aiua-10431	88	10	,	,	PUNCT
aiua-10431	88	11	insulin	insulin	NOUN
aiua-10431	88	12	resistance	resistance	NOUN
aiua-10431	88	13	status	status	NOUN
aiua-10431	88	14	,	,	PUNCT
aiua-10431	88	15	and	and	CCONJ
aiua-10431	88	16	aging	aging	NOUN
aiua-10431	88	17	may	may	AUX
aiua-10431	88	18	be	be	AUX
aiua-10431	88	19	the	the	DET
aiua-10431	88	20	significant	significant	ADJ
aiua-10431	88	21	contributory	contributory	NOUN
aiua-10431	88	22	factor	factor	NOUN
aiua-10431	88	23	in	in	ADP
aiua-10431	88	24	testosterone	testosterone	NOUN
aiua-10431	88	25	deficiency	deficiency	NOUN
aiua-10431	88	26	in	in	ADP
aiua-10431	88	27	type	type	NOUN
aiua-10431	88	28	2	2	NUM
aiua-10431	88	29	dm	dm	NOUN
aiua-10431	88	30	patients	patient	NOUN
aiua-10431	88	31	rather	rather	ADV
aiua-10431	88	32	than	than	ADP
aiua-10431	88	33	diabetes	diabetes	VERB
aiua-10431	88	34	itself	itself	PRON
aiua-10431	88	35	(	(	PUNCT
aiua-10431	88	36	16	16	NUM
aiua-10431	88	37	)	)	PUNCT
aiua-10431	88	38	.	.	PUNCT
aiua-10431	89	1	the	the	DET
aiua-10431	89	2	main	main	ADJ
aiua-10431	89	3	result	result	NOUN
aiua-10431	89	4	in	in	ADP
aiua-10431	89	5	this	this	DET
aiua-10431	89	6	cross	cross	ADJ
aiua-10431	89	7	-	-	ADJ
aiua-10431	89	8	sectional	sectional	ADJ
aiua-10431	89	9	study	study	NOUN
aiua-10431	89	10	is	be	AUX
aiua-10431	89	11	that	that	SCONJ
aiua-10431	89	12	visceral	visceral	ADJ
aiua-10431	89	13	adiposity	adiposity	NOUN
aiua-10431	89	14	functional	functional	ADJ
aiua-10431	89	15	activity	activity	NOUN
aiua-10431	89	16	evaluated	evaluate	VERB
aiua-10431	89	17	by	by	ADP
aiua-10431	89	18	vai	vai	PROPN
aiua-10431	89	19	is	be	AUX
aiua-10431	89	20	the	the	DET
aiua-10431	89	21	main	main	ADJ
aiua-10431	89	22	risk	risk	NOUN
aiua-10431	89	23	factor	factor	NOUN
aiua-10431	89	24	in	in	ADP
aiua-10431	89	25	type	type	NOUN
aiua-10431	89	26	2	2	NUM
aiua-10431	89	27	diabetic	diabetic	ADJ
aiua-10431	89	28	males	male	NOUN
aiua-10431	89	29	with	with	ADP
aiua-10431	89	30	bmi	bmi	NOUN
aiua-10431	89	31	below	below	ADP
aiua-10431	89	32	30	30	NUM
aiua-10431	89	33	.	.	PUNCT
aiua-10431	90	1	moreover	moreover	ADV
aiua-10431	90	2	,	,	PUNCT
aiua-10431	90	3	vai	vai	PROPN
aiua-10431	90	4	was	be	AUX
aiua-10431	90	5	the	the	DET
aiua-10431	90	6	only	only	ADJ
aiua-10431	90	7	predictor	predictor	NOUN
aiua-10431	90	8	for	for	ADP
aiua-10431	90	9	testosterone	testosterone	NOUN
aiua-10431	90	10	levels	level	NOUN
aiua-10431	90	11	in	in	ADP
aiua-10431	90	12	non	non	ADJ
aiua-10431	90	13	-	-	ADJ
aiua-10431	90	14	obese	obese	ADJ
aiua-10431	90	15	type	type	NOUN
aiua-10431	90	16	2	2	NUM
aiua-10431	90	17	diabetic	diabetic	ADJ
aiua-10431	90	18	males	male	NOUN
aiua-10431	90	19	even	even	ADV
aiua-10431	90	20	after	after	ADP
aiua-10431	90	21	adjustment	adjustment	NOUN
aiua-10431	90	22	for	for	ADP
aiua-10431	90	23	age	age	NOUN
aiua-10431	90	24	and	and	CCONJ
aiua-10431	90	25	bmi	bmi	NOUN
aiua-10431	90	26	,	,	PUNCT
aiua-10431	90	27	although	although	SCONJ
aiua-10431	90	28	testosterone	testosterone	NOUN
aiua-10431	90	29	levels	level	NOUN
aiua-10431	90	30	table	table	VERB
aiua-10431	90	31	2	2	NUM
aiua-10431	90	32	.	.	PUNCT
aiua-10431	90	33	comparison	comparison	NOUN
aiua-10431	90	34	of	of	ADP
aiua-10431	90	35	clinical	clinical	ADJ
aiua-10431	90	36	and	and	CCONJ
aiua-10431	90	37	laboratory	laboratory	NOUN
aiua-10431	90	38	characteristics	characteristic	NOUN
aiua-10431	90	39	of	of	ADP
aiua-10431	90	40	male	male	ADJ
aiua-10431	90	41	type	type	NOUN
aiua-10431	90	42	2	2	NUM
aiua-10431	90	43	dm	dm	NOUN
aiua-10431	90	44	patients	patient	NOUN
aiua-10431	90	45	with	with	ADP
aiua-10431	90	46	tt	tt	PROPN
aiua-10431	90	47	>	>	ADP
aiua-10431	90	48	300	300	NUM
aiua-10431	90	49	vs	vs	ADP
aiua-10431	90	50	ng	ng	PROPN
aiua-10431	90	51	/	/	SYM
aiua-10431	90	52	dl	dl	PROPN
aiua-10431	90	53	those	those	PRON
aiua-10431	90	54	with	with	ADP
aiua-10431	90	55	tt	tt	PROPN
aiua-10431	90	56	≤	≤	PROPN
aiua-10431	91	1	300	300	NUM
aiua-10431	91	2	ng	ng	PROPN
aiua-10431	91	3	/	/	SYM
aiua-10431	91	4	dl	dl	PROPN
aiua-10431	91	5	.	.	PUNCT
aiua-10431	91	6	tt	tt	PROPN
aiua-10431	91	7	>	>	X
aiua-10431	91	8	300	300	NUM
aiua-10431	91	9	ng	ng	PROPN
aiua-10431	91	10	/	/	SYM
aiua-10431	91	11	dl	dl	PROPN
aiua-10431	91	12	(	(	PUNCT
aiua-10431	91	13	n	n	NOUN
aiua-10431	91	14	=	=	SYM
aiua-10431	91	15	68	68	NUM
aiua-10431	91	16	)	)	PUNCT
aiua-10431	92	1	tt	tt	PROPN
aiua-10431	92	2	≤	≤	PROPN
aiua-10431	92	3	300	300	NUM
aiua-10431	92	4	ng	ng	PROPN
aiua-10431	92	5	/	/	SYM
aiua-10431	92	6	dl	dl	PROPN
aiua-10431	92	7	(	(	PUNCT
aiua-10431	92	8	n	n	NOUN
aiua-10431	92	9	=	=	SYM
aiua-10431	92	10	28	28	NUM
aiua-10431	92	11	)	)	PUNCT
aiua-10431	92	12	p	p	NOUN
aiua-10431	92	13	value	value	NOUN
aiua-10431	92	14	age	age	NOUN
aiua-10431	92	15	(	(	PUNCT
aiua-10431	92	16	year	year	NOUN
aiua-10431	92	17	)	)	PUNCT
aiua-10431	92	18	52.1	52.1	NUM
aiua-10431	92	19	±	±	NUM
aiua-10431	92	20	7.29	7.29	NUM
aiua-10431	92	21	49.71	49.71	NUM
aiua-10431	92	22	±	±	NUM
aiua-10431	92	23	6.69	6.69	NUM
aiua-10431	92	24	0.139	0.139	NUM
aiua-10431	93	1	dm	dm	PROPN
aiua-10431	93	2	duration	duration	NOUN
aiua-10431	93	3	(	(	PUNCT
aiua-10431	93	4	year	year	NOUN
aiua-10431	93	5	)	)	PUNCT
aiua-10431	93	6	9.34	9.34	NUM
aiua-10431	93	7	±	±	NUM
aiua-10431	93	8	4.27	4.27	NUM
aiua-10431	93	9	10.21	10.21	NUM
aiua-10431	93	10	±	±	NUM
aiua-10431	93	11	3.98	3.98	NUM
aiua-10431	93	12	0.354	0.354	NUM
aiua-10431	93	13	smoker	smoker	NOUN
aiua-10431	93	14	ratio	ratio	NOUN
aiua-10431	93	15	30	30	NUM
aiua-10431	93	16	(	(	PUNCT
aiua-10431	93	17	44.1	44.1	NUM
aiua-10431	93	18	%	%	NOUN
aiua-10431	93	19	)	)	PUNCT
aiua-10431	93	20	11	11	NUM
aiua-10431	93	21	(	(	PUNCT
aiua-10431	93	22	39.2	39.2	NUM
aiua-10431	93	23	%	%	NOUN
aiua-10431	93	24	)	)	PUNCT
aiua-10431	93	25	0.821	0.821	NUM
aiua-10431	93	26	height	height	NOUN
aiua-10431	93	27	(	(	PUNCT
aiua-10431	93	28	m	m	NOUN
aiua-10431	93	29	)	)	PUNCT
aiua-10431	93	30	1.78	1.78	NUM
aiua-10431	93	31	±	±	NUM
aiua-10431	93	32	.06	.06	NUM
aiua-10431	93	33	1.7675	1.7675	NUM
aiua-10431	93	34	±	±	NUM
aiua-10431	93	35	.05	.05	NUM
aiua-10431	93	36	0.290	0.290	NUM
aiua-10431	93	37	body	body	NOUN
aiua-10431	93	38	weight	weight	NOUN
aiua-10431	93	39	(	(	PUNCT
aiua-10431	93	40	kg	kg	NOUN
aiua-10431	93	41	)	)	PUNCT
aiua-10431	93	42	86.54	86.54	NUM
aiua-10431	93	43	±	±	NUM
aiua-10431	93	44	8.39	8.39	NUM
aiua-10431	93	45	87.04	87.04	NUM
aiua-10431	93	46	±	±	NUM
aiua-10431	93	47	6.96	6.96	NUM
aiua-10431	93	48	0.785	0.785	NUM
aiua-10431	93	49	bmi	bmi	NOUN
aiua-10431	93	50	(	(	PUNCT
aiua-10431	93	51	kg	kg	NOUN
aiua-10431	93	52	/	/	SYM
aiua-10431	93	53	m2	m2	PROPN
aiua-10431	93	54	)	)	PUNCT
aiua-10431	93	55	27.75	27.75	NUM
aiua-10431	93	56	(	(	PUNCT
aiua-10431	93	57	3.44	3.44	NUM
aiua-10431	93	58	)	)	PUNCT
aiua-10431	93	59	28.73	28.73	NUM
aiua-10431	93	60	(	(	PUNCT
aiua-10431	93	61	2.13	2.13	NUM
aiua-10431	93	62	)	)	PUNCT
aiua-10431	93	63	0.197	0.197	NUM
aiua-10431	93	64	wc	wc	PROPN
aiua-10431	93	65	(	(	PUNCT
aiua-10431	93	66	cm	cm	NOUN
aiua-10431	93	67	)	)	PUNCT
aiua-10431	93	68	98.24	98.24	NUM
aiua-10431	93	69	±	±	NUM
aiua-10431	93	70	9.35	9.35	NUM
aiua-10431	93	71	102.50	102.50	NUM
aiua-10431	93	72	±	±	NUM
aiua-10431	93	73	9.95	9.95	NUM
aiua-10431	93	74	0.049	0.049	NUM
aiua-10431	93	75	systolic	systolic	ADJ
aiua-10431	93	76	bp	bp	PROPN
aiua-10431	93	77	(	(	PUNCT
aiua-10431	93	78	mmhg	mmhg	PROPN
aiua-10431	93	79	)	)	PUNCT
aiua-10431	93	80	135.00	135.00	NUM
aiua-10431	93	81	(	(	PUNCT
aiua-10431	93	82	15	15	NUM
aiua-10431	93	83	)	)	PUNCT
aiua-10431	93	84	137.50	137.50	NUM
aiua-10431	93	85	(	(	PUNCT
aiua-10431	93	86	14	14	NUM
aiua-10431	93	87	)	)	PUNCT
aiua-10431	93	88	0.218	0.218	NUM
aiua-10431	93	89	diastolic	diastolic	NOUN
aiua-10431	93	90	bp	bp	PROPN
aiua-10431	93	91	(	(	PUNCT
aiua-10431	93	92	mmhg	mmhg	PROPN
aiua-10431	93	93	)	)	PUNCT
aiua-10431	93	94	85	85	NUM
aiua-10431	93	95	(	(	PUNCT
aiua-10431	93	96	15	15	NUM
aiua-10431	93	97	)	)	SYM
aiua-10431	93	98	85	85	NUM
aiua-10431	93	99	(	(	PUNCT
aiua-10431	93	100	13	13	NUM
aiua-10431	93	101	)	)	PUNCT
aiua-10431	93	102	0.09	0.09	NUM
aiua-10431	93	103	microalbumiric	microalbumiric	NOUN
aiua-10431	93	104	24	24	NUM
aiua-10431	93	105	(	(	PUNCT
aiua-10431	93	106	35.5	35.5	NUM
aiua-10431	93	107	%	%	NOUN
aiua-10431	93	108	)	)	PUNCT
aiua-10431	93	109	12	12	NUM
aiua-10431	93	110	(	(	PUNCT
aiua-10431	93	111	42.8	42.8	NUM
aiua-10431	93	112	%	%	NOUN
aiua-10431	93	113	)	)	PUNCT
aiua-10431	93	114	0.497	0.497	NUM
aiua-10431	93	115	retinopathy	retinopathy	ADJ
aiua-10431	93	116	ratio	ratio	NOUN
aiua-10431	93	117	16	16	NUM
aiua-10431	93	118	(	(	PUNCT
aiua-10431	93	119	23.5	23.5	NUM
aiua-10431	93	120	%	%	NOUN
aiua-10431	93	121	)	)	PUNCT
aiua-10431	93	122	13	13	NUM
aiua-10431	93	123	(	(	PUNCT
aiua-10431	93	124	46.4	46.4	NUM
aiua-10431	93	125	%	%	NOUN
aiua-10431	93	126	)	)	PUNCT
aiua-10431	93	127	0.049	0.049	NUM
aiua-10431	93	128	tv	tv	NOUN
aiua-10431	93	129	mg	mg	PROPN
aiua-10431	93	130	/	/	SYM
aiua-10431	93	131	dl	dl	PROPN
aiua-10431	93	132	249.96	249.96	NUM
aiua-10431	93	133	±	±	NUM
aiua-10431	93	134	41.94	41.94	NUM
aiua-10431	93	135	245.11	245.11	NUM
aiua-10431	93	136	±	±	NOUN
aiua-10431	93	137	47.02	47.02	NUM
aiua-10431	93	138	0.620	0.620	NUM
aiua-10431	93	139	ldl	ldl	PROPN
aiua-10431	93	140	-	-	PUNCT
aiua-10431	93	141	c	c	NOUN
aiua-10431	93	142	mg	mg	PROPN
aiua-10431	93	143	/	/	SYM
aiua-10431	93	144	dl	dl	PROPN
aiua-10431	93	145	158.51	158.51	NUM
aiua-10431	93	146	±	±	NUM
aiua-10431	93	147	45.48	45.48	NUM
aiua-10431	93	148	149.49	149.49	NUM
aiua-10431	93	149	±	±	NOUN
aiua-10431	93	150	53.93	53.93	NUM
aiua-10431	93	151	0.405	0.405	NUM
aiua-10431	93	152	hdl	hdl	PROPN
aiua-10431	93	153	-	-	PUNCT
aiua-10431	93	154	c	c	NOUN
aiua-10431	93	155	mg	mg	PROPN
aiua-10431	93	156	/	/	SYM
aiua-10431	93	157	dl	dl	PROPN
aiua-10431	93	158	44.56	44.56	NUM
aiua-10431	93	159	±	±	NUM
aiua-10431	93	160	7.53	7.53	NUM
aiua-10431	93	161	42.07	42.07	NUM
aiua-10431	93	162	±	±	NUM
aiua-10431	93	163	4.44	4.44	NUM
aiua-10431	93	164	0106	0106	NUM
aiua-10431	94	1	tg	tg	INTJ
aiua-10431	94	2	mg	mg	PROPN
aiua-10431	94	3	/	/	SYM
aiua-10431	94	4	dl	dl	PROPN
aiua-10431	94	5	234.43	234.43	NUM
aiua-10431	94	6	±	±	NUM
aiua-10431	94	7	76	76	NUM
aiua-10431	94	8	267.71	267.71	NUM
aiua-10431	94	9	±	±	NUM
aiua-10431	94	10	66.14	66.14	NUM
aiua-10431	94	11	0.046	0.046	NUM
aiua-10431	94	12	hba1c	hba1c	PROPN
aiua-10431	94	13	%	%	NOUN
aiua-10431	94	14	8.36	8.36	NUM
aiua-10431	94	15	±	±	NUM
aiua-10431	94	16	1.53	1.53	NUM
aiua-10431	94	17	8.93	8.93	NUM
aiua-10431	94	18	±	±	NUM
aiua-10431	94	19	1.7	1.7	NUM
aiua-10431	94	20	0.111	0.111	NUM
aiua-10431	94	21	lh	lh	PROPN
aiua-10431	94	22	miu	miu	PROPN
aiua-10431	94	23	/	/	SYM
aiua-10431	94	24	l	l	NOUN
aiua-10431	94	25	7.2	7.2	NUM
aiua-10431	94	26	±	±	NUM
aiua-10431	94	27	1.85	1.85	NUM
aiua-10431	94	28	8.02	8.02	NUM
aiua-10431	94	29	±	±	NUM
aiua-10431	94	30	4.01	4.01	NUM
aiua-10431	94	31	0.173	0.173	NUM
aiua-10431	94	32	uacr	uacr	INTJ
aiua-10431	94	33	mg	mg	PROPN
aiua-10431	94	34	/	/	SYM
aiua-10431	94	35	gm	gm	PROPN
aiua-10431	94	36	28	28	NUM
aiua-10431	94	37	(	(	PUNCT
aiua-10431	94	38	62.53	62.53	NUM
aiua-10431	94	39	)	)	PUNCT
aiua-10431	94	40	28	28	NUM
aiua-10431	94	41	(	(	PUNCT
aiua-10431	94	42	74	74	NUM
aiua-10431	94	43	)	)	PUNCT
aiua-10431	94	44	0.812	0.812	NUM
aiua-10431	94	45	vai	vai	NOUN
aiua-10431	94	46	3.03	3.03	NUM
aiua-10431	94	47	(	(	PUNCT
aiua-10431	94	48	1.54	1.54	NUM
aiua-10431	94	49	)	)	PUNCT
aiua-10431	94	50	3.86	3.86	NUM
aiua-10431	94	51	(	(	PUNCT
aiua-10431	94	52	1.77	1.77	NUM
aiua-10431	94	53	)	)	PUNCT
aiua-10431	94	54	0.006	0.006	NUM
aiua-10431	94	55	data	datum	NOUN
aiua-10431	94	56	are	be	AUX
aiua-10431	94	57	presented	present	VERB
aiua-10431	94	58	as	as	ADP
aiua-10431	94	59	the	the	DET
aiua-10431	94	60	mean	mean	ADJ
aiua-10431	94	61	±	±	NUM
aiua-10431	94	62	sd	sd	NOUN
aiua-10431	94	63	.	.	PUNCT
aiua-10431	95	1	median	median	PROPN
aiua-10431	95	2	(	(	PUNCT
aiua-10431	95	3	iq	iq	NOUN
aiua-10431	95	4	range	range	PROPN
aiua-10431	95	5	)	)	PUNCT
aiua-10431	95	6	or	or	CCONJ
aiua-10431	95	7	the	the	DET
aiua-10431	95	8	number	number	NOUN
aiua-10431	95	9	of	of	ADP
aiua-10431	95	10	patients	patient	NOUN
aiua-10431	95	11	in	in	ADP
aiua-10431	95	12	each	each	DET
aiua-10431	95	13	group	group	NOUN
aiua-10431	95	14	with	with	ADP
aiua-10431	95	15	percentages	percentage	NOUN
aiua-10431	95	16	.	.	PUNCT
aiua-10431	96	1	bm	bm	PROPN
aiua-10431	96	2	:	:	PUNCT
aiua-10431	96	3	body	body	NOUN
aiua-10431	96	4	mass	mass	PROPN
aiua-10431	96	5	index	index	NOUN
aiua-10431	96	6	;	;	PUNCT
aiua-10431	96	7	wc	wc	PROPN
aiua-10431	96	8	:	:	PUNCT
aiua-10431	96	9	waist	waist	NOUN
aiua-10431	96	10	circumference	circumference	NOUN
aiua-10431	96	11	;	;	PUNCT
aiua-10431	96	12	sbp	sbp	NOUN
aiua-10431	96	13	:	:	PUNCT
aiua-10431	96	14	systolic	systolic	ADJ
aiua-10431	96	15	blood	blood	NOUN
aiua-10431	96	16	pressure	pressure	NOUN
aiua-10431	96	17	;	;	PUNCT
aiua-10431	96	18	dbp	dbp	PROPN
aiua-10431	96	19	:	:	PUNCT
aiua-10431	96	20	diastolic	diastolic	ADJ
aiua-10431	96	21	blood	blood	NOUN
aiua-10431	96	22	pressure	pressure	NOUN
aiua-10431	96	23	;	;	PUNCT
aiua-10431	96	24	ldl	ldl	NOUN
aiua-10431	96	25	:	:	PUNCT
aiua-10431	96	26	low	low	ADJ
aiua-10431	96	27	-	-	PUNCT
aiua-10431	96	28	density	density	NOUN
aiua-10431	96	29	lipoprotein	lipoprotein	NOUN
aiua-10431	96	30	;	;	PUNCT
aiua-10431	96	31	hdl	hdl	NOUN
aiua-10431	96	32	:	:	PUNCT
aiua-10431	96	33	high	high	ADJ
aiua-10431	96	34	-	-	PUNCT
aiua-10431	96	35	density	density	NOUN
aiua-10431	96	36	lipoprotein	lipoprotein	NOUN
aiua-10431	96	37	;	;	PUNCT
aiua-10431	96	38	tg	tg	PRON
aiua-10431	96	39	:	:	PUNCT
aiua-10431	96	40	triglyceride	triglyceride	ADJ
aiua-10431	96	41	;	;	PUNCT
aiua-10431	96	42	;	;	PUNCT
aiua-10431	96	43	hba1c	hba1c	PROPN
aiua-10431	96	44	:	:	PUNCT
aiua-10431	96	45	glycated	glycate	VERB
aiua-10431	96	46	hemoglobin	hemoglobin	NOUN
aiua-10431	96	47	;	;	PUNCT
aiua-10431	96	48	lh	lh	PROPN
aiua-10431	96	49	:	:	PUNCT
aiua-10431	96	50	luteinizing	luteinize	VERB
aiua-10431	96	51	hormone	hormone	NOUN
aiua-10431	96	52	;	;	PUNCT
aiua-10431	96	53	uacr	uacr	ADJ
aiua-10431	96	54	:	:	PUNCT
aiua-10431	96	55	urinary	urinary	ADJ
aiua-10431	96	56	albumin	albumin	ADJ
aiua-10431	96	57	creatinine	creatinine	NOUN
aiua-10431	96	58	ratio	ratio	NOUN
aiua-10431	96	59	;	;	PUNCT
aiua-10431	96	60	vai	vai	ADJ
aiua-10431	96	61	:	:	PUNCT
aiua-10431	96	62	visceral	visceral	ADJ
aiua-10431	96	63	adiposity	adiposity	NOUN
aiua-10431	96	64	index	index	NOUN
aiua-10431	96	65	.	.	PUNCT
aiua-10431	97	1	table	table	NOUN
aiua-10431	98	1	3	3	NUM
aiua-10431	98	2	.	.	PUNCT
aiua-10431	98	3	pearson	pearson	PROPN
aiua-10431	98	4	correlation	correlation	NOUN
aiua-10431	98	5	and	and	CCONJ
aiua-10431	98	6	stepwise	stepwise	ADJ
aiua-10431	98	7	multiple	multiple	ADJ
aiua-10431	98	8	regression	regression	NOUN
aiua-10431	98	9	analysis	analysis	NOUN
aiua-10431	98	10	between	between	ADP
aiua-10431	98	11	total	total	ADJ
aiua-10431	98	12	testosterone	testosterone	NOUN
aiua-10431	98	13	levels	level	NOUN
aiua-10431	98	14	with	with	ADP
aiua-10431	98	15	other	other	ADJ
aiua-10431	98	16	statistically	statistically	ADV
aiua-10431	98	17	significant	significant	ADJ
aiua-10431	98	18	correlated	correlate	VERB
aiua-10431	98	19	independent	independent	ADJ
aiua-10431	98	20	factor	factor	NOUN
aiua-10431	98	21	.	.	PUNCT
aiua-10431	99	1	r	r	NOUN
aiua-10431	99	2	p	p	NOUN
aiua-10431	99	3	value	value	NOUN
aiua-10431	99	4	b	b	PROPN
aiua-10431	99	5	β	β	X
aiua-10431	99	6	p	p	NOUN
aiua-10431	99	7	value	value	NOUN
aiua-10431	99	8	age	age	NOUN
aiua-10431	99	9	.218	.218	NUM
aiua-10431	99	10	.033	.033	NUM
aiua-10431	99	11	2.723	2.723	NUM
aiua-10431	99	12	.146	.146	NUM
aiua-10431	99	13	.145	.145	NUM
aiua-10431	99	14	log	log	PROPN
aiua-10431	99	15	bmi	bmi	X
aiua-10431	99	16	.213	.213	NUM
aiua-10431	99	17	.037	.037	NUM
aiua-10431	99	18	25.488	25.488	NUM
aiua-10431	99	19	.040	.040	NUM
aiua-10431	99	20	.760	.760	NUM
aiua-10431	99	21	wc	wc	PROPN
aiua-10431	99	22	-.255	-.255	PROPN
aiua-10431	99	23	.012	.012	NUM
aiua-10431	99	24	-1.723	-1.723	PROPN
aiua-10431	99	25	-.125	-.125	PROPN
aiua-10431	99	26	.352	.352	NUM
aiua-10431	99	27	lh	lh	PROPN
aiua-10431	99	28	-.222	-.222	PROPN
aiua-10431	99	29	.030	.030	NUM
aiua-10431	100	1	-8.630	-8.630	PROPN
aiua-10431	100	2	-.172	-.172	NOUN
aiua-10431	100	3	.082	.082	NUM
aiua-10431	101	1	log	log	PROPN
aiua-10431	101	2	vai	vai	ADJ
aiua-10431	101	3	-.278	-.278	PROPN
aiua-10431	101	4	.006	.006	NUM
aiua-10431	101	5	-164.284	-164.284	NUM
aiua-10431	101	6	-.208	-.208	PROPN
aiua-10431	101	7	.041	.041	NUM
aiua-10431	102	1	bm	bm	PROPN
aiua-10431	102	2	:	:	PUNCT
aiua-10431	102	3	body	body	NOUN
aiua-10431	102	4	mass	mass	PROPN
aiua-10431	102	5	index	index	NOUN
aiua-10431	102	6	;	;	PUNCT
aiua-10431	102	7	wc	wc	PROPN
aiua-10431	102	8	:	:	PUNCT
aiua-10431	102	9	waist	waist	NOUN
aiua-10431	102	10	circumference	circumference	NOUN
aiua-10431	102	11	;	;	PUNCT
aiua-10431	102	12	lh	lh	PROPN
aiua-10431	102	13	:	:	PUNCT
aiua-10431	102	14	luteinizing	luteinize	VERB
aiua-10431	102	15	hormone	hormone	NOUN
aiua-10431	102	16	;	;	PUNCT
aiua-10431	102	17	vai	vai	ADJ
aiua-10431	102	18	:	:	PUNCT
aiua-10431	102	19	visceral	visceral	ADJ
aiua-10431	102	20	adiposity	adiposity	NOUN
aiua-10431	102	21	index	index	NOUN
aiua-10431	102	22	.	.	PUNCT
aiua-10431	103	1	table	table	NOUN
aiua-10431	104	1	4	4	NUM
aiua-10431	104	2	.	.	X
aiua-10431	104	3	association	association	NOUN
aiua-10431	104	4	between	between	ADP
aiua-10431	104	5	total	total	ADJ
aiua-10431	104	6	testosterone	testosterone	NOUN
aiua-10431	104	7	levels	level	NOUN
aiua-10431	104	8	and	and	CCONJ
aiua-10431	104	9	other	other	ADJ
aiua-10431	104	10	statistically	statistically	ADV
aiua-10431	104	11	significant	significant	ADJ
aiua-10431	104	12	correlated	correlate	VERB
aiua-10431	104	13	independent	independent	ADJ
aiua-10431	104	14	factors	factor	NOUN
aiua-10431	104	15	in	in	ADP
aiua-10431	104	16	regression	regression	NOUN
aiua-10431	104	17	analysis	analysis	NOUN
aiua-10431	104	18	after	after	ADP
aiua-10431	104	19	adjustment	adjustment	NOUN
aiua-10431	104	20	for	for	ADP
aiua-10431	104	21	bmi	bmi	NOUN
aiua-10431	104	22	and	and	CCONJ
aiua-10431	104	23	age	age	NOUN
aiua-10431	104	24	.	.	PUNCT
aiua-10431	105	1	model	model	NOUN
aiua-10431	105	2	1	1	NUM
aiua-10431	105	3	model	model	NOUN
aiua-10431	105	4	2	2	NUM
aiua-10431	105	5	b	b	PROPN
aiua-10431	105	6	β	β	X
aiua-10431	105	7	p	p	NOUN
aiua-10431	105	8	value	value	NOUN
aiua-10431	105	9	b	b	PROPN
aiua-10431	105	10	β	β	X
aiua-10431	105	11	p	p	NOUN
aiua-10431	105	12	value	value	NOUN
aiua-10431	105	13	age	age	NOUN
aiua-10431	105	14	2.723	2.723	NUM
aiua-10431	105	15	.146	.146	NUM
aiua-10431	105	16	.145	.145	NUM
aiua-10431	105	17	2.721	2.721	NUM
aiua-10431	105	18	.146	.146	NUM
aiua-10431	105	19	.147	.147	NUM
aiua-10431	105	20	wc	wc	PROPN
aiua-10431	105	21	-1.723	-1.723	PROPN
aiua-10431	105	22	-.125	-.125	PROPN
aiua-10431	105	23	.352	.352	NUM
aiua-10431	105	24	-1.638	-1.638	NUM
aiua-10431	105	25	.118	.118	NUM
aiua-10431	105	26	.397	.397	NUM
aiua-10431	106	1	bmi	bmi	NOUN
aiua-10431	106	2	(	(	PUNCT
aiua-10431	106	3	log	log	PROPN
aiua-10431	106	4	)	)	PUNCT
aiua-10431	106	5	25.488	25.488	NUM
aiua-10431	106	6	-.208	-.208	NOUN
aiua-10431	106	7	.760	.760	NUM
aiua-10431	107	1	4.984	4.984	NUM
aiua-10431	107	2	.008	.008	NUM
aiua-10431	107	3	974	974	NUM
aiua-10431	107	4	lh	lh	NOUN
aiua-10431	107	5	-8.630	-8.630	PROPN
aiua-10431	107	6	-.172	-.172	PROPN
aiua-10431	107	7	.082	.082	NUM
aiua-10431	107	8	-8.654	-8.654	PUNCT
aiua-10431	108	1	-.173	-.173	PROPN
aiua-10431	108	2	.083	.083	NUM
aiua-10431	108	3	vai	vai	PROPN
aiua-10431	108	4	(	(	PUNCT
aiua-10431	108	5	log	log	PROPN
aiua-10431	108	6	)	)	PUNCT
aiua-10431	108	7	-164.284	-164.284	PROPN
aiua-10431	108	8	040	040	NUM
aiua-10431	108	9	.041	.041	NUM
aiua-10431	109	1	-165.076	-165.076	NUM
aiua-10431	109	2	-.209	-.209	ADJ
aiua-10431	109	3	.041	.041	NUM
aiua-10431	109	4	model	model	NOUN
aiua-10431	109	5	1	1	NUM
aiua-10431	109	6	adjusted	adjust	VERB
aiua-10431	109	7	for	for	ADP
aiua-10431	109	8	age	age	NOUN
aiua-10431	109	9	and	and	CCONJ
aiua-10431	109	10	model	model	NOUN
aiua-10431	109	11	2	2	NUM
aiua-10431	109	12	adjusted	adjust	VERB
aiua-10431	109	13	for	for	ADP
aiua-10431	109	14	bmi	bmi	NOUN
aiua-10431	109	15	and	and	CCONJ
aiua-10431	109	16	age	age	NOUN
aiua-10431	109	17	.	.	PUNCT
aiua-10431	110	1	bm	bm	PROPN
aiua-10431	110	2	:	:	PUNCT
aiua-10431	110	3	body	body	NOUN
aiua-10431	110	4	mass	mass	PROPN
aiua-10431	110	5	index	index	NOUN
aiua-10431	110	6	;	;	PUNCT
aiua-10431	110	7	wc	wc	PROPN
aiua-10431	110	8	:	:	PUNCT
aiua-10431	110	9	waist	waist	NOUN
aiua-10431	110	10	circumference	circumference	NOUN
aiua-10431	110	11	;	;	PUNCT
aiua-10431	110	12	lh	lh	PROPN
aiua-10431	110	13	:	:	PUNCT
aiua-10431	110	14	luteinizing	luteinize	VERB
aiua-10431	110	15	hormone	hormone	NOUN
aiua-10431	110	16	;	;	PUNCT
aiua-10431	110	17	vai	vai	ADJ
aiua-10431	110	18	:	:	PUNCT
aiua-10431	110	19	visceral	visceral	ADJ
aiua-10431	110	20	adiposity	adiposity	NOUN
aiua-10431	110	21	index	index	NOUN
aiua-10431	110	22	.	.	PUNCT
aiua-10431	111	1	table	table	NOUN
aiua-10431	111	2	5	5	NUM
aiua-10431	111	3	.	.	PUNCT
aiua-10431	112	1	logistic	logistic	ADJ
aiua-10431	112	2	regression	regression	NOUN
aiua-10431	112	3	analysis	analysis	NOUN
aiua-10431	112	4	for	for	ADP
aiua-10431	112	5	risk	risk	NOUN
aiua-10431	112	6	factor	factor	NOUN
aiua-10431	112	7	of	of	ADP
aiua-10431	112	8	testosterone	testosterone	NOUN
aiua-10431	112	9	deficiency	deficiency	NOUN
aiua-10431	112	10	.	.	PUNCT
aiua-10431	113	1	b	b	X
aiua-10431	113	2	s.e	s.e	PROPN
aiua-10431	113	3	wald	wald	PROPN
aiua-10431	113	4	p	p	NOUN
aiua-10431	113	5	value	value	NOUN
aiua-10431	113	6	or	or	CCONJ
aiua-10431	113	7	95	95	NUM
aiua-10431	113	8	%	%	NOUN
aiua-10431	113	9	c.i	c.i	NOUN
aiua-10431	113	10	.	.	NOUN
aiua-10431	113	11	for	for	ADP
aiua-10431	113	12	odds	odd	NOUN
aiua-10431	113	13	ratio	ratio	NOUN
aiua-10431	113	14	lower	low	ADJ
aiua-10431	113	15	upper	upper	ADJ
aiua-10431	113	16	age	age	NOUN
aiua-10431	113	17	-.046	-.046	NOUN
aiua-10431	113	18	.037	.037	NUM
aiua-10431	113	19	1.563	1.563	NUM
aiua-10431	113	20	.218	.218	NUM
aiua-10431	113	21	.956	.956	NUM
aiua-10431	113	22	.891	.891	NUM
aiua-10431	114	1	1.027	1.027	NUM
aiua-10431	114	2	overweight	overweight	NOUN
aiua-10431	114	3	-.802	-.802	ADP
aiua-10431	114	4	.878	.878	NUM
aiua-10431	114	5	.834	.834	NUM
aiua-10431	114	6	.367	.367	NUM
aiua-10431	114	7	2.373	2.373	NUM
aiua-10431	114	8	.363	.363	NUM
aiua-10431	114	9	15.536	15.536	NUM
aiua-10431	114	10	waist	waist	NOUN
aiua-10431	114	11	.045	.045	NUM
aiua-10431	114	12	.033	.033	NUM
aiua-10431	114	13	1.891	1.891	NUM
aiua-10431	114	14	.207	.207	NUM
aiua-10431	114	15	.344	.344	NUM
aiua-10431	114	16	.066	.066	NUM
aiua-10431	114	17	1.806	1.806	NUM
aiua-10431	114	18	log	log	NOUN
aiua-10431	114	19	vai	vai	NOUN
aiua-10431	114	20	3.629	3.629	NUM
aiua-10431	114	21	1.629	1.629	NUM
aiua-10431	114	22	4.965	4.965	NUM
aiua-10431	114	23	.046	.046	NUM
aiua-10431	114	24	1.436	1.436	NUM
aiua-10431	114	25	1.007	1.007	NUM
aiua-10431	114	26	2.048	2.048	NUM
aiua-10431	114	27	retinopathy	retinopathy	ADJ
aiua-10431	114	28	-1.138	-1.138	NUM
aiua-10431	114	29	.514	.514	NUM
aiua-10431	114	30	4.901	4.901	NUM
aiua-10431	114	31	.060	.060	NUM
aiua-10431	114	32	.382	.382	NUM
aiua-10431	114	33	.140	.140	NUM
aiua-10431	114	34	1.043	1.043	NUM
aiua-10431	114	35	lh	lh	PROPN
aiua-10431	114	36	.049	.049	NUM
aiua-10431	114	37	0.84	0.84	NUM
aiua-10431	114	38	.308	.308	NUM
aiua-10431	114	39	.579	.579	NUM
aiua-10431	114	40	1.050	1.050	NUM
aiua-10431	114	41	.883	.883	NUM
aiua-10431	114	42	1.249	1.249	NUM
aiua-10431	114	43	b	b	NOUN
aiua-10431	114	44	:	:	PUNCT
aiua-10431	114	45	estimated	estimated	ADJ
aiua-10431	114	46	coefficient	coefficient	NOUN
aiua-10431	114	47	;	;	PUNCT
aiua-10431	114	48	s.e	s.e	PROPN
aiua-10431	114	49	:	:	PUNCT
aiua-10431	114	50	standard	standard	ADJ
aiua-10431	114	51	error	error	NOUN
aiua-10431	114	52	;	;	PUNCT
aiua-10431	114	53	ci	ci	NOUN
aiua-10431	114	54	:	:	PUNCT
aiua-10431	114	55	confidence	confidence	NOUN
aiua-10431	114	56	interval	interval	NOUN
aiua-10431	114	57	;	;	PUNCT
aiua-10431	114	58	wc	wc	PROPN
aiua-10431	114	59	,	,	PUNCT
aiua-10431	114	60	waist	waist	NOUN
aiua-10431	114	61	circumference	circumference	NOUN
aiua-10431	114	62	;	;	PUNCT
aiua-10431	114	63	vai	vai	ADJ
aiua-10431	114	64	:	:	PUNCT
aiua-10431	114	65	visceral	visceral	ADJ
aiua-10431	114	66	adiposity	adiposity	NOUN
aiua-10431	114	67	index	index	NOUN
aiua-10431	114	68	;	;	PUNCT
aiua-10431	114	69	lh	lh	PROPN
aiua-10431	114	70	:	:	PUNCT
aiua-10431	114	71	luteinizing	luteinize	VERB
aiua-10431	114	72	hormone	hormone	NOUN
aiua-10431	114	73	.	.	PUNCT
aiua-10431	115	1	467archivio	467archivio	PROPN
aiua-10431	115	2	italiano	italiano	NOUN
aiua-10431	115	3	di	di	X
aiua-10431	115	4	urologia	urologia	PROPN
aiua-10431	115	5	e	e	PROPN
aiua-10431	115	6	andrologia	andrologia	PROPN
aiua-10431	115	7	2022	2022	NUM
aiua-10431	115	8	;	;	PUNCT
aiua-10431	115	9	94	94	NUM
aiua-10431	115	10	,	,	PUNCT
aiua-10431	115	11	4	4	NUM
aiua-10431	115	12	testosterone	testosterone	NOUN
aiua-10431	115	13	deficiency	deficiency	NOUN
aiua-10431	115	14	in	in	ADP
aiua-10431	115	15	non	non	ADJ
aiua-10431	115	16	-	-	ADJ
aiua-10431	115	17	obese	obese	ADJ
aiua-10431	115	18	type	type	NOUN
aiua-10431	115	19	2	2	NUM
aiua-10431	115	20	diabetic	diabetic	ADJ
aiua-10431	115	21	male	male	ADJ
aiua-10431	115	22	patients	patient	NOUN
aiua-10431	115	23	in	in	ADP
aiua-10431	115	24	our	our	PRON
aiua-10431	115	25	study	study	NOUN
aiua-10431	115	26	correlated	correlate	VERB
aiua-10431	115	27	with	with	ADP
aiua-10431	115	28	anthropometric	anthropometric	ADJ
aiua-10431	115	29	parameters	parameter	NOUN
aiua-10431	115	30	such	such	ADJ
aiua-10431	115	31	as	as	ADP
aiua-10431	115	32	bmi	bmi	NOUN
aiua-10431	115	33	and	and	CCONJ
aiua-10431	115	34	waist	waist	NOUN
aiua-10431	115	35	circumference	circumference	NOUN
aiua-10431	115	36	.	.	PUNCT
aiua-10431	116	1	vai	vai	NOUN
aiua-10431	116	2	as	as	ADP
aiua-10431	116	3	a	a	DET
aiua-10431	116	4	index	index	NOUN
aiua-10431	116	5	for	for	ADP
aiua-10431	116	6	visceral	visceral	ADJ
aiua-10431	116	7	fat	fat	ADJ
aiua-10431	116	8	dysfunction	dysfunction	NOUN
aiua-10431	116	9	is	be	AUX
aiua-10431	116	10	more	more	ADV
aiua-10431	116	11	reliable	reliable	ADJ
aiua-10431	116	12	than	than	ADP
aiua-10431	116	13	other	other	ADJ
aiua-10431	116	14	obesity	obesity	NOUN
aiua-10431	116	15	parameters	parameter	NOUN
aiua-10431	116	16	in	in	ADP
aiua-10431	116	17	predicting	predict	VERB
aiua-10431	116	18	testosterone	testosterone	NOUN
aiua-10431	116	19	deficiency	deficiency	NOUN
aiua-10431	116	20	.	.	PUNCT
aiua-10431	117	1	low	low	PROPN
aiua-10431	117	2	tt	tt	PROPN
aiua-10431	117	3	levels	level	NOUN
aiua-10431	117	4	were	be	AUX
aiua-10431	117	5	strongly	strongly	ADV
aiua-10431	117	6	associated	associate	VERB
aiua-10431	117	7	with	with	ADP
aiua-10431	117	8	increased	increase	VERB
aiua-10431	117	9	vai	vai	NOUN
aiua-10431	117	10	in	in	ADP
aiua-10431	117	11	our	our	PRON
aiua-10431	117	12	cross	cross	ADJ
aiua-10431	117	13	-	-	ADJ
aiua-10431	117	14	sectional	sectional	ADJ
aiua-10431	117	15	study	study	NOUN
aiua-10431	117	16	regardless	regardless	ADV
aiua-10431	117	17	of	of	ADP
aiua-10431	117	18	age	age	NOUN
aiua-10431	117	19	,	,	PUNCT
aiua-10431	117	20	or	or	CCONJ
aiua-10431	117	21	diabetes	diabetes	NOUN
aiua-10431	117	22	status	status	NOUN
aiua-10431	117	23	control	control	NOUN
aiua-10431	117	24	.	.	PUNCT
aiua-10431	118	1	although	although	SCONJ
aiua-10431	118	2	many	many	ADJ
aiua-10431	118	3	studies	study	NOUN
aiua-10431	118	4	evaluated	evaluate	VERB
aiua-10431	118	5	hypogonadism	hypogonadism	NOUN
aiua-10431	118	6	in	in	ADP
aiua-10431	118	7	diabetic	diabetic	ADJ
aiua-10431	118	8	patients	patient	NOUN
aiua-10431	118	9	,	,	PUNCT
aiua-10431	118	10	only	only	ADV
aiua-10431	118	11	a	a	DET
aiua-10431	118	12	few	few	ADJ
aiua-10431	118	13	studies	study	NOUN
aiua-10431	118	14	evaluated	evaluate	VERB
aiua-10431	118	15	obesity	obesity	NOUN
aiua-10431	118	16	by	by	ADP
aiua-10431	118	17	vai	vai	PROPN
aiua-10431	118	18	.	.	PUNCT
aiua-10431	119	1	a	a	DET
aiua-10431	119	2	recent	recent	ADJ
aiua-10431	119	3	population	population	NOUN
aiua-10431	119	4	-	-	PUNCT
aiua-10431	119	5	based	base	VERB
aiua-10431	119	6	study	study	NOUN
aiua-10431	119	7	among	among	ADP
aiua-10431	119	8	diabetic	diabetic	ADJ
aiua-10431	119	9	and	and	CCONJ
aiua-10431	119	10	nondiabetic	nondiabetic	ADJ
aiua-10431	119	11	observed	observe	VERB
aiua-10431	119	12	that	that	SCONJ
aiua-10431	119	13	vai	vai	PROPN
aiua-10431	119	14	was	be	AUX
aiua-10431	119	15	the	the	DET
aiua-10431	119	16	best	good	ADJ
aiua-10431	119	17	predictor	predictor	NOUN
aiua-10431	119	18	of	of	ADP
aiua-10431	119	19	male	male	ADJ
aiua-10431	119	20	hypogonadism	hypogonadism	NOUN
aiua-10431	119	21	among	among	ADP
aiua-10431	119	22	different	different	ADJ
aiua-10431	119	23	obesity	obesity	NOUN
aiua-10431	119	24	indices	index	NOUN
aiua-10431	119	25	(	(	PUNCT
aiua-10431	119	26	17	17	NUM
aiua-10431	119	27	,	,	PUNCT
aiua-10431	119	28	18	18	NUM
aiua-10431	119	29	)	)	PUNCT
aiua-10431	119	30	.	.	PUNCT
aiua-10431	120	1	likewise	likewise	ADV
aiua-10431	120	2	,	,	PUNCT
aiua-10431	120	3	vai	vai	PROPN
aiua-10431	120	4	is	be	AUX
aiua-10431	120	5	more	more	ADV
aiua-10431	120	6	reliable	reliable	ADJ
aiua-10431	120	7	than	than	ADP
aiua-10431	120	8	other	other	ADJ
aiua-10431	120	9	metabolic	metabolic	NOUN
aiua-10431	120	10	or	or	CCONJ
aiua-10431	120	11	anthropometric	anthropometric	ADJ
aiua-10431	120	12	parameters	parameter	NOUN
aiua-10431	120	13	in	in	ADP
aiua-10431	120	14	the	the	DET
aiua-10431	120	15	evaluation	evaluation	NOUN
aiua-10431	120	16	of	of	ADP
aiua-10431	120	17	visceral	visceral	ADJ
aiua-10431	120	18	adiposity	adiposity	NOUN
aiua-10431	120	19	effect	effect	NOUN
aiua-10431	120	20	on	on	ADP
aiua-10431	120	21	erectile	erectile	ADJ
aiua-10431	120	22	dysfunction	dysfunction	NOUN
aiua-10431	120	23	(	(	PUNCT
aiua-10431	120	24	19	19	NUM
aiua-10431	120	25	,	,	PUNCT
aiua-10431	120	26	20	20	NUM
aiua-10431	120	27	)	)	PUNCT
aiua-10431	120	28	.	.	PUNCT
aiua-10431	121	1	in	in	ADP
aiua-10431	121	2	this	this	DET
aiua-10431	121	3	cross	cross	ADJ
aiua-10431	121	4	-	-	ADJ
aiua-10431	121	5	sectional	sectional	ADJ
aiua-10431	121	6	study	study	NOUN
aiua-10431	121	7	,	,	PUNCT
aiua-10431	121	8	the	the	DET
aiua-10431	121	9	prevalence	prevalence	NOUN
aiua-10431	121	10	of	of	ADP
aiua-10431	121	11	testosterone	testosterone	NOUN
aiua-10431	121	12	deficiency	deficiency	NOUN
aiua-10431	121	13	was	be	AUX
aiua-10431	121	14	29.1	29.1	NUM
aiua-10431	121	15	per	per	ADP
aiua-10431	121	16	cent	cent	NOUN
aiua-10431	121	17	.	.	PUNCT
aiua-10431	122	1	this	this	DET
aiua-10431	122	2	prevalence	prevalence	NOUN
aiua-10431	122	3	of	of	ADP
aiua-10431	122	4	testosterone	testosterone	NOUN
aiua-10431	122	5	deficiency	deficiency	NOUN
aiua-10431	122	6	in	in	ADP
aiua-10431	122	7	type	type	NOUN
aiua-10431	122	8	2	2	NUM
aiua-10431	122	9	diabetic	diabetic	ADJ
aiua-10431	122	10	males	male	NOUN
aiua-10431	122	11	was	be	AUX
aiua-10431	122	12	lower	low	ADJ
aiua-10431	122	13	than	than	ADP
aiua-10431	122	14	that	that	PRON
aiua-10431	122	15	reported	report	VERB
aiua-10431	122	16	in	in	ADP
aiua-10431	122	17	previous	previous	ADJ
aiua-10431	122	18	studies	study	NOUN
aiua-10431	122	19	in	in	ADP
aiua-10431	122	20	egypt	egypt	PROPN
aiua-10431	122	21	(	(	PUNCT
aiua-10431	122	22	21	21	NUM
aiua-10431	122	23	)	)	PUNCT
aiua-10431	122	24	and	and	CCONJ
aiua-10431	122	25	the	the	DET
aiua-10431	122	26	middle	middle	PROPN
aiua-10431	122	27	east	east	PROPN
aiua-10431	122	28	region	region	NOUN
aiua-10431	122	29	(	(	PUNCT
aiua-10431	122	30	22	22	NUM
aiua-10431	122	31	)	)	PUNCT
aiua-10431	122	32	.	.	PUNCT
aiua-10431	123	1	the	the	DET
aiua-10431	123	2	difference	difference	NOUN
aiua-10431	123	3	is	be	AUX
aiua-10431	123	4	expected	expect	VERB
aiua-10431	123	5	by	by	ADP
aiua-10431	123	6	the	the	DET
aiua-10431	123	7	selection	selection	NOUN
aiua-10431	123	8	of	of	ADP
aiua-10431	123	9	our	our	PRON
aiua-10431	123	10	patients	patient	NOUN
aiua-10431	123	11	with	with	ADP
aiua-10431	123	12	bmi	bmi	PROPN
aiua-10431	123	13	below	below	ADP
aiua-10431	123	14	30	30	NUM
aiua-10431	123	15	.	.	PUNCT
aiua-10431	124	1	surprisingly	surprisingly	ADV
aiua-10431	124	2	,	,	PUNCT
aiua-10431	124	3	we	we	PRON
aiua-10431	124	4	have	have	VERB
aiua-10431	124	5	a	a	DET
aiua-10431	124	6	high	high	ADJ
aiua-10431	124	7	prevalence	prevalence	NOUN
aiua-10431	124	8	of	of	ADP
aiua-10431	124	9	hypergonadotropic	hypergonadotropic	NOUN
aiua-10431	124	10	hypogonadism	hypogonadism	NOUN
aiua-10431	124	11	.	.	PUNCT
aiua-10431	125	1	we	we	PRON
aiua-10431	125	2	observed	observe	VERB
aiua-10431	125	3	high	high	ADJ
aiua-10431	125	4	abnormal	abnormal	ADJ
aiua-10431	125	5	level	level	NOUN
aiua-10431	125	6	of	of	ADP
aiua-10431	125	7	lh	lh	PROPN
aiua-10431	125	8	in	in	ADP
aiua-10431	125	9	14	14	NUM
aiua-10431	125	10	patients	patient	NOUN
aiua-10431	125	11	(	(	PUNCT
aiua-10431	125	12	50	50	NUM
aiua-10431	125	13	%	%	NOUN
aiua-10431	125	14	)	)	PUNCT
aiua-10431	125	15	with	with	ADP
aiua-10431	125	16	low	low	ADJ
aiua-10431	125	17	testosterone	testosterone	NOUN
aiua-10431	125	18	levels	level	NOUN
aiua-10431	125	19	.	.	PUNCT
aiua-10431	126	1	in	in	ADP
aiua-10431	126	2	our	our	PRON
aiua-10431	126	3	study	study	NOUN
aiua-10431	126	4	,	,	PUNCT
aiua-10431	126	5	we	we	PRON
aiua-10431	126	6	observed	observe	VERB
aiua-10431	126	7	that	that	SCONJ
aiua-10431	126	8	other	other	ADJ
aiua-10431	126	9	obesity	obesity	NOUN
aiua-10431	126	10	parameters	parameter	NOUN
aiua-10431	126	11	such	such	ADJ
aiua-10431	126	12	as	as	ADP
aiua-10431	126	13	bmi	bmi	NOUN
aiua-10431	126	14	or	or	CCONJ
aiua-10431	126	15	waist	waist	NOUN
aiua-10431	126	16	diameters	diameter	NOUN
aiua-10431	126	17	correlated	correlate	VERB
aiua-10431	126	18	with	with	ADP
aiua-10431	126	19	testosterone	testosterone	NOUN
aiua-10431	126	20	levels	level	NOUN
aiua-10431	126	21	in	in	ADP
aiua-10431	126	22	pearson	pearson	PROPN
aiua-10431	126	23	correlation	correlation	NOUN
aiua-10431	126	24	.	.	PUNCT
aiua-10431	127	1	however	however	ADV
aiua-10431	127	2	,	,	PUNCT
aiua-10431	127	3	bmi	bmi	PROPN
aiua-10431	127	4	and	and	CCONJ
aiua-10431	127	5	wc	wc	PROPN
aiua-10431	127	6	were	be	AUX
aiua-10431	127	7	not	not	PART
aiua-10431	127	8	a	a	DET
aiua-10431	127	9	significant	significant	ADJ
aiua-10431	127	10	predictor	predictor	NOUN
aiua-10431	127	11	for	for	ADP
aiua-10431	127	12	testosterone	testosterone	NOUN
aiua-10431	127	13	levels	level	NOUN
aiua-10431	127	14	in	in	ADP
aiua-10431	127	15	regression	regression	NOUN
aiua-10431	127	16	analysis	analysis	NOUN
aiua-10431	127	17	.	.	PUNCT
aiua-10431	128	1	several	several	ADJ
aiua-10431	128	2	studies	study	NOUN
aiua-10431	128	3	consistently	consistently	ADV
aiua-10431	128	4	reported	report	VERB
aiua-10431	128	5	a	a	DET
aiua-10431	128	6	negative	negative	ADJ
aiua-10431	128	7	impact	impact	NOUN
aiua-10431	128	8	for	for	ADP
aiua-10431	128	9	obesity	obesity	NOUN
aiua-10431	128	10	on	on	ADP
aiua-10431	128	11	testosterone	testosterone	NOUN
aiua-10431	128	12	levels	level	NOUN
aiua-10431	128	13	(	(	PUNCT
aiua-10431	128	14	18	18	NUM
aiua-10431	128	15	,	,	PUNCT
aiua-10431	128	16	19	19	NUM
aiua-10431	128	17	,	,	PUNCT
aiua-10431	128	18	23	23	NUM
aiua-10431	128	19	)	)	PUNCT
aiua-10431	128	20	.	.	PUNCT
aiua-10431	129	1	these	these	DET
aiua-10431	129	2	results	result	NOUN
aiua-10431	129	3	in	in	ADP
aiua-10431	129	4	non	non	ADJ
aiua-10431	129	5	-	-	ADJ
aiua-10431	129	6	obese	obese	ADJ
aiua-10431	129	7	type	type	NOUN
aiua-10431	129	8	2	2	NUM
aiua-10431	129	9	diabetic	diabetic	ADJ
aiua-10431	129	10	male	male	ADJ
aiua-10431	129	11	patients	patient	NOUN
aiua-10431	129	12	could	could	AUX
aiua-10431	129	13	point	point	VERB
aiua-10431	129	14	to	to	ADP
aiua-10431	129	15	the	the	DET
aiua-10431	129	16	role	role	NOUN
aiua-10431	129	17	of	of	ADP
aiua-10431	129	18	abdominal	abdominal	ADJ
aiua-10431	129	19	obesity	obesity	NOUN
aiua-10431	129	20	in	in	ADP
aiua-10431	129	21	the	the	DET
aiua-10431	129	22	pathogenesis	pathogenesis	NOUN
aiua-10431	129	23	of	of	ADP
aiua-10431	129	24	male	male	ADJ
aiua-10431	129	25	hypogonadism	hypogonadism	NOUN
aiua-10431	129	26	in	in	ADP
aiua-10431	129	27	t2	t2	PROPN
aiua-10431	129	28	dm	dm	PROPN
aiua-10431	129	29	.	.	PUNCT
aiua-10431	130	1	the	the	DET
aiua-10431	130	2	results	result	NOUN
aiua-10431	130	3	in	in	ADP
aiua-10431	130	4	this	this	DET
aiua-10431	130	5	study	study	NOUN
aiua-10431	130	6	may	may	AUX
aiua-10431	130	7	indicate	indicate	VERB
aiua-10431	130	8	that	that	SCONJ
aiua-10431	130	9	adipose	adipose	ADJ
aiua-10431	130	10	fat	fat	ADJ
aiua-10431	130	11	function	function	NOUN
aiua-10431	130	12	may	may	AUX
aiua-10431	130	13	be	be	AUX
aiua-10431	130	14	important	important	ADJ
aiua-10431	130	15	than	than	ADP
aiua-10431	130	16	fat	fat	ADJ
aiua-10431	130	17	mass	mass	NOUN
aiua-10431	130	18	.	.	PUNCT
aiua-10431	131	1	in	in	ADP
aiua-10431	131	2	this	this	DET
aiua-10431	131	3	study	study	NOUN
aiua-10431	131	4	,	,	PUNCT
aiua-10431	131	5	age	age	NOUN
aiua-10431	131	6	correlated	correlate	VERB
aiua-10431	131	7	with	with	ADP
aiua-10431	131	8	testosterone	testosterone	NOUN
aiua-10431	131	9	levels	level	NOUN
aiua-10431	131	10	.	.	PUNCT
aiua-10431	132	1	this	this	DET
aiua-10431	132	2	result	result	NOUN
aiua-10431	132	3	was	be	AUX
aiua-10431	132	4	in	in	ADP
aiua-10431	132	5	concordance	concordance	NOUN
aiua-10431	132	6	with	with	ADP
aiua-10431	132	7	many	many	ADJ
aiua-10431	132	8	previous	previous	ADJ
aiua-10431	132	9	studies	study	NOUN
aiua-10431	132	10	that	that	PRON
aiua-10431	132	11	observed	observe	VERB
aiua-10431	132	12	decreased	decrease	VERB
aiua-10431	132	13	levels	level	NOUN
aiua-10431	132	14	of	of	ADP
aiua-10431	132	15	testosterone	testosterone	NOUN
aiua-10431	132	16	with	with	ADP
aiua-10431	132	17	aging	aging	NOUN
aiua-10431	132	18	in	in	ADP
aiua-10431	132	19	diabetic	diabetic	ADJ
aiua-10431	132	20	patients	patient	NOUN
aiua-10431	132	21	(	(	PUNCT
aiua-10431	132	22	11	11	NUM
aiua-10431	132	23	,	,	PUNCT
aiua-10431	132	24	24	24	NUM
aiua-10431	132	25	,	,	PUNCT
aiua-10431	132	26	25	25	NUM
aiua-10431	132	27	)	)	PUNCT
aiua-10431	132	28	and	and	CCONJ
aiua-10431	132	29	the	the	DET
aiua-10431	132	30	general	general	ADJ
aiua-10431	132	31	population	population	NOUN
aiua-10431	132	32	(	(	PUNCT
aiua-10431	132	33	26	26	NUM
aiua-10431	132	34	)	)	PUNCT
aiua-10431	132	35	.	.	PUNCT
aiua-10431	133	1	however	however	ADV
aiua-10431	133	2	few	few	ADJ
aiua-10431	133	3	studies	study	NOUN
aiua-10431	133	4	did	do	AUX
aiua-10431	133	5	not	not	PART
aiua-10431	133	6	observe	observe	VERB
aiua-10431	133	7	this	this	DET
aiua-10431	133	8	link	link	NOUN
aiua-10431	133	9	in	in	ADP
aiua-10431	133	10	type	type	NOUN
aiua-10431	133	11	2	2	NUM
aiua-10431	133	12	diabetic	diabetic	ADJ
aiua-10431	133	13	patients	patient	NOUN
aiua-10431	133	14	(	(	PUNCT
aiua-10431	133	15	27	27	NUM
aiua-10431	133	16	,	,	PUNCT
aiua-10431	133	17	28	28	NUM
aiua-10431	133	18	)	)	PUNCT
aiua-10431	133	19	.	.	PUNCT
aiua-10431	134	1	in	in	ADP
aiua-10431	134	2	this	this	DET
aiua-10431	134	3	study	study	NOUN
aiua-10431	134	4	,	,	PUNCT
aiua-10431	134	5	we	we	PRON
aiua-10431	134	6	observed	observe	VERB
aiua-10431	134	7	significantly	significantly	ADV
aiua-10431	134	8	higher	high	ADJ
aiua-10431	134	9	triglyceride	triglyceride	ADP
aiua-10431	134	10	levels	level	NOUN
aiua-10431	134	11	in	in	ADP
aiua-10431	134	12	testosterone	testosterone	NOUN
aiua-10431	134	13	deficient	deficient	ADJ
aiua-10431	134	14	diabetics	diabetic	NOUN
aiua-10431	134	15	.	.	PUNCT
aiua-10431	135	1	however	however	ADV
aiua-10431	135	2	,	,	PUNCT
aiua-10431	135	3	hdlc	hdlc	PROPN
aiua-10431	135	4	levels	level	NOUN
aiua-10431	135	5	were	be	AUX
aiua-10431	135	6	insignificantly	insignificantly	ADV
aiua-10431	135	7	different	different	ADJ
aiua-10431	135	8	between	between	ADP
aiua-10431	135	9	the	the	DET
aiua-10431	135	10	two	two	NUM
aiua-10431	135	11	groups	group	NOUN
aiua-10431	135	12	.	.	PUNCT
aiua-10431	136	1	this	this	PRON
aiua-10431	136	2	may	may	AUX
aiua-10431	136	3	be	be	AUX
aiua-10431	136	4	attributed	attribute	VERB
aiua-10431	136	5	to	to	ADP
aiua-10431	136	6	the	the	DET
aiua-10431	136	7	effect	effect	NOUN
aiua-10431	136	8	of	of	ADP
aiua-10431	136	9	patients	patient	NOUN
aiua-10431	136	10	’	'	PUNCT
aiua-10431	136	11	selection	selection	NOUN
aiua-10431	136	12	and	and	CCONJ
aiua-10431	136	13	lifestyle	lifestyle	NOUN
aiua-10431	136	14	such	such	ADJ
aiua-10431	136	15	as	as	ADP
aiua-10431	136	16	exercise	exercise	NOUN
aiua-10431	136	17	and	and	CCONJ
aiua-10431	136	18	diet	diet	NOUN
aiua-10431	136	19	that	that	PRON
aiua-10431	136	20	could	could	AUX
aiua-10431	136	21	affect	affect	VERB
aiua-10431	136	22	hdl	hdl	PROPN
aiua-10431	136	23	levels	level	NOUN
aiua-10431	136	24	.	.	PUNCT
aiua-10431	137	1	many	many	ADJ
aiua-10431	137	2	studies	study	NOUN
aiua-10431	137	3	linked	link	VERB
aiua-10431	137	4	hypogonadism	hypogonadism	NOUN
aiua-10431	137	5	and	and	CCONJ
aiua-10431	137	6	dyslipidaemia	dyslipidaemia	NOUN
aiua-10431	137	7	(	(	PUNCT
aiua-10431	137	8	21	21	NUM
aiua-10431	137	9	,	,	PUNCT
aiua-10431	137	10	22	22	NUM
aiua-10431	137	11	,	,	PUNCT
aiua-10431	137	12	27	27	NUM
aiua-10431	137	13	)	)	PUNCT
aiua-10431	137	14	.	.	PUNCT
aiua-10431	138	1	moreover	moreover	ADV
aiua-10431	138	2	,	,	PUNCT
aiua-10431	138	3	controlled	control	VERB
aiua-10431	138	4	trials	trial	NOUN
aiua-10431	138	5	on	on	ADP
aiua-10431	138	6	testosterone	testosterone	NOUN
aiua-10431	138	7	replacement	replacement	NOUN
aiua-10431	138	8	observed	observe	VERB
aiua-10431	138	9	favourable	favourable	ADJ
aiua-10431	138	10	effects	effect	NOUN
aiua-10431	138	11	for	for	ADP
aiua-10431	138	12	testosterone	testosterone	NOUN
aiua-10431	138	13	on	on	ADP
aiua-10431	138	14	lipid	lipid	NOUN
aiua-10431	138	15	profile	profile	NOUN
aiua-10431	138	16	in	in	ADP
aiua-10431	138	17	diabetics	diabetic	NOUN
aiua-10431	138	18	(	(	PUNCT
aiua-10431	138	19	29	29	NUM
aiua-10431	138	20	)	)	PUNCT
aiua-10431	138	21	.	.	PUNCT
aiua-10431	139	1	however	however	ADV
aiua-10431	139	2	,	,	PUNCT
aiua-10431	139	3	the	the	DET
aiua-10431	139	4	effect	effect	NOUN
aiua-10431	139	5	of	of	ADP
aiua-10431	139	6	dyslipidaemias	dyslipidaemia	NOUN
aiua-10431	139	7	on	on	ADP
aiua-10431	139	8	testosterone	testosterone	NOUN
aiua-10431	139	9	levels	level	NOUN
aiua-10431	139	10	is	be	AUX
aiua-10431	139	11	still	still	ADV
aiua-10431	139	12	unexplored	unexplored	ADJ
aiua-10431	139	13	.	.	PUNCT
aiua-10431	140	1	vai	vai	PROPN
aiua-10431	140	2	includes	include	VERB
aiua-10431	140	3	anthropometric	anthropometric	ADJ
aiua-10431	140	4	and	and	CCONJ
aiua-10431	140	5	metabolic	metabolic	NOUN
aiua-10431	140	6	parameters	parameter	NOUN
aiua-10431	140	7	as	as	ADP
aiua-10431	140	8	tg	tg	PROPN
aiua-10431	140	9	or	or	CCONJ
aiua-10431	140	10	hdlc	hdlc	NOUN
aiua-10431	140	11	.	.	PUNCT
aiua-10431	141	1	hence	hence	ADV
aiua-10431	141	2	,	,	PUNCT
aiua-10431	141	3	the	the	DET
aiua-10431	141	4	correlation	correlation	NOUN
aiua-10431	141	5	between	between	ADP
aiua-10431	141	6	testosterone	testosterone	NOUN
aiua-10431	141	7	and	and	CCONJ
aiua-10431	141	8	tg	tg	PROPN
aiua-10431	141	9	or	or	CCONJ
aiua-10431	141	10	hdl	hdl	PROPN
aiua-10431	141	11	-	-	PUNCT
aiua-10431	141	12	c	c	PROPN
aiua-10431	141	13	can	can	AUX
aiua-10431	141	14	not	not	PART
aiua-10431	141	15	be	be	AUX
aiua-10431	141	16	excluded	exclude	VERB
aiua-10431	141	17	.	.	PUNCT
aiua-10431	142	1	surprisingly	surprisingly	ADV
aiua-10431	142	2	,	,	PUNCT
aiua-10431	142	3	testosterone	testosterone	NOUN
aiua-10431	142	4	deficiency	deficiency	NOUN
aiua-10431	142	5	was	be	AUX
aiua-10431	142	6	not	not	PART
aiua-10431	142	7	related	relate	VERB
aiua-10431	142	8	to	to	ADP
aiua-10431	142	9	diabetic	diabetic	ADJ
aiua-10431	142	10	status	status	NOUN
aiua-10431	142	11	.	.	PUNCT
aiua-10431	143	1	testosterone	testosterone	NOUN
aiua-10431	143	2	deficiency	deficiency	NOUN
aiua-10431	143	3	in	in	ADP
aiua-10431	143	4	this	this	DET
aiua-10431	143	5	study	study	NOUN
aiua-10431	143	6	did	do	AUX
aiua-10431	143	7	not	not	PART
aiua-10431	143	8	correlate	correlate	VERB
aiua-10431	143	9	with	with	ADP
aiua-10431	143	10	glycated	glycate	VERB
aiua-10431	143	11	haemoglobin	haemoglobin	NOUN
aiua-10431	143	12	or	or	CCONJ
aiua-10431	143	13	the	the	DET
aiua-10431	143	14	duration	duration	NOUN
aiua-10431	143	15	of	of	ADP
aiua-10431	143	16	diabetes	diabetes	NOUN
aiua-10431	143	17	.	.	PUNCT
aiua-10431	144	1	these	these	DET
aiua-10431	144	2	results	result	NOUN
aiua-10431	144	3	are	be	AUX
aiua-10431	144	4	in	in	ADP
aiua-10431	144	5	agreement	agreement	NOUN
aiua-10431	144	6	with	with	ADP
aiua-10431	144	7	many	many	ADJ
aiua-10431	144	8	studies	study	NOUN
aiua-10431	144	9	in	in	ADP
aiua-10431	144	10	diabetics	diabetic	NOUN
aiua-10431	144	11	in	in	ADP
aiua-10431	144	12	general	general	ADJ
aiua-10431	144	13	(	(	PUNCT
aiua-10431	144	14	28	28	NUM
aiua-10431	144	15	)	)	PUNCT
aiua-10431	144	16	.	.	PUNCT
aiua-10431	145	1	however	however	ADV
aiua-10431	145	2	,	,	PUNCT
aiua-10431	145	3	our	our	PRON
aiua-10431	145	4	findings	finding	NOUN
aiua-10431	145	5	contradict	contradict	VERB
aiua-10431	145	6	another	another	DET
aiua-10431	145	7	large	large	ADJ
aiua-10431	145	8	study	study	NOUN
aiua-10431	145	9	which	which	PRON
aiua-10431	145	10	correlated	correlate	VERB
aiua-10431	145	11	testosterone	testosterone	NOUN
aiua-10431	145	12	levels	level	NOUN
aiua-10431	145	13	with	with	ADP
aiua-10431	145	14	diabetic	diabetic	ADJ
aiua-10431	145	15	status	status	NOUN
aiua-10431	145	16	control	control	NOUN
aiua-10431	145	17	(	(	PUNCT
aiua-10431	145	18	30	30	NUM
aiua-10431	145	19	)	)	PUNCT
aiua-10431	145	20	.	.	PUNCT
aiua-10431	146	1	in	in	ADP
aiua-10431	146	2	this	this	DET
aiua-10431	146	3	study	study	NOUN
aiua-10431	146	4	,	,	PUNCT
aiua-10431	146	5	we	we	PRON
aiua-10431	146	6	found	find	VERB
aiua-10431	146	7	that	that	SCONJ
aiua-10431	146	8	non	non	ADJ
aiua-10431	146	9	-	-	ADJ
aiua-10431	146	10	obese	obese	ADJ
aiua-10431	146	11	diabetics	diabetic	NOUN
aiua-10431	146	12	with	with	ADP
aiua-10431	146	13	testosterone	testosterone	NOUN
aiua-10431	146	14	deficiency	deficiency	NOUN
aiua-10431	146	15	had	have	VERB
aiua-10431	146	16	higher	high	ADJ
aiua-10431	146	17	significant	significant	ADJ
aiua-10431	146	18	retinopathy	retinopathy	ADJ
aiua-10431	146	19	prevalence	prevalence	NOUN
aiua-10431	146	20	.	.	PUNCT
aiua-10431	147	1	however	however	ADV
aiua-10431	147	2	,	,	PUNCT
aiua-10431	147	3	we	we	PRON
aiua-10431	147	4	found	find	VERB
aiua-10431	147	5	non	non	ADJ
aiua-10431	147	6	-	-	ADJ
aiua-10431	147	7	significant	significant	ADJ
aiua-10431	147	8	different	different	ADJ
aiua-10431	147	9	urinary	urinary	ADJ
aiua-10431	147	10	albumin	albumin	NOUN
aiua-10431	147	11	excretion	excretion	NOUN
aiua-10431	147	12	between	between	ADP
aiua-10431	147	13	both	both	DET
aiua-10431	147	14	groups	group	NOUN
aiua-10431	147	15	.	.	PUNCT
aiua-10431	148	1	the	the	DET
aiua-10431	148	2	effect	effect	NOUN
aiua-10431	148	3	of	of	ADP
aiua-10431	148	4	nephropathy	nephropathy	NOUN
aiua-10431	148	5	was	be	AUX
aiua-10431	148	6	not	not	PART
aiua-10431	148	7	assessed	assess	VERB
aiua-10431	148	8	in	in	ADP
aiua-10431	148	9	this	this	DET
aiua-10431	148	10	study	study	NOUN
aiua-10431	148	11	as	as	SCONJ
aiua-10431	148	12	we	we	PRON
aiua-10431	148	13	excluded	exclude	VERB
aiua-10431	148	14	macro	macro	ADJ
aiua-10431	148	15	-	-	ADJ
aiua-10431	148	16	albuminuria	albuminuria	ADJ
aiua-10431	148	17	patients	patient	NOUN
aiua-10431	148	18	.	.	PUNCT
aiua-10431	149	1	micro	micro	ADJ
aiua-10431	149	2	-	-	ADJ
aiua-10431	149	3	vascular	vascular	ADJ
aiua-10431	149	4	complications	complication	NOUN
aiua-10431	149	5	were	be	AUX
aiua-10431	149	6	reported	report	VERB
aiua-10431	149	7	in	in	ADP
aiua-10431	149	8	many	many	ADJ
aiua-10431	149	9	studies	study	NOUN
aiua-10431	149	10	to	to	PART
aiua-10431	149	11	correlate	correlate	VERB
aiua-10431	149	12	with	with	ADP
aiua-10431	149	13	low	low	ADJ
aiua-10431	149	14	testosterone	testosterone	NOUN
aiua-10431	149	15	levels	level	NOUN
aiua-10431	149	16	in	in	ADP
aiua-10431	149	17	males	male	NOUN
aiua-10431	149	18	(	(	PUNCT
aiua-10431	149	19	21	21	NUM
aiua-10431	149	20	,	,	PUNCT
aiua-10431	149	21	22	22	NUM
aiua-10431	149	22	,	,	PUNCT
aiua-10431	149	23	31	31	NUM
aiua-10431	149	24	)	)	PUNCT
aiua-10431	149	25	.	.	PUNCT
aiua-10431	150	1	although	although	SCONJ
aiua-10431	150	2	the	the	DET
aiua-10431	150	3	pathophysiological	pathophysiological	ADJ
aiua-10431	150	4	mechanism	mechanism	NOUN
aiua-10431	150	5	of	of	ADP
aiua-10431	150	6	testosterone	testosterone	NOUN
aiua-10431	150	7	deficiency	deficiency	NOUN
aiua-10431	150	8	in	in	ADP
aiua-10431	150	9	type	type	NOUN
aiua-10431	150	10	2	2	NUM
aiua-10431	150	11	dm	dm	NOUN
aiua-10431	150	12	is	be	AUX
aiua-10431	150	13	still	still	ADV
aiua-10431	150	14	not	not	PART
aiua-10431	150	15	fully	fully	ADV
aiua-10431	150	16	revealed	reveal	VERB
aiua-10431	150	17	,	,	PUNCT
aiua-10431	150	18	few	few	ADJ
aiua-10431	150	19	mechanisms	mechanism	NOUN
aiua-10431	150	20	have	have	AUX
aiua-10431	150	21	been	be	AUX
aiua-10431	150	22	hypothesized	hypothesize	VERB
aiua-10431	150	23	.	.	PUNCT
aiua-10431	151	1	the	the	DET
aiua-10431	151	2	role	role	NOUN
aiua-10431	151	3	of	of	ADP
aiua-10431	151	4	inflammatory	inflammatory	ADJ
aiua-10431	151	5	mediators	mediator	NOUN
aiua-10431	151	6	such	such	ADJ
aiua-10431	151	7	as	as	ADP
aiua-10431	151	8	tumour	tumour	NOUN
aiua-10431	151	9	necrosis	necrosis	NOUN
aiua-10431	151	10	factoralpha	factoralpha	NOUN
aiua-10431	151	11	and	and	CCONJ
aiua-10431	151	12	interleukin-1	interleukin-1	NOUN
aiua-10431	151	13	beta	beta	NOUN
aiua-10431	151	14	was	be	AUX
aiua-10431	151	15	postulated	postulate	VERB
aiua-10431	151	16	.	.	PUNCT
aiua-10431	152	1	obesity	obesity	NOUN
aiua-10431	152	2	is	be	AUX
aiua-10431	152	3	considered	consider	VERB
aiua-10431	152	4	as	as	ADP
aiua-10431	152	5	a	a	DET
aiua-10431	152	6	state	state	NOUN
aiua-10431	152	7	of	of	ADP
aiua-10431	152	8	chronic	chronic	ADJ
aiua-10431	152	9	inflammation	inflammation	NOUN
aiua-10431	152	10	(	(	PUNCT
aiua-10431	152	11	33	33	NUM
aiua-10431	152	12	)	)	PUNCT
aiua-10431	152	13	.	.	PUNCT
aiua-10431	153	1	these	these	DET
aiua-10431	153	2	mediators	mediator	NOUN
aiua-10431	153	3	have	have	AUX
aiua-10431	153	4	been	be	AUX
aiua-10431	153	5	reported	report	VERB
aiua-10431	153	6	to	to	PART
aiua-10431	153	7	suppress	suppress	VERB
aiua-10431	153	8	hypothalamic	hypothalamic	ADJ
aiua-10431	153	9	gonadotropin	gonadotropin	NOUN
aiua-10431	153	10	-	-	PUNCT
aiua-10431	153	11	releasing	release	VERB
aiua-10431	153	12	hormone	hormone	NOUN
aiua-10431	153	13	(	(	PUNCT
aiua-10431	153	14	gnrh	gnrh	NOUN
aiua-10431	153	15	)	)	PUNCT
aiua-10431	153	16	at	at	ADP
aiua-10431	153	17	the	the	DET
aiua-10431	153	18	hypothalamic	hypothalamic	ADJ
aiua-10431	153	19	level	level	NOUN
aiua-10431	153	20	(	(	PUNCT
aiua-10431	153	21	34	34	NUM
aiua-10431	153	22	)	)	PUNCT
aiua-10431	153	23	.	.	PUNCT
aiua-10431	154	1	insulin	insulin	NOUN
aiua-10431	154	2	resistance	resistance	NOUN
aiua-10431	154	3	is	be	AUX
aiua-10431	154	4	another	another	DET
aiua-10431	154	5	mechanism	mechanism	NOUN
aiua-10431	154	6	that	that	PRON
aiua-10431	154	7	could	could	AUX
aiua-10431	154	8	be	be	AUX
aiua-10431	154	9	involved	involve	VERB
aiua-10431	154	10	in	in	ADP
aiua-10431	154	11	hypogonadism	hypogonadism	NOUN
aiua-10431	154	12	pathogenesis	pathogenesis	NOUN
aiua-10431	154	13	.	.	PUNCT
aiua-10431	155	1	insulin	insulin	NOUN
aiua-10431	155	2	resistance	resistance	NOUN
aiua-10431	155	3	and	and	CCONJ
aiua-10431	155	4	brain	brain	NOUN
aiua-10431	155	5	insulin	insulin	NOUN
aiua-10431	155	6	resistance	resistance	NOUN
aiua-10431	155	7	,	,	PUNCT
aiua-10431	155	8	which	which	PRON
aiua-10431	155	9	was	be	AUX
aiua-10431	155	10	defined	define	VERB
aiua-10431	155	11	as	as	ADP
aiua-10431	155	12	impaired	impaired	ADJ
aiua-10431	155	13	insulin	insulin	NOUN
aiua-10431	155	14	action	action	NOUN
aiua-10431	155	15	in	in	ADP
aiua-10431	155	16	the	the	DET
aiua-10431	155	17	neuron	neuron	NOUN
aiua-10431	155	18	(	(	PUNCT
aiua-10431	155	19	34	34	NUM
aiua-10431	155	20	)	)	PUNCT
aiua-10431	155	21	.	.	PUNCT
aiua-10431	156	1	normal	normal	ADJ
aiua-10431	156	2	insulin	insulin	NOUN
aiua-10431	156	3	response	response	NOUN
aiua-10431	156	4	is	be	AUX
aiua-10431	156	5	required	require	VERB
aiua-10431	156	6	for	for	SCONJ
aiua-10431	156	7	the	the	DET
aiua-10431	156	8	hpg	hpg	NOUN
aiua-10431	156	9	axis	axis	NOUN
aiua-10431	156	10	's	's	PART
aiua-10431	156	11	functional	functional	ADJ
aiua-10431	156	12	integrity	integrity	NOUN
aiua-10431	156	13	to	to	PART
aiua-10431	156	14	be	be	AUX
aiua-10431	156	15	maintained	maintain	VERB
aiua-10431	156	16	(	(	PUNCT
aiua-10431	156	17	35	35	NUM
aiua-10431	156	18	)	)	PUNCT
aiua-10431	156	19	.	.	PUNCT
aiua-10431	157	1	according	accord	VERB
aiua-10431	157	2	to	to	ADP
aiua-10431	157	3	one	one	NUM
aiua-10431	157	4	study	study	NOUN
aiua-10431	157	5	,	,	PUNCT
aiua-10431	157	6	hyperinsulinemia	hyperinsulinemia	NOUN
aiua-10431	157	7	caused	cause	VERB
aiua-10431	157	8	by	by	ADP
aiua-10431	157	9	neuronal	neuronal	ADJ
aiua-10431	157	10	insulin	insulin	NOUN
aiua-10431	157	11	receptor	receptor	NOUN
aiua-10431	157	12	knockout	knockout	NOUN
aiua-10431	157	13	can	can	AUX
aiua-10431	157	14	result	result	VERB
aiua-10431	157	15	in	in	ADP
aiua-10431	157	16	a	a	DET
aiua-10431	157	17	60	60	NUM
aiua-10431	157	18	-	-	SYM
aiua-10431	157	19	90	90	NUM
aiua-10431	157	20	%	%	NOUN
aiua-10431	157	21	decrease	decrease	NOUN
aiua-10431	157	22	in	in	ADP
aiua-10431	157	23	lh	lh	PROPN
aiua-10431	157	24	concentrations	concentration	NOUN
aiua-10431	157	25	(	(	PUNCT
aiua-10431	157	26	33	33	NUM
aiua-10431	157	27	)	)	PUNCT
aiua-10431	157	28	.	.	PUNCT
aiua-10431	158	1	another	another	DET
aiua-10431	158	2	mechanism	mechanism	NOUN
aiua-10431	158	3	could	could	AUX
aiua-10431	158	4	be	be	AUX
aiua-10431	158	5	related	relate	VERB
aiua-10431	158	6	to	to	ADP
aiua-10431	158	7	adipokines	adipokine	NOUN
aiua-10431	158	8	such	such	ADJ
aiua-10431	158	9	as	as	ADP
aiua-10431	158	10	leptin	leptin	NOUN
aiua-10431	158	11	and	and	CCONJ
aiua-10431	158	12	adiponectin	adiponectin	NOUN
aiua-10431	158	13	which	which	PRON
aiua-10431	158	14	have	have	AUX
aiua-10431	158	15	been	be	AUX
aiua-10431	158	16	reported	report	VERB
aiua-10431	158	17	to	to	PART
aiua-10431	158	18	have	have	VERB
aiua-10431	158	19	a	a	DET
aiua-10431	158	20	permissive	permissive	ADJ
aiua-10431	158	21	role	role	NOUN
aiua-10431	158	22	in	in	ADP
aiua-10431	158	23	the	the	DET
aiua-10431	158	24	regulation	regulation	NOUN
aiua-10431	158	25	of	of	ADP
aiua-10431	158	26	the	the	DET
aiua-10431	158	27	hypothalamic	hypothalamic	ADJ
aiua-10431	158	28	-	-	PUNCT
aiua-10431	158	29	pituitary	pituitary	ADJ
aiua-10431	158	30	-	-	PUNCT
aiua-10431	158	31	gonadal	gonadal	NOUN
aiua-10431	158	32	(	(	PUNCT
aiua-10431	158	33	hpg	hpg	NOUN
aiua-10431	158	34	)	)	PUNCT
aiua-10431	158	35	axis	axis	NOUN
aiua-10431	158	36	.	.	PUNCT
aiua-10431	159	1	leptin	leptin	NOUN
aiua-10431	159	2	resistance	resistance	NOUN
aiua-10431	159	3	in	in	ADP
aiua-10431	159	4	the	the	DET
aiua-10431	159	5	hypothalamus	hypothalamus	NOUN
aiua-10431	159	6	or	or	CCONJ
aiua-10431	159	7	other	other	ADJ
aiua-10431	159	8	neurons	neuron	NOUN
aiua-10431	159	9	may	may	AUX
aiua-10431	159	10	play	play	VERB
aiua-10431	159	11	a	a	DET
aiua-10431	159	12	role	role	NOUN
aiua-10431	159	13	in	in	ADP
aiua-10431	159	14	the	the	DET
aiua-10431	159	15	pathogenesis	pathogenesis	NOUN
aiua-10431	159	16	of	of	ADP
aiua-10431	159	17	hypogonadism	hypogonadism	NOUN
aiua-10431	159	18	seen	see	VERB
aiua-10431	159	19	in	in	ADP
aiua-10431	159	20	obesity	obesity	NOUN
aiua-10431	159	21	,	,	PUNCT
aiua-10431	159	22	insulin	insulin	NOUN
aiua-10431	159	23	resistance	resistance	NOUN
aiua-10431	159	24	,	,	PUNCT
aiua-10431	159	25	and	and	CCONJ
aiua-10431	159	26	t2	t2	NOUN
aiua-10431	159	27	dm	dm	X
aiua-10431	159	28	(	(	PUNCT
aiua-10431	159	29	29	29	NUM
aiua-10431	159	30	)	)	PUNCT
aiua-10431	159	31	.	.	PUNCT
aiua-10431	160	1	furthermore	furthermore	ADV
aiua-10431	160	2	,	,	PUNCT
aiua-10431	160	3	leptin	leptin	VERB
aiua-10431	160	4	directly	directly	ADV
aiua-10431	160	5	suppresses	suppress	VERB
aiua-10431	160	6	the	the	DET
aiua-10431	160	7	stimulatory	stimulatory	ADJ
aiua-10431	160	8	action	action	NOUN
aiua-10431	160	9	of	of	ADP
aiua-10431	160	10	gonadotropins	gonadotropin	NOUN
aiua-10431	160	11	on	on	ADP
aiua-10431	160	12	the	the	DET
aiua-10431	160	13	testicular	testicular	ADJ
aiua-10431	160	14	leydig	leydig	NOUN
aiua-10431	160	15	cells	cell	NOUN
aiua-10431	160	16	,	,	PUNCT
aiua-10431	160	17	reducing	reduce	VERB
aiua-10431	160	18	testosterone	testosterone	NOUN
aiua-10431	160	19	formation	formation	NOUN
aiua-10431	160	20	(	(	PUNCT
aiua-10431	160	21	28	28	NUM
aiua-10431	160	22	)	)	PUNCT
aiua-10431	160	23	.	.	PUNCT
aiua-10431	161	1	furthermore	furthermore	ADV
aiua-10431	161	2	,	,	PUNCT
aiua-10431	161	3	testosterone	testosterone	NOUN
aiua-10431	161	4	has	have	VERB
aiua-10431	161	5	a	a	DET
aiua-10431	161	6	direct	direct	ADJ
aiua-10431	161	7	correlation	correlation	NOUN
aiua-10431	161	8	with	with	ADP
aiua-10431	161	9	circulating	circulate	VERB
aiua-10431	161	10	adiponectin	adiponectin	NOUN
aiua-10431	161	11	(	(	PUNCT
aiua-10431	161	12	36	36	NUM
aiua-10431	161	13	)	)	PUNCT
aiua-10431	161	14	.	.	PUNCT
aiua-10431	162	1	finally	finally	ADV
aiua-10431	162	2	,	,	PUNCT
aiua-10431	162	3	the	the	DET
aiua-10431	162	4	aromatase	aromatase	NOUN
aiua-10431	162	5	enzyme	enzyme	NOUN
aiua-10431	162	6	converts	convert	NOUN
aiua-10431	162	7	testosterone	testosterone	NOUN
aiua-10431	162	8	to	to	ADP
aiua-10431	162	9	oestrogen	oestrogen	NOUN
aiua-10431	162	10	in	in	ADP
aiua-10431	162	11	adipose	adipose	ADJ
aiua-10431	162	12	tissue	tissue	NOUN
aiua-10431	162	13	,	,	PUNCT
aiua-10431	162	14	resulting	result	VERB
aiua-10431	162	15	in	in	ADP
aiua-10431	162	16	hypothalamic	hypothalamic	ADJ
aiua-10431	162	17	-	-	PUNCT
aiua-10431	162	18	pituitary	pituitary	ADJ
aiua-10431	162	19	-	-	PUNCT
aiua-10431	162	20	gonadal	gonadal	NOUN
aiua-10431	162	21	axis	axis	NOUN
aiua-10431	162	22	inhibition	inhibition	NOUN
aiua-10431	162	23	and	and	CCONJ
aiua-10431	162	24	subsequent	subsequent	ADJ
aiua-10431	162	25	hypogonadism	hypogonadism	NOUN
aiua-10431	162	26	(	(	PUNCT
aiua-10431	162	27	37	37	NUM
aiua-10431	162	28	)	)	PUNCT
aiua-10431	162	29	.	.	PUNCT
aiua-10431	163	1	in	in	ADP
aiua-10431	163	2	the	the	DET
aiua-10431	163	3	light	light	NOUN
aiua-10431	163	4	of	of	ADP
aiua-10431	163	5	those	those	DET
aiua-10431	163	6	postulated	postulate	VERB
aiua-10431	163	7	mechanisms	mechanism	NOUN
aiua-10431	163	8	for	for	ADP
aiua-10431	163	9	male	male	ADJ
aiua-10431	163	10	hypogonadism	hypogonadism	NOUN
aiua-10431	163	11	in	in	ADP
aiua-10431	163	12	diabetic	diabetic	ADJ
aiua-10431	163	13	patients	patient	NOUN
aiua-10431	163	14	,	,	PUNCT
aiua-10431	163	15	vai	vai	NOUN
aiua-10431	163	16	could	could	AUX
aiua-10431	163	17	be	be	AUX
aiua-10431	163	18	a	a	DET
aiua-10431	163	19	valuable	valuable	ADJ
aiua-10431	163	20	index	index	NOUN
aiua-10431	163	21	for	for	ADP
aiua-10431	163	22	predicting	predict	VERB
aiua-10431	163	23	male	male	ADJ
aiua-10431	163	24	hypogonadism	hypogonadism	NOUN
aiua-10431	163	25	and	and	CCONJ
aiua-10431	163	26	is	be	AUX
aiua-10431	163	27	linked	link	VERB
aiua-10431	163	28	with	with	ADP
aiua-10431	163	29	these	these	DET
aiua-10431	163	30	postulated	postulate	VERB
aiua-10431	163	31	mechanisms	mechanism	NOUN
aiua-10431	163	32	.	.	PUNCT
aiua-10431	164	1	vai	vai	VERB
aiua-10431	164	2	by	by	ADP
aiua-10431	164	3	involving	involve	VERB
aiua-10431	164	4	the	the	DET
aiua-10431	164	5	metabolic	metabolic	NOUN
aiua-10431	164	6	parameters	parameter	NOUN
aiua-10431	164	7	could	could	AUX
aiua-10431	164	8	reflect	reflect	VERB
aiua-10431	164	9	chronic	chronic	ADJ
aiua-10431	164	10	inflammatory	inflammatory	ADJ
aiua-10431	164	11	status	status	NOUN
aiua-10431	164	12	.	.	PUNCT
aiua-10431	165	1	decreases	decrease	NOUN
aiua-10431	165	2	in	in	ADP
aiua-10431	165	3	serum	serum	NOUN
aiua-10431	165	4	hdl	hdl	PROPN
aiua-10431	165	5	and	and	CCONJ
aiua-10431	165	6	increases	increase	NOUN
aiua-10431	165	7	in	in	ADP
aiua-10431	165	8	triglycerides	triglyceride	NOUN
aiua-10431	165	9	were	be	AUX
aiua-10431	165	10	reported	report	VERB
aiua-10431	165	11	to	to	PART
aiua-10431	165	12	be	be	AUX
aiua-10431	165	13	linked	link	VERB
aiua-10431	165	14	with	with	ADP
aiua-10431	165	15	inflammatory	inflammatory	ADJ
aiua-10431	165	16	status	status	NOUN
aiua-10431	165	17	and	and	CCONJ
aiua-10431	165	18	mediators	mediator	NOUN
aiua-10431	165	19	(	(	PUNCT
aiua-10431	165	20	38	38	NUM
aiua-10431	165	21	)	)	PUNCT
aiua-10431	165	22	.	.	PUNCT
aiua-10431	166	1	likewise	likewise	ADV
aiua-10431	166	2	,	,	PUNCT
aiua-10431	166	3	vai	vai	PROPN
aiua-10431	166	4	was	be	AUX
aiua-10431	166	5	reported	report	VERB
aiua-10431	166	6	to	to	PART
aiua-10431	166	7	be	be	AUX
aiua-10431	166	8	strongly	strongly	ADV
aiua-10431	166	9	correlated	correlate	VERB
aiua-10431	166	10	with	with	ADP
aiua-10431	166	11	insulin	insulin	NOUN
aiua-10431	166	12	resistance	resistance	NOUN
aiua-10431	166	13	estimated	estimate	VERB
aiua-10431	166	14	by	by	ADP
aiua-10431	166	15	homa	homa	PROPN
aiua-10431	166	16	-	-	PUNCT
aiua-10431	166	17	ir	ir	PROPN
aiua-10431	166	18	and	and	CCONJ
aiua-10431	166	19	metabolic	metabolic	NOUN
aiua-10431	166	20	syndrome	syndrome	NOUN
aiua-10431	166	21	(	(	PUNCT
aiua-10431	166	22	39	39	NUM
aiua-10431	166	23	,	,	PUNCT
aiua-10431	166	24	40	40	NUM
aiua-10431	166	25	)	)	PUNCT
aiua-10431	166	26	.	.	PUNCT
aiua-10431	167	1	furthermore	furthermore	ADV
aiua-10431	167	2	,	,	PUNCT
aiua-10431	167	3	among	among	ADP
aiua-10431	167	4	the	the	DET
aiua-10431	167	5	most	most	ADV
aiua-10431	167	6	commonly	commonly	ADV
aiua-10431	167	7	used	use	VERB
aiua-10431	167	8	adiposity	adiposity	NOUN
aiua-10431	167	9	assessment	assessment	NOUN
aiua-10431	167	10	indices	index	NOUN
aiua-10431	167	11	,	,	PUNCT
aiua-10431	167	12	vai	vai	NOUN
aiua-10431	167	13	has	have	VERB
aiua-10431	167	14	the	the	DET
aiua-10431	167	15	strongest	strong	ADJ
aiua-10431	167	16	correlation	correlation	NOUN
aiua-10431	167	17	with	with	ADP
aiua-10431	167	18	the	the	DET
aiua-10431	167	19	most	most	ADV
aiua-10431	167	20	well	well	ADV
aiua-10431	167	21	-	-	PUNCT
aiua-10431	167	22	known	know	VERB
aiua-10431	167	23	adipocytokines	adipocytokine	NOUN
aiua-10431	167	24	in	in	ADP
aiua-10431	167	25	diabetic	diabetic	ADJ
aiua-10431	167	26	patients	patient	NOUN
aiua-10431	167	27	(	(	PUNCT
aiua-10431	167	28	41	41	NUM
aiua-10431	167	29	)	)	PUNCT
aiua-10431	167	30	and	and	CCONJ
aiua-10431	167	31	non	non	ADJ
aiua-10431	167	32	-	-	ADJ
aiua-10431	167	33	diabetic	diabetic	ADJ
aiua-10431	167	34	(	(	PUNCT
aiua-10431	167	35	42	42	NUM
aiua-10431	167	36	)	)	PUNCT
aiua-10431	167	37	.	.	PUNCT
aiua-10431	168	1	finally	finally	ADV
aiua-10431	168	2	,	,	PUNCT
aiua-10431	168	3	a	a	DET
aiua-10431	168	4	population	population	NOUN
aiua-10431	168	5	-	-	PUNCT
aiua-10431	168	6	based	base	VERB
aiua-10431	168	7	study	study	NOUN
aiua-10431	168	8	observed	observe	VERB
aiua-10431	168	9	that	that	SCONJ
aiua-10431	168	10	vai	vai	PROPN
aiua-10431	168	11	correlates	correlate	VERB
aiua-10431	168	12	with	with	ADP
aiua-10431	168	13	estradiol	estradiol	PROPN
aiua-10431	168	14	levels	level	NOUN
aiua-10431	168	15	in	in	ADP
aiua-10431	168	16	males	male	NOUN
aiua-10431	168	17	which	which	PRON
aiua-10431	168	18	reflect	reflect	VERB
aiua-10431	168	19	aromatase	aromatase	ADJ
aiua-10431	168	20	enzyme	enzyme	NOUN
aiua-10431	168	21	activity	activity	NOUN
aiua-10431	168	22	(	(	PUNCT
aiua-10431	168	23	43	43	NUM
aiua-10431	168	24	)	)	PUNCT
aiua-10431	168	25	.	.	PUNCT
aiua-10431	169	1	hence	hence	ADV
aiua-10431	169	2	,	,	PUNCT
aiua-10431	169	3	the	the	DET
aiua-10431	169	4	vai	vai	ADJ
aiua-10431	169	5	value	value	NOUN
aiua-10431	169	6	could	could	AUX
aiua-10431	169	7	better	well	ADV
aiua-10431	169	8	reveal	reveal	VERB
aiua-10431	169	9	the	the	DET
aiua-10431	169	10	effects	effect	NOUN
aiua-10431	169	11	of	of	ADP
aiua-10431	169	12	wc	wc	PROPN
aiua-10431	169	13	,	,	PUNCT
aiua-10431	169	14	bmi	bmi	PROPN
aiua-10431	169	15	,	,	PUNCT
aiua-10431	169	16	hdl	hdl	PROPN
aiua-10431	169	17	,	,	PUNCT
aiua-10431	169	18	and	and	CCONJ
aiua-10431	169	19	tg	tg	PROPN
aiua-10431	169	20	on	on	ADP
aiua-10431	169	21	testosterone	testosterone	NOUN
aiua-10431	169	22	levels	level	NOUN
aiua-10431	169	23	.	.	PUNCT
aiua-10431	170	1	this	this	DET
aiua-10431	170	2	cross	cross	ADJ
aiua-10431	170	3	-	-	ADJ
aiua-10431	170	4	sectional	sectional	ADJ
aiua-10431	170	5	study	study	NOUN
aiua-10431	170	6	can	can	AUX
aiua-10431	170	7	not	not	PART
aiua-10431	170	8	inform	inform	VERB
aiua-10431	170	9	whether	whether	SCONJ
aiua-10431	170	10	low	low	ADJ
aiua-10431	170	11	testosterone	testosterone	NOUN
aiua-10431	170	12	is	be	AUX
aiua-10431	170	13	the	the	DET
aiua-10431	170	14	cause	cause	NOUN
aiua-10431	170	15	or	or	CCONJ
aiua-10431	170	16	the	the	DET
aiua-10431	170	17	result	result	NOUN
aiua-10431	170	18	of	of	ADP
aiua-10431	170	19	visceral	visceral	ADJ
aiua-10431	170	20	obesity	obesity	NOUN
aiua-10431	170	21	.	.	PUNCT
aiua-10431	171	1	current	current	ADJ
aiua-10431	171	2	evidence	evidence	NOUN
aiua-10431	171	3	,	,	PUNCT
aiua-10431	171	4	however	however	ADV
aiua-10431	171	5	,	,	PUNCT
aiua-10431	171	6	suggests	suggest	VERB
aiua-10431	171	7	that	that	SCONJ
aiua-10431	171	8	this	this	DET
aiua-10431	171	9	relationship	relationship	NOUN
aiua-10431	171	10	is	be	AUX
aiua-10431	171	11	bidirectional	bidirectional	ADJ
aiua-10431	171	12	(	(	PUNCT
aiua-10431	171	13	11	11	NUM
aiua-10431	171	14	)	)	PUNCT
aiua-10431	171	15	.	.	PUNCT
aiua-10431	172	1	a	a	DET
aiua-10431	172	2	two	two	NUM
aiua-10431	172	3	-	-	PUNCT
aiua-10431	172	4	way	way	NOUN
aiua-10431	172	5	relationship	relationship	NOUN
aiua-10431	172	6	between	between	ADP
aiua-10431	172	7	low	low	ADJ
aiua-10431	172	8	testosterone	testosterone	NOUN
aiua-10431	172	9	levels	level	NOUN
aiua-10431	172	10	and	and	CCONJ
aiua-10431	172	11	abdominal	abdominal	ADJ
aiua-10431	172	12	obesity	obesity	NOUN
aiua-10431	172	13	archivio	archivio	NOUN
aiua-10431	172	14	italiano	italiano	X
aiua-10431	172	15	di	di	X
aiua-10431	172	16	urologia	urologia	PROPN
aiua-10431	172	17	e	e	PROPN
aiua-10431	172	18	andrologia	andrologia	PROPN
aiua-10431	172	19	2022	2022	NUM
aiua-10431	172	20	;	;	PUNCT
aiua-10431	172	21	94	94	NUM
aiua-10431	172	22	,	,	PUNCT
aiua-10431	172	23	4	4	NUM
aiua-10431	172	24	s.i	s.i	PROPN
aiua-10431	172	25	.	.	PROPN
aiua-10431	172	26	gouda	gouda	PROPN
aiua-10431	172	27	,	,	PUNCT
aiua-10431	172	28	m.m	m.m	PROPN
aiua-10431	172	29	.	.	PROPN
aiua-10431	172	30	aboelnaga	aboelnaga	PROPN
aiua-10431	172	31	,	,	PUNCT
aiua-10431	172	32	a.m.g	a.m.g	NOUN
aiua-10431	172	33	.	.	PUNCT
aiua-10431	172	34	elbeltagy	elbeltagy	NOUN
aiua-10431	172	35	,	,	PUNCT
aiua-10431	172	36	a.	a.	PROPN
aiua-10431	172	37	elbaz	elbaz	PROPN
aiua-10431	172	38	468	468	NUM
aiua-10431	172	39	was	be	AUX
aiua-10431	172	40	reported	report	VERB
aiua-10431	172	41	(	(	PUNCT
aiua-10431	172	42	44	44	NUM
aiua-10431	172	43	)	)	PUNCT
aiua-10431	172	44	.	.	PUNCT
aiua-10431	173	1	weight	weight	NOUN
aiua-10431	173	2	loss	loss	NOUN
aiua-10431	173	3	could	could	AUX
aiua-10431	173	4	increase	increase	VERB
aiua-10431	173	5	testosterone	testosterone	NOUN
aiua-10431	173	6	levels	level	NOUN
aiua-10431	173	7	,	,	PUNCT
aiua-10431	173	8	indicating	indicate	VERB
aiua-10431	173	9	that	that	SCONJ
aiua-10431	173	10	testosterone	testosterone	NOUN
aiua-10431	173	11	deficiency	deficiency	NOUN
aiua-10431	173	12	is	be	AUX
aiua-10431	173	13	functional	functional	ADJ
aiua-10431	173	14	(	(	PUNCT
aiua-10431	173	15	45	45	NUM
aiua-10431	173	16	)	)	PUNCT
aiua-10431	173	17	.	.	PUNCT
aiua-10431	174	1	weight	weight	NOUN
aiua-10431	174	2	loss	loss	NOUN
aiua-10431	174	3	bariatric	bariatric	ADJ
aiua-10431	174	4	surgery	surgery	NOUN
aiua-10431	174	5	-	-	PUNCT
aiua-10431	174	6	induced	induce	VERB
aiua-10431	174	7	resulted	result	VERB
aiua-10431	174	8	in	in	ADP
aiua-10431	174	9	a	a	DET
aiua-10431	174	10	significant	significant	ADJ
aiua-10431	174	11	increase	increase	NOUN
aiua-10431	174	12	in	in	ADP
aiua-10431	174	13	testosterone	testosterone	NOUN
aiua-10431	174	14	levels	level	NOUN
aiua-10431	174	15	(	(	PUNCT
aiua-10431	174	16	46	46	NUM
aiua-10431	174	17	)	)	PUNCT
aiua-10431	174	18	.	.	PUNCT
aiua-10431	175	1	in	in	ADP
aiua-10431	175	2	contrast	contrast	NOUN
aiua-10431	175	3	,	,	PUNCT
aiua-10431	175	4	lower	low	ADJ
aiua-10431	175	5	testosterone	testosterone	NOUN
aiua-10431	175	6	level	level	NOUN
aiua-10431	175	7	after	after	SCONJ
aiua-10431	175	8	androgen	androgen	NOUN
aiua-10431	175	9	deprivation	deprivation	NOUN
aiua-10431	175	10	therapy	therapy	NOUN
aiua-10431	175	11	is	be	AUX
aiua-10431	175	12	associated	associate	VERB
aiua-10431	175	13	with	with	ADP
aiua-10431	175	14	weight	weight	NOUN
aiua-10431	175	15	gain	gain	NOUN
aiua-10431	175	16	(	(	PUNCT
aiua-10431	175	17	45	45	NUM
aiua-10431	175	18	)	)	PUNCT
aiua-10431	175	19	.	.	PUNCT
aiua-10431	176	1	in	in	ADP
aiua-10431	176	2	our	our	PRON
aiua-10431	176	3	study	study	NOUN
aiua-10431	176	4	,	,	PUNCT
aiua-10431	176	5	a	a	DET
aiua-10431	176	6	higher	high	ADJ
aiua-10431	176	7	prevalence	prevalence	NOUN
aiua-10431	176	8	of	of	ADP
aiua-10431	176	9	hypergonadtropic	hypergonadtropic	ADJ
aiua-10431	176	10	hypogonadism	hypogonadism	NOUN
aiua-10431	176	11	could	could	AUX
aiua-10431	176	12	point	point	VERB
aiua-10431	176	13	to	to	ADP
aiua-10431	176	14	an	an	DET
aiua-10431	176	15	increased	increase	VERB
aiua-10431	176	16	risk	risk	NOUN
aiua-10431	176	17	of	of	ADP
aiua-10431	176	18	t2	t2	NOUN
aiua-10431	176	19	dm	dm	NOUN
aiua-10431	176	20	with	with	ADP
aiua-10431	176	21	testosterone	testosterone	NOUN
aiua-10431	176	22	deficiency	deficiency	NOUN
aiua-10431	176	23	.	.	PUNCT
aiua-10431	177	1	this	this	DET
aiua-10431	177	2	study	study	NOUN
aiua-10431	177	3	is	be	AUX
aiua-10431	177	4	not	not	PART
aiua-10431	177	5	devoid	devoid	ADJ
aiua-10431	177	6	of	of	ADP
aiua-10431	177	7	some	some	DET
aiua-10431	177	8	limitations	limitation	NOUN
aiua-10431	177	9	,	,	PUNCT
aiua-10431	177	10	firstly	firstly	ADV
aiua-10431	177	11	the	the	DET
aiua-10431	177	12	cross	cross	ADJ
aiua-10431	177	13	-	-	ADJ
aiua-10431	177	14	sectional	sectional	ADJ
aiua-10431	177	15	design	design	NOUN
aiua-10431	177	16	.	.	PUNCT
aiua-10431	178	1	the	the	DET
aiua-10431	178	2	second	second	ADJ
aiua-10431	178	3	limitation	limitation	NOUN
aiua-10431	178	4	was	be	AUX
aiua-10431	178	5	the	the	DET
aiua-10431	178	6	relatively	relatively	ADV
aiua-10431	178	7	small	small	ADJ
aiua-10431	178	8	case	case	NOUN
aiua-10431	178	9	number	number	NOUN
aiua-10431	178	10	that	that	PRON
aiua-10431	178	11	might	might	AUX
aiua-10431	178	12	limit	limit	VERB
aiua-10431	178	13	the	the	DET
aiua-10431	178	14	power	power	NOUN
aiua-10431	178	15	to	to	PART
aiua-10431	178	16	detect	detect	VERB
aiua-10431	178	17	a	a	DET
aiua-10431	178	18	difference	difference	NOUN
aiua-10431	178	19	.	.	PUNCT
aiua-10431	179	1	thirdly	thirdly	ADV
aiua-10431	179	2	,	,	PUNCT
aiua-10431	179	3	because	because	SCONJ
aiua-10431	179	4	free	free	ADJ
aiua-10431	179	5	testosterone	testosterone	NOUN
aiua-10431	179	6	levels	level	NOUN
aiua-10431	179	7	can	can	AUX
aiua-10431	179	8	reflect	reflect	VERB
aiua-10431	179	9	the	the	DET
aiua-10431	179	10	extent	extent	NOUN
aiua-10431	179	11	of	of	ADP
aiua-10431	179	12	testosterone	testosterone	NOUN
aiua-10431	179	13	's	's	PART
aiua-10431	179	14	biological	biological	ADJ
aiua-10431	179	15	activities	activity	NOUN
aiua-10431	179	16	,	,	PUNCT
aiua-10431	179	17	free	free	ADJ
aiua-10431	179	18	testosterone	testosterone	NOUN
aiua-10431	179	19	concentration	concentration	NOUN
aiua-10431	179	20	should	should	AUX
aiua-10431	179	21	be	be	AUX
aiua-10431	179	22	used	use	VERB
aiua-10431	179	23	to	to	PART
aiua-10431	179	24	assess	assess	VERB
aiua-10431	179	25	hypogonadism	hypogonadism	NOUN
aiua-10431	179	26	.	.	PUNCT
aiua-10431	180	1	however	however	ADV
aiua-10431	180	2	,	,	PUNCT
aiua-10431	180	3	free	free	ADJ
aiua-10431	180	4	testosterone	testosterone	NOUN
aiua-10431	180	5	determination	determination	NOUN
aiua-10431	180	6	is	be	AUX
aiua-10431	180	7	difficult	difficult	ADJ
aiua-10431	180	8	,	,	PUNCT
aiua-10431	180	9	so	so	ADV
aiua-10431	180	10	free	free	ADJ
aiua-10431	180	11	testosterone	testosterone	NOUN
aiua-10431	180	12	is	be	AUX
aiua-10431	180	13	frequently	frequently	ADV
aiua-10431	180	14	calculated	calculate	VERB
aiua-10431	180	15	with	with	ADP
aiua-10431	180	16	a	a	DET
aiua-10431	180	17	formula	formula	NOUN
aiua-10431	180	18	in	in	ADP
aiua-10431	180	19	practical	practical	ADJ
aiua-10431	180	20	activity	activity	NOUN
aiua-10431	180	21	.	.	PUNCT
aiua-10431	181	1	finally	finally	ADV
aiua-10431	181	2	,	,	PUNCT
aiua-10431	181	3	this	this	DET
aiua-10431	181	4	study	study	NOUN
aiua-10431	181	5	is	be	AUX
aiua-10431	181	6	a	a	DET
aiua-10431	181	7	single	single	ADJ
aiua-10431	181	8	-	-	PUNCT
aiua-10431	181	9	centre	centre	NOUN
aiua-10431	181	10	study	study	NOUN
aiua-10431	181	11	in	in	ADP
aiua-10431	181	12	a	a	DET
aiua-10431	181	13	tertiary	tertiary	ADJ
aiua-10431	181	14	hospital	hospital	NOUN
aiua-10431	181	15	.	.	PUNCT
aiua-10431	182	1	therefore	therefore	ADV
aiua-10431	182	2	,	,	PUNCT
aiua-10431	182	3	patient	patient	ADJ
aiua-10431	182	4	selection	selection	NOUN
aiua-10431	182	5	bias	bias	NOUN
aiua-10431	182	6	might	might	AUX
aiua-10431	182	7	exist	exist	VERB
aiua-10431	182	8	.	.	PUNCT
aiua-10431	183	1	this	this	DET
aiua-10431	183	2	research	research	NOUN
aiua-10431	183	3	highlights	highlight	VERB
aiua-10431	183	4	the	the	DET
aiua-10431	183	5	value	value	NOUN
aiua-10431	183	6	of	of	ADP
aiua-10431	183	7	an	an	DET
aiua-10431	183	8	easily	easily	ADV
aiua-10431	183	9	applicable	applicable	ADJ
aiua-10431	183	10	tool	tool	NOUN
aiua-10431	183	11	such	such	ADJ
aiua-10431	183	12	as	as	ADP
aiua-10431	183	13	the	the	DET
aiua-10431	183	14	visceral	visceral	ADJ
aiua-10431	183	15	adiposity	adiposity	NOUN
aiua-10431	183	16	index	index	NOUN
aiua-10431	183	17	in	in	ADP
aiua-10431	183	18	predicting	predict	VERB
aiua-10431	183	19	testosterone	testosterone	NOUN
aiua-10431	183	20	deficiency	deficiency	NOUN
aiua-10431	183	21	in	in	ADP
aiua-10431	183	22	non	non	ADJ
aiua-10431	183	23	-	-	ADJ
aiua-10431	183	24	obese	obese	ADJ
aiua-10431	183	25	diabetics	diabetic	NOUN
aiua-10431	183	26	.	.	PUNCT
aiua-10431	184	1	vai	vai	NOUN
aiua-10431	184	2	could	could	AUX
aiua-10431	184	3	be	be	AUX
aiua-10431	184	4	more	more	ADV
aiua-10431	184	5	reliable	reliable	ADJ
aiua-10431	184	6	than	than	ADP
aiua-10431	184	7	other	other	ADJ
aiua-10431	184	8	parameters	parameter	NOUN
aiua-10431	184	9	in	in	ADP
aiua-10431	184	10	predicting	predict	VERB
aiua-10431	184	11	testosterone	testosterone	NOUN
aiua-10431	184	12	deficiency	deficiency	NOUN
aiua-10431	184	13	in	in	ADP
aiua-10431	184	14	diabetics	diabetic	NOUN
aiua-10431	184	15	.	.	PUNCT
aiua-10431	185	1	in	in	ADP
aiua-10431	185	2	conclusion	conclusion	NOUN
aiua-10431	185	3	,	,	PUNCT
aiua-10431	185	4	the	the	DET
aiua-10431	185	5	elevated	elevated	ADJ
aiua-10431	185	6	vai	vai	NOUN
aiua-10431	185	7	index	index	NOUN
aiua-10431	185	8	is	be	AUX
aiua-10431	185	9	associated	associate	VERB
aiua-10431	185	10	with	with	ADP
aiua-10431	185	11	higher	high	ADJ
aiua-10431	185	12	risks	risk	NOUN
aiua-10431	185	13	of	of	ADP
aiua-10431	185	14	testosterone	testosterone	NOUN
aiua-10431	185	15	deficiency	deficiency	NOUN
aiua-10431	185	16	in	in	ADP
aiua-10431	185	17	non	non	ADJ
aiua-10431	185	18	-	-	ADJ
aiua-10431	185	19	obese	obese	ADJ
aiua-10431	185	20	diabetic	diabetic	ADJ
aiua-10431	185	21	males	male	NOUN
aiua-10431	185	22	.	.	PUNCT
aiua-10431	186	1	vai	vai	PROPN
aiua-10431	186	2	is	be	AUX
aiua-10431	186	3	an	an	DET
aiua-10431	186	4	easily	easily	ADV
aiua-10431	186	5	applicable	applicable	ADJ
aiua-10431	186	6	reliable	reliable	ADJ
aiua-10431	186	7	index	index	NOUN
aiua-10431	186	8	for	for	ADP
aiua-10431	186	9	the	the	DET
aiua-10431	186	10	prediction	prediction	NOUN
aiua-10431	186	11	of	of	ADP
aiua-10431	186	12	male	male	ADJ
aiua-10431	186	13	hypogonadism	hypogonadism	NOUN
aiua-10431	186	14	in	in	ADP
aiua-10431	186	15	non	non	ADJ
aiua-10431	186	16	-	-	ADJ
aiua-10431	186	17	obese	obese	ADJ
aiua-10431	186	18	type	type	NOUN
aiua-10431	186	19	2	2	NUM
aiua-10431	186	20	diabetic	diabetic	ADJ
aiua-10431	186	21	male	male	ADJ
aiua-10431	186	22	patients	patient	NOUN
aiua-10431	186	23	.	.	PUNCT
aiua-10431	187	1	references	reference	NOUN
aiua-10431	187	2	1	1	NUM
aiua-10431	187	3	.	.	PUNCT
aiua-10431	188	1	hassan	hassan	PROPN
aiua-10431	188	2	m	m	PROPN
aiua-10431	188	3	,	,	PUNCT
aiua-10431	188	4	hatata	hatata	PROPN
aiua-10431	188	5	ez	ez	PROPN
aiua-10431	188	6	,	,	PUNCT
aiua-10431	188	7	al	al	PROPN
aiua-10431	188	8	-	-	PUNCT
aiua-10431	188	9	arman	arman	PROPN
aiua-10431	188	10	m	m	PROPN
aiua-10431	188	11	,	,	PUNCT
aiua-10431	188	12	aboelnaga	aboelnaga	NOUN
aiua-10431	188	13	mm	mm	INTJ
aiua-10431	188	14	.	.	PUNCT
aiua-10431	189	1	urinary	urinary	ADJ
aiua-10431	189	2	cystatin	cystatin	PROPN
aiua-10431	189	3	c	c	PROPN
aiua-10431	189	4	as	as	ADP
aiua-10431	189	5	a	a	DET
aiua-10431	189	6	biomarker	biomarker	NOUN
aiua-10431	189	7	of	of	ADP
aiua-10431	189	8	early	early	ADJ
aiua-10431	189	9	renal	renal	ADJ
aiua-10431	189	10	dysfunction	dysfunction	NOUN
aiua-10431	189	11	in	in	ADP
aiua-10431	189	12	type	type	NOUN
aiua-10431	189	13	2	2	NUM
aiua-10431	189	14	diabetic	diabetic	ADJ
aiua-10431	189	15	patients	patient	NOUN
aiua-10431	189	16	.	.	PUNCT
aiua-10431	190	1	diabetes	diabetes	VERB
aiua-10431	190	2	metab	metab	NOUN
aiua-10431	190	3	syndr	syndr	NOUN
aiua-10431	190	4	.	.	PUNCT
aiua-10431	190	5	2021	2021	NUM
aiua-10431	190	6	;	;	PUNCT
aiua-10431	190	7	15:102152	15:102152	NUM
aiua-10431	190	8	.	.	X
aiua-10431	191	1	2	2	NUM
aiua-10431	191	2	.	.	X
aiua-10431	191	3	gianatti	gianatti	PROPN
aiua-10431	191	4	ej	ej	PROPN
aiua-10431	191	5	,	,	PUNCT
aiua-10431	191	6	grossmann	grossmann	ADJ
aiua-10431	191	7	m.	m.	NOUN
aiua-10431	191	8	testosterone	testosterone	NOUN
aiua-10431	191	9	deficiency	deficiency	NOUN
aiua-10431	191	10	in	in	ADP
aiua-10431	191	11	men	man	NOUN
aiua-10431	191	12	with	with	ADP
aiua-10431	191	13	type	type	NOUN
aiua-10431	191	14	2	2	NUM
aiua-10431	191	15	diabetes	diabetes	NOUN
aiua-10431	191	16	:	:	PUNCT
aiua-10431	191	17	pathophysiology	pathophysiology	NOUN
aiua-10431	191	18	and	and	CCONJ
aiua-10431	191	19	treatment	treatment	NOUN
aiua-10431	191	20	.	.	PUNCT
aiua-10431	192	1	diabet	diabet	PROPN
aiua-10431	192	2	med	med	PROPN
aiua-10431	192	3	.	.	PUNCT
aiua-10431	192	4	2020	2020	NUM
aiua-10431	192	5	;	;	PUNCT
aiua-10431	192	6	37:174	37:174	ADV
aiua-10431	192	7	-	-	SYM
aiua-10431	192	8	186	186	NUM
aiua-10431	192	9	.	.	PUNCT
aiua-10431	193	1	3	3	X
aiua-10431	193	2	.	.	PUNCT
aiua-10431	193	3	anupam	anupam	PROPN
aiua-10431	193	4	b	b	PROPN
aiua-10431	193	5	,	,	PUNCT
aiua-10431	193	6	shivaprasad	shivaprasad	PROPN
aiua-10431	193	7	c	c	NOUN
aiua-10431	193	8	,	,	PUNCT
aiua-10431	193	9	vijaya	vijaya	PROPN
aiua-10431	193	10	s	s	PROPN
aiua-10431	193	11	,	,	PUNCT
aiua-10431	193	12	et	et	PROPN
aiua-10431	193	13	al	al	PROPN
aiua-10431	193	14	.	.	PUNCT
aiua-10431	194	1	prevalence	prevalence	NOUN
aiua-10431	194	2	of	of	ADP
aiua-10431	194	3	hypogonadism	hypogonadism	NOUN
aiua-10431	194	4	in	in	ADP
aiua-10431	194	5	patients	patient	NOUN
aiua-10431	194	6	with	with	ADP
aiua-10431	194	7	type	type	NOUN
aiua-10431	194	8	2	2	NUM
aiua-10431	194	9	diabetes	diabetes	NOUN
aiua-10431	194	10	mellitus	mellitus	NOUN
aiua-10431	194	11	among	among	ADP
aiua-10431	194	12	the	the	DET
aiua-10431	194	13	indian	indian	ADJ
aiua-10431	194	14	population	population	NOUN
aiua-10431	194	15	.	.	PUNCT
aiua-10431	195	1	diabetes	diabetes	VERB
aiua-10431	195	2	metab	metab	ADJ
aiua-10431	195	3	syndr	syndr	NOUN
aiua-10431	195	4	.	.	PUNCT
aiua-10431	196	1	2020	2020	NUM
aiua-10431	196	2	;	;	PUNCT
aiua-10431	196	3	14:1299	14:1299	X
aiua-10431	196	4	-	-	NOUN
aiua-10431	196	5	1304	1304	NUM
aiua-10431	196	6	.	.	PUNCT
aiua-10431	197	1	4	4	X
aiua-10431	197	2	.	.	AUX
aiua-10431	197	3	gianatti	gianatti	PROPN
aiua-10431	197	4	ej	ej	PROPN
aiua-10431	197	5	,	,	PUNCT
aiua-10431	197	6	grossmann	grossmann	ADJ
aiua-10431	197	7	m.	m.	NOUN
aiua-10431	197	8	testosterone	testosterone	NOUN
aiua-10431	197	9	deficiency	deficiency	NOUN
aiua-10431	197	10	in	in	ADP
aiua-10431	197	11	men	man	NOUN
aiua-10431	197	12	with	with	ADP
aiua-10431	197	13	type	type	NOUN
aiua-10431	197	14	2	2	NUM
aiua-10431	197	15	diabetes	diabetes	NOUN
aiua-10431	197	16	:	:	PUNCT
aiua-10431	197	17	pathophysiology	pathophysiology	NOUN
aiua-10431	197	18	and	and	CCONJ
aiua-10431	197	19	treatment	treatment	NOUN
aiua-10431	197	20	.	.	PUNCT
aiua-10431	198	1	diabet	diabet	PROPN
aiua-10431	198	2	med	med	PROPN
aiua-10431	198	3	.	.	PUNCT
aiua-10431	198	4	2020	2020	NUM
aiua-10431	198	5	;	;	PUNCT
aiua-10431	198	6	37:174	37:174	ADV
aiua-10431	198	7	-	-	SYM
aiua-10431	198	8	186	186	NUM
aiua-10431	198	9	.	.	PUNCT
aiua-10431	199	1	5	5	NUM
aiua-10431	199	2	.	.	X
aiua-10431	199	3	castellano	castellano	NOUN
aiua-10431	199	4	-	-	PUNCT
aiua-10431	199	5	castillo	castillo	PROPN
aiua-10431	199	6	d	d	PROPN
aiua-10431	199	7	,	,	PUNCT
aiua-10431	199	8	royo	royo	PROPN
aiua-10431	199	9	jl	jl	PROPN
aiua-10431	199	10	,	,	PUNCT
aiua-10431	199	11	martínez	martínez	PROPN
aiua-10431	199	12	-	-	PUNCT
aiua-10431	199	13	escribano	escribano	PROPN
aiua-10431	199	14	a	a	X
aiua-10431	199	15	,	,	PUNCT
aiua-10431	199	16	et	et	PROPN
aiua-10431	199	17	al	al	PROPN
aiua-10431	199	18	.	.	PUNCT
aiua-10431	200	1	effects	effect	NOUN
aiua-10431	200	2	of	of	ADP
aiua-10431	200	3	shbg	shbg	ADJ
aiua-10431	200	4	rs1799941	rs1799941	NOUN
aiua-10431	200	5	polymorphism	polymorphism	NOUN
aiua-10431	200	6	on	on	ADP
aiua-10431	200	7	free	free	ADJ
aiua-10431	200	8	testosterone	testosterone	NOUN
aiua-10431	200	9	levels	level	NOUN
aiua-10431	200	10	and	and	CCONJ
aiua-10431	200	11	hypogonadism	hypogonadism	NOUN
aiua-10431	200	12	risk	risk	NOUN
aiua-10431	200	13	in	in	ADP
aiua-10431	200	14	young	young	ADJ
aiua-10431	200	15	non	non	ADJ
aiua-10431	200	16	-	-	ADJ
aiua-10431	200	17	diabetic	diabetic	ADJ
aiua-10431	200	18	obese	obese	ADJ
aiua-10431	200	19	males	male	NOUN
aiua-10431	200	20	.	.	PUNCT
aiua-10431	201	1	j	j	PROPN
aiua-10431	201	2	clin	clin	PROPN
aiua-10431	201	3	med	med	PROPN
aiua-10431	201	4	.	.	PROPN
aiua-10431	201	5	2019	2019	NUM
aiua-10431	201	6	;	;	PUNCT
aiua-10431	201	7	8:1136	8:1136	NUM
aiua-10431	201	8	.	.	NOUN
aiua-10431	201	9	6	6	NUM
aiua-10431	201	10	.	.	X
aiua-10431	201	11	gianatti	gianatti	PROPN
aiua-10431	201	12	ej	ej	PROPN
aiua-10431	201	13	,	,	PUNCT
aiua-10431	201	14	grossmann	grossmann	ADJ
aiua-10431	201	15	m.	m.	NOUN
aiua-10431	201	16	testosterone	testosterone	NOUN
aiua-10431	201	17	deficiency	deficiency	NOUN
aiua-10431	201	18	in	in	ADP
aiua-10431	201	19	men	man	NOUN
aiua-10431	201	20	with	with	ADP
aiua-10431	201	21	type	type	NOUN
aiua-10431	201	22	2	2	NUM
aiua-10431	201	23	diabetes	diabetes	NOUN
aiua-10431	201	24	:	:	PUNCT
aiua-10431	201	25	pathophysiology	pathophysiology	NOUN
aiua-10431	201	26	and	and	CCONJ
aiua-10431	201	27	treatment	treatment	NOUN
aiua-10431	201	28	.	.	PUNCT
aiua-10431	202	1	diabet	diabet	PROPN
aiua-10431	202	2	med	med	PROPN
aiua-10431	202	3	.	.	PUNCT
aiua-10431	202	4	2020	2020	NUM
aiua-10431	202	5	;	;	PUNCT
aiua-10431	202	6	37:174	37:174	ADV
aiua-10431	202	7	-	-	SYM
aiua-10431	202	8	186	186	NUM
aiua-10431	202	9	.	.	PUNCT
aiua-10431	203	1	7	7	X
aiua-10431	203	2	.	.	X
aiua-10431	203	3	grossmann	grossmann	PROPN
aiua-10431	203	4	m.	m.	NOUN
aiua-10431	203	5	low	low	ADJ
aiua-10431	203	6	testosterone	testosterone	NOUN
aiua-10431	203	7	in	in	ADP
aiua-10431	203	8	men	man	NOUN
aiua-10431	203	9	with	with	ADP
aiua-10431	203	10	type	type	NOUN
aiua-10431	203	11	2	2	NUM
aiua-10431	203	12	diabetes	diabetes	NOUN
aiua-10431	203	13	:	:	PUNCT
aiua-10431	203	14	significance	significance	NOUN
aiua-10431	203	15	and	and	CCONJ
aiua-10431	203	16	treatment	treatment	NOUN
aiua-10431	203	17	.	.	PUNCT
aiua-10431	204	1	j	j	PROPN
aiua-10431	204	2	clin	clin	PROPN
aiua-10431	204	3	endocrinol	endocrinol	PROPN
aiua-10431	204	4	metab	metab	NOUN
aiua-10431	204	5	.	.	PUNCT
aiua-10431	205	1	2011	2011	NUM
aiua-10431	205	2	;	;	PUNCT
aiua-10431	205	3	96:23412353	96:23412353	X
aiua-10431	205	4	.	.	NOUN
aiua-10431	205	5	8	8	NUM
aiua-10431	205	6	.	.	PUNCT
aiua-10431	205	7	mozafar	mozafar	PROPN
aiua-10431	205	8	saadati	saadati	PROPN
aiua-10431	205	9	h	h	PROPN
aiua-10431	205	10	,	,	PUNCT
aiua-10431	205	11	sabour	sabour	PROPN
aiua-10431	205	12	s	s	PROPN
aiua-10431	205	13	,	,	PUNCT
aiua-10431	205	14	mansournia	mansournia	PROPN
aiua-10431	205	15	ma	ma	PROPN
aiua-10431	205	16	,	,	PUNCT
aiua-10431	205	17	et	et	PROPN
aiua-10431	205	18	al	al	PROPN
aiua-10431	205	19	.	.	PROPN
aiua-10431	205	20	effect	effect	PROPN
aiua-10431	205	21	modification	modification	NOUN
aiua-10431	205	22	of	of	ADP
aiua-10431	205	23	general	general	ADJ
aiua-10431	205	24	and	and	CCONJ
aiua-10431	205	25	central	central	ADJ
aiua-10431	205	26	obesity	obesity	NOUN
aiua-10431	205	27	by	by	ADP
aiua-10431	205	28	sex	sex	NOUN
aiua-10431	205	29	and	and	CCONJ
aiua-10431	205	30	age	age	NOUN
aiua-10431	205	31	on	on	ADP
aiua-10431	205	32	cardiovascular	cardiovascular	ADJ
aiua-10431	205	33	outcomes	outcome	NOUN
aiua-10431	205	34	:	:	PUNCT
aiua-10431	205	35	targeted	target	VERB
aiua-10431	205	36	maximum	maximum	ADJ
aiua-10431	205	37	likelihood	likelihood	NOUN
aiua-10431	205	38	estimation	estimation	NOUN
aiua-10431	205	39	in	in	ADP
aiua-10431	205	40	the	the	DET
aiua-10431	205	41	atherosclerosis	atherosclerosis	NOUN
aiua-10431	205	42	risk	risk	NOUN
aiua-10431	205	43	in	in	ADP
aiua-10431	205	44	communities	community	NOUN
aiua-10431	205	45	study	study	NOUN
aiua-10431	205	46	.	.	PUNCT
aiua-10431	206	1	diabetes	diabete	VERB
aiua-10431	206	2	metab	metab	NOUN
aiua-10431	206	3	syndr	syndr	NOUN
aiua-10431	206	4	.	.	PUNCT
aiua-10431	206	5	2021	2021	NUM
aiua-10431	206	6	;	;	PUNCT
aiua-10431	206	7	15:479	15:479	NUM
aiua-10431	206	8	-	-	SYM
aiua-10431	206	9	485	485	NUM
aiua-10431	206	10	.	.	NOUN
aiua-10431	207	1	9	9	NUM
aiua-10431	207	2	.	.	X
aiua-10431	207	3	fernandez	fernandez	PROPN
aiua-10431	207	4	cj	cj	PROPN
aiua-10431	207	5	,	,	PUNCT
aiua-10431	207	6	chacko	chacko	NOUN
aiua-10431	207	7	ec	ec	PROPN
aiua-10431	207	8	,	,	PUNCT
aiua-10431	207	9	pappachan	pappachan	PROPN
aiua-10431	207	10	jm	jm	PROPN
aiua-10431	207	11	.	.	PROPN
aiua-10431	207	12	male	male	ADJ
aiua-10431	207	13	obesity	obesity	NOUN
aiua-10431	207	14	-	-	PUNCT
aiua-10431	207	15	related	relate	VERB
aiua-10431	207	16	secondary	secondary	ADJ
aiua-10431	207	17	hypogonadism	hypogonadism	NOUN
aiua-10431	207	18	pathophysiology	pathophysiology	NOUN
aiua-10431	207	19	,	,	PUNCT
aiua-10431	207	20	clinical	clinical	ADJ
aiua-10431	207	21	implications	implication	NOUN
aiua-10431	207	22	and	and	CCONJ
aiua-10431	207	23	management	management	NOUN
aiua-10431	207	24	.	.	PUNCT
aiua-10431	208	1	eur	eur	PROPN
aiua-10431	208	2	endocrinol	endocrinol	NOUN
aiua-10431	208	3	.	.	PUNCT
aiua-10431	209	1	2019	2019	NUM
aiua-10431	209	2	;	;	PUNCT
aiua-10431	209	3	15:83	15:83	NUM
aiua-10431	209	4	-	-	SYM
aiua-10431	209	5	90	90	NUM
aiua-10431	209	6	.	.	PUNCT
aiua-10431	210	1	10	10	NUM
aiua-10431	210	2	.	.	PUNCT
aiua-10431	211	1	lee	lee	PROPN
aiua-10431	211	2	dm	dm	PROPN
aiua-10431	211	3	,	,	PUNCT
aiua-10431	211	4	o'neill	o'neill	PROPN
aiua-10431	211	5	tw	tw	PROPN
aiua-10431	211	6	,	,	PUNCT
aiua-10431	211	7	pye	pye	PROPN
aiua-10431	211	8	sr	sr	PROPN
aiua-10431	211	9	,	,	PUNCT
aiua-10431	211	10	et	et	PROPN
aiua-10431	211	11	al	al	PROPN
aiua-10431	211	12	.	.	PUNCT
aiua-10431	212	1	the	the	DET
aiua-10431	212	2	european	european	ADJ
aiua-10431	212	3	male	male	ADJ
aiua-10431	212	4	ageing	age	VERB
aiua-10431	212	5	study	study	NOUN
aiua-10431	212	6	(	(	PUNCT
aiua-10431	212	7	emas	emas	PROPN
aiua-10431	212	8	):	):	PUNCT
aiua-10431	212	9	design	design	NOUN
aiua-10431	212	10	,	,	PUNCT
aiua-10431	212	11	methods	method	NOUN
aiua-10431	212	12	and	and	CCONJ
aiua-10431	212	13	recruitment	recruitment	NOUN
aiua-10431	212	14	.	.	PUNCT
aiua-10431	213	1	int	int	PROPN
aiua-10431	214	1	j	j	PROPN
aiua-10431	214	2	androl	androl	PROPN
aiua-10431	214	3	.	.	PROPN
aiua-10431	214	4	2009	2009	NUM
aiua-10431	214	5	;	;	PUNCT
aiua-10431	214	6	32:11	32:11	NUM
aiua-10431	214	7	-	-	SYM
aiua-10431	214	8	24	24	NUM
aiua-10431	214	9	.	.	PUNCT
aiua-10431	215	1	11	11	NUM
aiua-10431	215	2	.	.	PUNCT
aiua-10431	215	3	ng	ng	PROPN
aiua-10431	215	4	tang	tang	PROPN
aiua-10431	215	5	fui	fui	PROPN
aiua-10431	215	6	m	m	PROPN
aiua-10431	215	7	,	,	PUNCT
aiua-10431	215	8	hoermann	hoermann	PROPN
aiua-10431	215	9	r	r	NOUN
aiua-10431	215	10	,	,	PUNCT
aiua-10431	215	11	et	et	PROPN
aiua-10431	215	12	al	al	PROPN
aiua-10431	215	13	.	.	PROPN
aiua-10431	215	14	obesity	obesity	NOUN
aiua-10431	215	15	and	and	CCONJ
aiua-10431	215	16	age	age	NOUN
aiua-10431	215	17	as	as	ADP
aiua-10431	215	18	dominant	dominant	ADJ
aiua-10431	215	19	correlates	correlate	NOUN
aiua-10431	215	20	of	of	ADP
aiua-10431	215	21	low	low	ADJ
aiua-10431	215	22	testosterone	testosterone	NOUN
aiua-10431	215	23	in	in	ADP
aiua-10431	215	24	men	man	NOUN
aiua-10431	215	25	irrespective	irrespective	ADV
aiua-10431	215	26	of	of	ADP
aiua-10431	215	27	diabetes	diabetes	NOUN
aiua-10431	215	28	status	status	NOUN
aiua-10431	215	29	.	.	PUNCT
aiua-10431	216	1	andrology	andrology	PROPN
aiua-10431	216	2	.	.	PUNCT
aiua-10431	217	1	2013	2013	NUM
aiua-10431	217	2	;	;	PUNCT
aiua-10431	217	3	1:906	1:906	NUM
aiua-10431	217	4	-	-	SYM
aiua-10431	217	5	912	912	NUM
aiua-10431	217	6	.	.	PUNCT
aiua-10431	218	1	12	12	NUM
aiua-10431	218	2	.	.	PUNCT
aiua-10431	219	1	amato	amato	PROPN
aiua-10431	219	2	mc	mc	PROPN
aiua-10431	219	3	,	,	PUNCT
aiua-10431	219	4	giordano	giordano	PROPN
aiua-10431	219	5	c	c	PROPN
aiua-10431	219	6	,	,	PUNCT
aiua-10431	219	7	galia	galia	PROPN
aiua-10431	219	8	m	m	PROPN
aiua-10431	219	9	,	,	PUNCT
aiua-10431	219	10	et	et	PROPN
aiua-10431	219	11	al	al	PROPN
aiua-10431	219	12	.	.	PUNCT
aiua-10431	220	1	visceral	visceral	ADJ
aiua-10431	220	2	adiposity	adiposity	NOUN
aiua-10431	220	3	index	index	NOUN
aiua-10431	220	4	:	:	PUNCT
aiua-10431	220	5	a	a	DET
aiua-10431	220	6	reliable	reliable	ADJ
aiua-10431	220	7	indicator	indicator	NOUN
aiua-10431	220	8	of	of	ADP
aiua-10431	220	9	visceral	visceral	ADJ
aiua-10431	220	10	fat	fat	ADJ
aiua-10431	220	11	function	function	NOUN
aiua-10431	220	12	associated	associate	VERB
aiua-10431	220	13	with	with	ADP
aiua-10431	220	14	cardiometabolic	cardiometabolic	ADJ
aiua-10431	220	15	risk	risk	NOUN
aiua-10431	220	16	.	.	PUNCT
aiua-10431	221	1	diabetes	diabetes	NOUN
aiua-10431	221	2	care	care	NOUN
aiua-10431	221	3	.	.	PUNCT
aiua-10431	222	1	2010	2010	NUM
aiua-10431	222	2	;	;	PUNCT
aiua-10431	222	3	33:920	33:920	NUM
aiua-10431	222	4	-	-	SYM
aiua-10431	222	5	922	922	NUM
aiua-10431	222	6	.	.	NOUN
aiua-10431	222	7	13	13	NUM
aiua-10431	222	8	.	.	PUNCT
aiua-10431	223	1	bhasin	bhasin	PROPN
aiua-10431	223	2	s	s	PROPN
aiua-10431	223	3	,	,	PUNCT
aiua-10431	223	4	cunningham	cunningham	PROPN
aiua-10431	223	5	gr	gr	PROPN
aiua-10431	223	6	,	,	PUNCT
aiua-10431	223	7	hayes	hayes	PROPN
aiua-10431	223	8	fj	fj	PROPN
aiua-10431	223	9	,	,	PUNCT
aiua-10431	223	10	et	et	PROPN
aiua-10431	223	11	al	al	PROPN
aiua-10431	223	12	.	.	PUNCT
aiua-10431	223	13	testosterone	testosterone	NOUN
aiua-10431	223	14	therapy	therapy	NOUN
aiua-10431	223	15	in	in	ADP
aiua-10431	223	16	men	man	NOUN
aiua-10431	223	17	with	with	ADP
aiua-10431	223	18	androgen	androgen	NOUN
aiua-10431	223	19	deficiency	deficiency	NOUN
aiua-10431	223	20	syndromes	syndrome	NOUN
aiua-10431	223	21	:	:	PUNCT
aiua-10431	223	22	an	an	DET
aiua-10431	223	23	endocrine	endocrine	ADJ
aiua-10431	223	24	society	society	NOUN
aiua-10431	223	25	clinical	clinical	ADJ
aiua-10431	223	26	practice	practice	NOUN
aiua-10431	223	27	guideline	guideline	NOUN
aiua-10431	223	28	.	.	PUNCT
aiua-10431	224	1	j	j	PROPN
aiua-10431	224	2	clin	clin	PROPN
aiua-10431	224	3	endocrinol	endocrinol	PROPN
aiua-10431	224	4	metab	metab	NOUN
aiua-10431	224	5	.	.	PUNCT
aiua-10431	225	1	2010	2010	NUM
aiua-10431	225	2	;	;	PUNCT
aiua-10431	225	3	95:25362559	95:25362559	NUM
aiua-10431	225	4	(	(	PUNCT
aiua-10431	225	5	erratum	erratum	PROPN
aiua-10431	225	6	in	in	ADP
aiua-10431	225	7	j	j	PROPN
aiua-10431	225	8	clin	clin	PROPN
aiua-10431	225	9	endocrinol	endocrinol	PROPN
aiua-10431	225	10	metab	metab	NOUN
aiua-10431	225	11	.	.	PUNCT
aiua-10431	226	1	2021	2021	NUM
aiua-10431	226	2	;	;	PUNCT
aiua-10431	226	3	106	106	NUM
aiua-10431	226	4	:	:	PUNCT
aiua-10431	226	5	e2848	e2848	NUM
aiua-10431	226	6	)	)	PUNCT
aiua-10431	226	7	14	14	NUM
aiua-10431	226	8	.	.	PUNCT
aiua-10431	227	1	tajar	tajar	VERB
aiua-10431	227	2	a	a	DET
aiua-10431	227	3	,	,	PUNCT
aiua-10431	227	4	forti	forti	NOUN
aiua-10431	227	5	g	g	PROPN
aiua-10431	227	6	,	,	PUNCT
aiua-10431	227	7	o'neill	o'neill	PROPN
aiua-10431	227	8	tw	tw	PROPN
aiua-10431	227	9	,	,	PUNCT
aiua-10431	227	10	et	et	PROPN
aiua-10431	227	11	al	al	PROPN
aiua-10431	227	12	.	.	PROPN
aiua-10431	228	1	characteristics	characteristic	NOUN
aiua-10431	228	2	of	of	ADP
aiua-10431	228	3	secondary	secondary	ADJ
aiua-10431	228	4	,	,	PUNCT
aiua-10431	228	5	primary	primary	ADJ
aiua-10431	228	6	,	,	PUNCT
aiua-10431	228	7	and	and	CCONJ
aiua-10431	228	8	compensated	compensate	VERB
aiua-10431	228	9	hypogonadism	hypogonadism	NOUN
aiua-10431	228	10	in	in	ADP
aiua-10431	228	11	aging	age	VERB
aiua-10431	228	12	men	man	NOUN
aiua-10431	228	13	:	:	PUNCT
aiua-10431	228	14	evidence	evidence	NOUN
aiua-10431	228	15	from	from	ADP
aiua-10431	228	16	the	the	DET
aiua-10431	228	17	european	european	ADJ
aiua-10431	228	18	male	male	ADJ
aiua-10431	228	19	ageing	age	VERB
aiua-10431	228	20	study	study	NOUN
aiua-10431	228	21	.	.	PUNCT
aiua-10431	229	1	j	j	PROPN
aiua-10431	229	2	clin	clin	PROPN
aiua-10431	229	3	endocrinol	endocrinol	PROPN
aiua-10431	229	4	metab	metab	NOUN
aiua-10431	229	5	.	.	PUNCT
aiua-10431	230	1	2010	2010	NUM
aiua-10431	230	2	;	;	PUNCT
aiua-10431	230	3	95:1810	95:1810	NOUN
aiua-10431	230	4	-	-	SYM
aiua-10431	230	5	8	8	NUM
aiua-10431	230	6	.	.	NOUN
aiua-10431	230	7	15	15	NUM
aiua-10431	230	8	.	.	X
aiua-10431	231	1	ganesh	ganesh	PROPN
aiua-10431	231	2	hk	hk	PROPN
aiua-10431	231	3	,	,	PUNCT
aiua-10431	231	4	vijaya	vijaya	PROPN
aiua-10431	231	5	sarathi	sarathi	PROPN
aiua-10431	231	6	ha	ha	INTJ
aiua-10431	231	7	,	,	PUNCT
aiua-10431	231	8	george	george	PROPN
aiua-10431	231	9	j	j	PROPN
aiua-10431	231	10	,	,	PUNCT
aiua-10431	231	11	et	et	PROPN
aiua-10431	231	12	al	al	PROPN
aiua-10431	231	13	.	.	PUNCT
aiua-10431	232	1	prevalence	prevalence	NOUN
aiua-10431	232	2	of	of	ADP
aiua-10431	232	3	hypogonadism	hypogonadism	NOUN
aiua-10431	232	4	in	in	ADP
aiua-10431	232	5	patients	patient	NOUN
aiua-10431	232	6	with	with	ADP
aiua-10431	232	7	type	type	NOUN
aiua-10431	232	8	2	2	NUM
aiua-10431	232	9	diabetes	diabetes	NOUN
aiua-10431	232	10	mellitus	mellitus	NOUN
aiua-10431	232	11	in	in	ADP
aiua-10431	232	12	an	an	DET
aiua-10431	232	13	asian	asian	ADJ
aiua-10431	232	14	indian	indian	ADJ
aiua-10431	232	15	study	study	NOUN
aiua-10431	232	16	group	group	NOUN
aiua-10431	232	17	.	.	PUNCT
aiua-10431	233	1	endocr	endocr	PROPN
aiua-10431	233	2	pract	pract	PROPN
aiua-10431	233	3	.	.	PUNCT
aiua-10431	234	1	2009	2009	NUM
aiua-10431	234	2	;	;	PUNCT
aiua-10431	234	3	15:513	15:513	NUM
aiua-10431	234	4	-	-	SYM
aiua-10431	234	5	520	520	NUM
aiua-10431	234	6	.	.	PUNCT
aiua-10431	235	1	16	16	NUM
aiua-10431	235	2	.	.	PUNCT
aiua-10431	236	1	al	al	PROPN
aiua-10431	236	2	-	-	PUNCT
aiua-10431	236	3	goblan	goblan	NOUN
aiua-10431	236	4	as	as	ADP
aiua-10431	236	5	,	,	PUNCT
aiua-10431	236	6	al	al	PROPN
aiua-10431	236	7	-	-	PUNCT
aiua-10431	236	8	alfi	alfi	PROPN
aiua-10431	236	9	ma	ma	PROPN
aiua-10431	236	10	,	,	PUNCT
aiua-10431	236	11	khan	khan	PROPN
aiua-10431	236	12	mz	mz	PROPN
aiua-10431	236	13	.	.	PROPN
aiua-10431	236	14	mechanism	mechanism	NOUN
aiua-10431	236	15	linking	link	VERB
aiua-10431	236	16	diabetes	diabetes	NOUN
aiua-10431	236	17	mellitus	mellitus	NOUN
aiua-10431	236	18	and	and	CCONJ
aiua-10431	236	19	obesity	obesity	NOUN
aiua-10431	236	20	.	.	PUNCT
aiua-10431	237	1	diabetes	diabetes	NOUN
aiua-10431	237	2	metab	metab	NOUN
aiua-10431	237	3	syndr	syndr	NOUN
aiua-10431	237	4	obes	obe	NOUN
aiua-10431	237	5	.	.	PUNCT
aiua-10431	238	1	2014	2014	NUM
aiua-10431	238	2	;	;	PUNCT
aiua-10431	238	3	7:587	7:587	NUM
aiua-10431	238	4	-	-	SYM
aiua-10431	238	5	591	591	NUM
aiua-10431	238	6	.	.	PUNCT
aiua-10431	239	1	17	17	NUM
aiua-10431	239	2	.	.	PUNCT
aiua-10431	240	1	turan	turan	PROPN
aiua-10431	240	2	e	e	PROPN
aiua-10431	240	3	,	,	PUNCT
aiua-10431	240	4	öztekin	öztekin	PROPN
aiua-10431	240	5	ü.	ü.	NOUN
aiua-10431	240	6	relationship	relationship	NOUN
aiua-10431	240	7	between	between	ADP
aiua-10431	240	8	visceral	visceral	ADJ
aiua-10431	240	9	adiposity	adiposity	NOUN
aiua-10431	240	10	index	index	NOUN
aiua-10431	240	11	and	and	CCONJ
aiua-10431	240	12	male	male	ADJ
aiua-10431	240	13	infertility	infertility	NOUN
aiua-10431	240	14	.	.	PUNCT
aiua-10431	241	1	andrologia	andrologia	PROPN
aiua-10431	241	2	.	.	PUNCT
aiua-10431	242	1	2020	2020	NUM
aiua-10431	242	2	;	;	PUNCT
aiua-10431	242	3	52	52	NUM
aiua-10431	242	4	:	:	PUNCT
aiua-10431	242	5	e13548	e13548	PROPN
aiua-10431	242	6	.	.	PUNCT
aiua-10431	243	1	18	18	NUM
aiua-10431	243	2	.	.	PUNCT
aiua-10431	244	1	haymana	haymana	PROPN
aiua-10431	244	2	c	c	PROPN
aiua-10431	244	3	,	,	PUNCT
aiua-10431	244	4	sonmez	sonmez	NOUN
aiua-10431	244	5	a	a	PRON
aiua-10431	244	6	,	,	PUNCT
aiua-10431	244	7	aydogdu	aydogdu	ADV
aiua-10431	244	8	a	a	X
aiua-10431	244	9	,	,	PUNCT
aiua-10431	244	10	et	et	PROPN
aiua-10431	244	11	al	al	PROPN
aiua-10431	244	12	.	.	PUNCT
aiua-10431	245	1	visceral	visceral	ADJ
aiua-10431	245	2	adiposity	adiposity	NOUN
aiua-10431	245	3	index	index	NOUN
aiua-10431	245	4	and	and	CCONJ
aiua-10431	245	5	triglyceride	triglyceride	ADJ
aiua-10431	245	6	/	/	SYM
aiua-10431	245	7	high	high	ADJ
aiua-10431	245	8	-	-	PUNCT
aiua-10431	245	9	density	density	NOUN
aiua-10431	245	10	lipoprotein	lipoprotein	ADJ
aiua-10431	245	11	cholesterol	cholesterol	NOUN
aiua-10431	245	12	ratio	ratio	NOUN
aiua-10431	245	13	in	in	ADP
aiua-10431	245	14	hypogonadism	hypogonadism	NOUN
aiua-10431	245	15	.	.	PUNCT
aiua-10431	246	1	arch	arch	ADJ
aiua-10431	246	2	endocrinol	endocrinol	NOUN
aiua-10431	246	3	metab	metab	NOUN
aiua-10431	246	4	.	.	PUNCT
aiua-10431	247	1	2017	2017	NUM
aiua-10431	247	2	;	;	PUNCT
aiua-10431	247	3	61:282	61:282	NUM
aiua-10431	247	4	-	-	SYM
aiua-10431	247	5	287	287	NUM
aiua-10431	247	6	.	.	PUNCT
aiua-10431	248	1	19	19	NUM
aiua-10431	248	2	.	.	X
aiua-10431	248	3	akdemir	akdemir	PROPN
aiua-10431	248	4	ao	ao	PROPN
aiua-10431	248	5	,	,	PUNCT
aiua-10431	248	6	karabakan	karabakan	PROPN
aiua-10431	248	7	m	m	PROPN
aiua-10431	248	8	,	,	PUNCT
aiua-10431	248	9	aktas	akta	NOUN
aiua-10431	248	10	bk	bk	PROPN
aiua-10431	248	11	,	,	PUNCT
aiua-10431	248	12	et	et	PROPN
aiua-10431	248	13	al	al	PROPN
aiua-10431	248	14	.	.	PUNCT
aiua-10431	249	1	visceral	visceral	ADJ
aiua-10431	249	2	adiposity	adiposity	NOUN
aiua-10431	249	3	index	index	NOUN
aiua-10431	249	4	is	be	AUX
aiua-10431	249	5	useful	useful	ADJ
aiua-10431	249	6	for	for	ADP
aiua-10431	249	7	evaluating	evaluate	VERB
aiua-10431	249	8	obesity	obesity	NOUN
aiua-10431	249	9	effect	effect	NOUN
aiua-10431	249	10	on	on	ADP
aiua-10431	249	11	erectile	erectile	ADJ
aiua-10431	249	12	dysfunction	dysfunction	NOUN
aiua-10431	249	13	.	.	PUNCT
aiua-10431	250	1	andrologia	andrologia	NOUN
aiua-10431	250	2	.	.	PUNCT
aiua-10431	251	1	2019	2019	NUM
aiua-10431	251	2	;	;	PUNCT
aiua-10431	252	1	51	51	NUM
aiua-10431	252	2	:	:	PUNCT
aiua-10431	252	3	e13282	e13282	ADJ
aiua-10431	252	4	.	.	PUNCT
aiua-10431	253	1	20	20	NUM
aiua-10431	253	2	.	.	X
aiua-10431	253	3	dursun	dursun	PROPN
aiua-10431	253	4	m	m	PROPN
aiua-10431	253	5	,	,	PUNCT
aiua-10431	253	6	besiroglu	besiroglu	PROPN
aiua-10431	253	7	h	h	PROPN
aiua-10431	253	8	,	,	PUNCT
aiua-10431	253	9	cakir	cakir	PROPN
aiua-10431	253	10	ss	ss	PROPN
aiua-10431	253	11	,	,	PUNCT
aiua-10431	253	12	et	et	PROPN
aiua-10431	253	13	al	al	PROPN
aiua-10431	253	14	.	.	PROPN
aiua-10431	253	15	increased	increase	VERB
aiua-10431	253	16	visceral	visceral	ADJ
aiua-10431	253	17	adiposity	adiposity	NOUN
aiua-10431	253	18	index	index	NOUN
aiua-10431	253	19	associated	associate	VERB
aiua-10431	253	20	with	with	ADP
aiua-10431	253	21	sexual	sexual	ADJ
aiua-10431	253	22	dysfunction	dysfunction	NOUN
aiua-10431	253	23	in	in	ADP
aiua-10431	253	24	men	man	NOUN
aiua-10431	253	25	.	.	PUNCT
aiua-10431	254	1	aging	age	VERB
aiua-10431	254	2	male	male	NOUN
aiua-10431	254	3	.	.	PUNCT
aiua-10431	255	1	2018	2018	NUM
aiua-10431	255	2	;	;	PUNCT
aiua-10431	255	3	21:187	21:187	NUM
aiua-10431	255	4	-	-	SYM
aiua-10431	255	5	192	192	NUM
aiua-10431	255	6	.	.	PUNCT
aiua-10431	256	1	21	21	NUM
aiua-10431	256	2	.	.	PUNCT
aiua-10431	257	1	ghazi	ghazi	PROPN
aiua-10431	257	2	s	s	PROPN
aiua-10431	257	3	,	,	PUNCT
aiua-10431	257	4	zohdy	zohdy	PROPN
aiua-10431	257	5	w	w	PROPN
aiua-10431	257	6	,	,	PUNCT
aiua-10431	257	7	elkhiat	elkhiat	PROPN
aiua-10431	257	8	y	y	PROPN
aiua-10431	257	9	,	,	PUNCT
aiua-10431	257	10	shamloul	shamloul	PROPN
aiua-10431	257	11	r.	r.	PROPN
aiua-10431	257	12	serum	serum	PROPN
aiua-10431	257	13	testosterone	testosterone	NOUN
aiua-10431	257	14	levels	level	NOUN
aiua-10431	257	15	in	in	ADP
aiua-10431	257	16	diabetic	diabetic	ADJ
aiua-10431	257	17	men	man	NOUN
aiua-10431	257	18	with	with	ADP
aiua-10431	257	19	and	and	CCONJ
aiua-10431	257	20	without	without	ADP
aiua-10431	257	21	erectile	erectile	ADJ
aiua-10431	257	22	dysfunction	dysfunction	NOUN
aiua-10431	257	23	.	.	PUNCT
aiua-10431	258	1	andrologia	andrologia	NOUN
aiua-10431	258	2	.	.	PUNCT
aiua-10431	258	3	2012	2012	NUM
aiua-10431	258	4	;	;	PUNCT
aiua-10431	258	5	44:373	44:373	NUM
aiua-10431	258	6	-	-	SYM
aiua-10431	258	7	380	380	NUM
aiua-10431	258	8	.	.	PUNCT
aiua-10431	259	1	22	22	NUM
aiua-10431	259	2	.	.	PUNCT
aiua-10431	260	1	al	al	PROPN
aiua-10431	260	2	hayek	hayek	PROPN
aiua-10431	260	3	aa	aa	PROPN
aiua-10431	260	4	,	,	PUNCT
aiua-10431	260	5	khader	khader	PROPN
aiua-10431	260	6	ys	ys	PROPN
aiua-10431	260	7	,	,	PUNCT
aiua-10431	260	8	jafal	jafal	VERB
aiua-10431	260	9	s	s	PROPN
aiua-10431	260	10	,	,	PUNCT
aiua-10431	260	11	et	et	PROPN
aiua-10431	260	12	al	al	PROPN
aiua-10431	260	13	.	.	PUNCT
aiua-10431	261	1	prevalence	prevalence	NOUN
aiua-10431	261	2	of	of	ADP
aiua-10431	261	3	low	low	ADJ
aiua-10431	261	4	testosterone	testosterone	NOUN
aiua-10431	261	5	levels	level	NOUN
aiua-10431	261	6	in	in	ADP
aiua-10431	261	7	men	man	NOUN
aiua-10431	261	8	with	with	ADP
aiua-10431	261	9	type	type	NOUN
aiua-10431	261	10	2	2	NUM
aiua-10431	261	11	diabetes	diabetes	NOUN
aiua-10431	261	12	mellitus	mellitus	NOUN
aiua-10431	261	13	:	:	PUNCT
aiua-10431	261	14	a	a	DET
aiua-10431	261	15	cross	cross	ADJ
aiua-10431	261	16	-	-	ADJ
aiua-10431	261	17	sectional	sectional	ADJ
aiua-10431	261	18	study	study	NOUN
aiua-10431	261	19	.	.	PUNCT
aiua-10431	262	1	j	j	PROPN
aiua-10431	262	2	family	family	PROPN
aiua-10431	262	3	community	community	NOUN
aiua-10431	262	4	med	me	VERB
aiua-10431	262	5	.	.	PUNCT
aiua-10431	262	6	2013	2013	NUM
aiua-10431	262	7	;	;	PUNCT
aiua-10431	262	8	20:179	20:179	NUM
aiua-10431	262	9	-	-	SYM
aiua-10431	262	10	186	186	NUM
aiua-10431	262	11	.	.	PUNCT
aiua-10431	263	1	23	23	NUM
aiua-10431	263	2	.	.	PUNCT
aiua-10431	264	1	fui	fui	PROPN
aiua-10431	264	2	mn	mn	PROPN
aiua-10431	264	3	,	,	PUNCT
aiua-10431	264	4	dupuis	dupuis	PROPN
aiua-10431	264	5	p	p	NOUN
aiua-10431	264	6	,	,	PUNCT
aiua-10431	264	7	grossmann	grossmann	ADJ
aiua-10431	264	8	m.	m.	NOUN
aiua-10431	264	9	lowered	lower	VERB
aiua-10431	264	10	testosterone	testosterone	NOUN
aiua-10431	264	11	in	in	ADP
aiua-10431	264	12	male	male	ADJ
aiua-10431	264	13	obesity	obesity	NOUN
aiua-10431	264	14	:	:	PUNCT
aiua-10431	264	15	mechanisms	mechanism	NOUN
aiua-10431	264	16	,	,	PUNCT
aiua-10431	264	17	morbidity	morbidity	NOUN
aiua-10431	264	18	and	and	CCONJ
aiua-10431	264	19	management	management	NOUN
aiua-10431	264	20	.	.	PUNCT
aiua-10431	265	1	asian	asian	PROPN
aiua-10431	265	2	j	j	PROPN
aiua-10431	265	3	androl	androl	PROPN
aiua-10431	265	4	.	.	PROPN
aiua-10431	265	5	2014	2014	NUM
aiua-10431	265	6	;	;	PUNCT
aiua-10431	265	7	16:223	16:223	NUM
aiua-10431	265	8	-	-	SYM
aiua-10431	265	9	231	231	NUM
aiua-10431	265	10	.	.	PUNCT
aiua-10431	266	1	24	24	NUM
aiua-10431	266	2	.	.	PUNCT
aiua-10431	267	1	anupam	anupam	PROPN
aiua-10431	267	2	b	b	PROPN
aiua-10431	267	3	,	,	PUNCT
aiua-10431	267	4	shivaprasad	shivaprasad	PROPN
aiua-10431	267	5	c	c	NOUN
aiua-10431	267	6	,	,	PUNCT
aiua-10431	267	7	vijaya	vijaya	PROPN
aiua-10431	267	8	s	s	PROPN
aiua-10431	267	9	,	,	PUNCT
aiua-10431	267	10	et	et	PROPN
aiua-10431	267	11	al	al	PROPN
aiua-10431	267	12	.	.	PUNCT
aiua-10431	268	1	prevalence	prevalence	NOUN
aiua-10431	268	2	of	of	ADP
aiua-10431	268	3	hypogonadism	hypogonadism	NOUN
aiua-10431	268	4	in	in	ADP
aiua-10431	268	5	patients	patient	NOUN
aiua-10431	268	6	with	with	ADP
aiua-10431	268	7	type	type	NOUN
aiua-10431	268	8	2	2	NUM
aiua-10431	268	9	diabetes	diabetes	NOUN
aiua-10431	268	10	mellitus	mellitus	NOUN
aiua-10431	268	11	among	among	ADP
aiua-10431	268	12	the	the	DET
aiua-10431	268	13	indian	indian	ADJ
aiua-10431	268	14	population	population	NOUN
aiua-10431	268	15	.	.	PUNCT
aiua-10431	269	1	diabetes	diabetes	VERB
aiua-10431	269	2	metab	metab	ADJ
aiua-10431	269	3	syndr	syndr	NOUN
aiua-10431	269	4	.	.	PUNCT
aiua-10431	270	1	2020	2020	NUM
aiua-10431	270	2	;	;	PUNCT
aiua-10431	270	3	14:1299	14:1299	X
aiua-10431	270	4	-	-	SYM
aiua-10431	270	5	1304	1304	NUM
aiua-10431	270	6	.	.	PUNCT
aiua-10431	271	1	25	25	NUM
aiua-10431	271	2	.	.	PUNCT
aiua-10431	271	3	tajar	tajar	VERB
aiua-10431	271	4	a	a	DET
aiua-10431	271	5	,	,	PUNCT
aiua-10431	271	6	forti	forti	NOUN
aiua-10431	271	7	g	g	PROPN
aiua-10431	271	8	,	,	PUNCT
aiua-10431	271	9	o'neill	o'neill	PROPN
aiua-10431	271	10	tw	tw	PROPN
aiua-10431	271	11	,	,	PUNCT
aiua-10431	271	12	et	et	PROPN
aiua-10431	271	13	al	al	PROPN
aiua-10431	271	14	.	.	PROPN
aiua-10431	272	1	characteristics	characteristic	NOUN
aiua-10431	272	2	of	of	ADP
aiua-10431	272	3	secondary	secondary	ADJ
aiua-10431	272	4	,	,	PUNCT
aiua-10431	272	5	primary	primary	ADJ
aiua-10431	272	6	,	,	PUNCT
aiua-10431	272	7	and	and	CCONJ
aiua-10431	272	8	compensated	compensate	VERB
aiua-10431	272	9	hypogonadism	hypogonadism	NOUN
aiua-10431	272	10	in	in	ADP
aiua-10431	272	11	aging	age	VERB
aiua-10431	272	12	men	man	NOUN
aiua-10431	272	13	:	:	PUNCT
aiua-10431	272	14	evidence	evidence	NOUN
aiua-10431	272	15	from	from	ADP
aiua-10431	272	16	the	the	DET
aiua-10431	272	17	european	european	ADJ
aiua-10431	272	18	male	male	ADJ
aiua-10431	272	19	ageing	age	VERB
aiua-10431	272	20	study	study	NOUN
aiua-10431	272	21	.	.	PUNCT
aiua-10431	273	1	j	j	PROPN
aiua-10431	273	2	clin	clin	PROPN
aiua-10431	273	3	endocrinol	endocrinol	PROPN
aiua-10431	273	4	metab	metab	NOUN
aiua-10431	273	5	.	.	PUNCT
aiua-10431	274	1	2010	2010	NUM
aiua-10431	274	2	;	;	PUNCT
aiua-10431	274	3	95:1810	95:1810	NOUN
aiua-10431	274	4	-	-	SYM
aiua-10431	274	5	1818	1818	NUM
aiua-10431	274	6	.	.	PUNCT
aiua-10431	275	1	26	26	NUM
aiua-10431	275	2	.	.	PUNCT
aiua-10431	276	1	zheng	zheng	PROPN
aiua-10431	276	2	r	r	PROPN
aiua-10431	276	3	,	,	PUNCT
aiua-10431	276	4	cao	cao	PROPN
aiua-10431	276	5	l	l	PROPN
aiua-10431	276	6	,	,	PUNCT
aiua-10431	276	7	cao	cao	PROPN
aiua-10431	276	8	w	w	PROPN
aiua-10431	276	9	,	,	PUNCT
aiua-10431	276	10	et	et	PROPN
aiua-10431	276	11	al	al	PROPN
aiua-10431	276	12	.	.	PUNCT
aiua-10431	276	13	risk	risk	NOUN
aiua-10431	276	14	factors	factor	NOUN
aiua-10431	276	15	for	for	ADP
aiua-10431	276	16	hypogonadism	hypogonadism	NOUN
aiua-10431	276	17	in	in	ADP
aiua-10431	276	18	male	male	ADJ
aiua-10431	276	19	patients	patient	NOUN
aiua-10431	276	20	with	with	ADP
aiua-10431	276	21	type	type	NOUN
aiua-10431	276	22	2	2	NUM
aiua-10431	276	23	diabetes	diabetes	NOUN
aiua-10431	276	24	.	.	PUNCT
aiua-10431	277	1	j	j	PROPN
aiua-10431	277	2	diabetes	diabetes	NOUN
aiua-10431	277	3	res	re	NOUN
aiua-10431	277	4	.	.	PROPN
aiua-10431	277	5	2016	2016	NUM
aiua-10431	277	6	;	;	PUNCT
aiua-10431	277	7	2016:5162167	2016:5162167	NUM
aiua-10431	277	8	.	.	X
aiua-10431	277	9	27	27	NUM
aiua-10431	277	10	.	.	PUNCT
aiua-10431	278	1	zheng	zheng	PROPN
aiua-10431	278	2	r	r	PROPN
aiua-10431	278	3	,	,	PUNCT
aiua-10431	278	4	cao	cao	PROPN
aiua-10431	278	5	l	l	PROPN
aiua-10431	278	6	,	,	PUNCT
aiua-10431	278	7	cao	cao	PROPN
aiua-10431	278	8	w	w	PROPN
aiua-10431	278	9	,	,	PUNCT
aiua-10431	278	10	et	et	PROPN
aiua-10431	278	11	al	al	PROPN
aiua-10431	278	12	.	.	PUNCT
aiua-10431	278	13	risk	risk	NOUN
aiua-10431	278	14	factors	factor	NOUN
aiua-10431	278	15	for	for	ADP
aiua-10431	278	16	hypogonadism	hypogonadism	NOUN
aiua-10431	278	17	in	in	ADP
aiua-10431	278	18	male	male	ADJ
aiua-10431	278	19	patients	patient	NOUN
aiua-10431	278	20	with	with	ADP
aiua-10431	278	21	type	type	NOUN
aiua-10431	278	22	2	2	NUM
aiua-10431	278	23	diabetes	diabetes	NOUN
aiua-10431	278	24	.	.	PUNCT
aiua-10431	279	1	j	j	PROPN
aiua-10431	279	2	diabetes	diabetes	NOUN
aiua-10431	279	3	res	re	NOUN
aiua-10431	279	4	.	.	PROPN
aiua-10431	279	5	2016	2016	NUM
aiua-10431	279	6	;	;	PUNCT
aiua-10431	280	1	2016:5162167	2016:5162167	NUM
aiua-10431	280	2	.	.	X
aiua-10431	281	1	469archivio	469archivio	PROPN
aiua-10431	281	2	italiano	italiano	NOUN
aiua-10431	281	3	di	di	NOUN
aiua-10431	281	4	urologia	urologia	PROPN
aiua-10431	281	5	e	e	PROPN
aiua-10431	281	6	andrologia	andrologia	PROPN
aiua-10431	281	7	2022	2022	NUM
aiua-10431	281	8	;	;	PUNCT
aiua-10431	281	9	94	94	NUM
aiua-10431	281	10	,	,	PUNCT
aiua-10431	281	11	4	4	NUM
aiua-10431	281	12	testosterone	testosterone	NOUN
aiua-10431	281	13	deficiency	deficiency	NOUN
aiua-10431	281	14	in	in	ADP
aiua-10431	281	15	non	non	ADJ
aiua-10431	281	16	-	-	ADJ
aiua-10431	281	17	obese	obese	ADJ
aiua-10431	281	18	type	type	NOUN
aiua-10431	281	19	2	2	NUM
aiua-10431	281	20	diabetic	diabetic	ADJ
aiua-10431	281	21	male	male	ADJ
aiua-10431	281	22	patients	patient	NOUN
aiua-10431	281	23	28	28	NUM
aiua-10431	281	24	.	.	PUNCT
aiua-10431	282	1	cai	cai	PROPN
aiua-10431	283	1	x	x	PROPN
aiua-10431	283	2	,	,	PUNCT
aiua-10431	283	3	tian	tian	PROPN
aiua-10431	283	4	y	y	PROPN
aiua-10431	283	5	,	,	PUNCT
aiua-10431	283	6	wu	wu	PROPN
aiua-10431	283	7	t	t	PROPN
aiua-10431	283	8	,	,	PUNCT
aiua-10431	283	9	et	et	PROPN
aiua-10431	283	10	al	al	PROPN
aiua-10431	283	11	.	.	PUNCT
aiua-10431	283	12	metabolic	metabolic	NOUN
aiua-10431	283	13	effects	effect	NOUN
aiua-10431	283	14	of	of	ADP
aiua-10431	283	15	testosterone	testosterone	NOUN
aiua-10431	283	16	replacement	replacement	NOUN
aiua-10431	283	17	therapy	therapy	NOUN
aiua-10431	283	18	on	on	ADP
aiua-10431	283	19	hypogonadal	hypogonadal	ADJ
aiua-10431	283	20	men	man	NOUN
aiua-10431	283	21	with	with	ADP
aiua-10431	283	22	type	type	NOUN
aiua-10431	283	23	2	2	NUM
aiua-10431	283	24	diabetes	diabetes	NOUN
aiua-10431	283	25	mellitus	mellitus	NOUN
aiua-10431	283	26	:	:	PUNCT
aiua-10431	283	27	a	a	DET
aiua-10431	283	28	systematic	systematic	ADJ
aiua-10431	283	29	review	review	NOUN
aiua-10431	283	30	and	and	CCONJ
aiua-10431	283	31	meta	meta	NOUN
aiua-10431	283	32	-	-	PUNCT
aiua-10431	283	33	analysis	analysis	NOUN
aiua-10431	283	34	of	of	ADP
aiua-10431	283	35	randomized	randomized	ADJ
aiua-10431	283	36	controlled	control	VERB
aiua-10431	283	37	trials	trial	NOUN
aiua-10431	283	38	.	.	PUNCT
aiua-10431	284	1	asian	asian	PROPN
aiua-10431	284	2	j	j	PROPN
aiua-10431	284	3	androl	androl	PROPN
aiua-10431	284	4	.	.	PROPN
aiua-10431	284	5	2014	2014	NUM
aiua-10431	284	6	;	;	PUNCT
aiua-10431	284	7	16:146	16:146	NUM
aiua-10431	284	8	-	-	SYM
aiua-10431	284	9	152	152	NUM
aiua-10431	284	10	.	.	PUNCT
aiua-10431	284	11	29	29	NUM
aiua-10431	284	12	.	.	PUNCT
aiua-10431	285	1	fukui	fukui	PROPN
aiua-10431	285	2	m	m	PROPN
aiua-10431	285	3	,	,	PUNCT
aiua-10431	285	4	tanaka	tanaka	PROPN
aiua-10431	285	5	m	m	PROPN
aiua-10431	285	6	,	,	PUNCT
aiua-10431	285	7	hasegawa	hasegawa	PROPN
aiua-10431	285	8	g	g	PROPN
aiua-10431	285	9	,	,	PUNCT
aiua-10431	285	10	et	et	PROPN
aiua-10431	285	11	al	al	PROPN
aiua-10431	285	12	.	.	PROPN
aiua-10431	285	13	association	association	PROPN
aiua-10431	285	14	between	between	ADP
aiua-10431	285	15	serum	serum	NOUN
aiua-10431	285	16	bioavailable	bioavailable	ADJ
aiua-10431	285	17	testosterone	testosterone	NOUN
aiua-10431	285	18	concentration	concentration	NOUN
aiua-10431	285	19	and	and	CCONJ
aiua-10431	285	20	the	the	DET
aiua-10431	285	21	ratio	ratio	NOUN
aiua-10431	285	22	of	of	ADP
aiua-10431	285	23	glycated	glycate	VERB
aiua-10431	285	24	albumin	albumin	NOUN
aiua-10431	285	25	to	to	ADP
aiua-10431	285	26	glycated	glycate	VERB
aiua-10431	285	27	hemoglobin	hemoglobin	NOUN
aiua-10431	285	28	in	in	ADP
aiua-10431	285	29	men	man	NOUN
aiua-10431	285	30	with	with	ADP
aiua-10431	285	31	type	type	NOUN
aiua-10431	285	32	2	2	NUM
aiua-10431	285	33	diabetes	diabetes	NOUN
aiua-10431	285	34	.	.	PUNCT
aiua-10431	286	1	diabetes	diabetes	NOUN
aiua-10431	286	2	care	care	NOUN
aiua-10431	286	3	.	.	PUNCT
aiua-10431	287	1	2008	2008	NUM
aiua-10431	287	2	;	;	PUNCT
aiua-10431	287	3	31:397	31:397	NUM
aiua-10431	287	4	-	-	SYM
aiua-10431	287	5	401	401	NUM
aiua-10431	287	6	.	.	PUNCT
aiua-10431	288	1	30	30	NUM
aiua-10431	288	2	.	.	PUNCT
aiua-10431	289	1	šimoniene	šimoniene	NOUN
aiua-10431	289	2	d	d	NOUN
aiua-10431	289	3	,	,	PUNCT
aiua-10431	289	4	platukiene	platukiene	VERB
aiua-10431	289	5	a	a	DET
aiua-10431	289	6	,	,	PUNCT
aiua-10431	289	7	prakapiene	prakapiene	NOUN
aiua-10431	289	8	e	e	NOUN
aiua-10431	289	9	,	,	PUNCT
aiua-10431	289	10	et	et	PROPN
aiua-10431	289	11	al	al	PROPN
aiua-10431	289	12	.	.	PUNCT
aiua-10431	290	1	insulin	insulin	NOUN
aiua-10431	290	2	resistance	resistance	NOUN
aiua-10431	290	3	in	in	ADP
aiua-10431	290	4	type	type	NOUN
aiua-10431	290	5	1	1	NUM
aiua-10431	290	6	diabetes	diabetes	NOUN
aiua-10431	290	7	mellitus	mellitus	NOUN
aiua-10431	290	8	and	and	CCONJ
aiua-10431	290	9	its	its	PRON
aiua-10431	290	10	association	association	NOUN
aiua-10431	290	11	with	with	ADP
aiua-10431	290	12	patient	patient	NOUN
aiua-10431	290	13	's	's	PART
aiua-10431	290	14	microand	microand	NOUN
aiua-10431	290	15	macrovascular	macrovascular	PROPN
aiua-10431	290	16	complications	complication	NOUN
aiua-10431	290	17	,	,	PUNCT
aiua-10431	290	18	sex	sex	NOUN
aiua-10431	290	19	hormones	hormone	NOUN
aiua-10431	290	20	,	,	PUNCT
aiua-10431	290	21	and	and	CCONJ
aiua-10431	290	22	other	other	ADJ
aiua-10431	290	23	clinical	clinical	ADJ
aiua-10431	290	24	data	datum	NOUN
aiua-10431	290	25	.	.	PUNCT
aiua-10431	291	1	diabetes	diabetes	NOUN
aiua-10431	291	2	ther	ther	ADV
aiua-10431	291	3	.	.	PUNCT
aiua-10431	292	1	2020	2020	NUM
aiua-10431	292	2	;	;	PUNCT
aiua-10431	292	3	11:161	11:161	NUM
aiua-10431	292	4	-	-	SYM
aiua-10431	292	5	174	174	NUM
aiua-10431	292	6	.	.	PUNCT
aiua-10431	293	1	31	31	NUM
aiua-10431	293	2	.	.	PUNCT
aiua-10431	294	1	blaya	blaya	NOUN
aiua-10431	294	2	r	r	PROPN
aiua-10431	294	3	,	,	PUNCT
aiua-10431	294	4	blaya	blaya	NOUN
aiua-10431	294	5	p	p	NOUN
aiua-10431	294	6	,	,	PUNCT
aiua-10431	294	7	rhoden	rhoden	ADJ
aiua-10431	294	8	l	l	NOUN
aiua-10431	294	9	,	,	PUNCT
aiua-10431	294	10	rhoden	rhoden	PROPN
aiua-10431	294	11	el	el	PROPN
aiua-10431	294	12	.	.	PROPN
aiua-10431	294	13	low	low	ADJ
aiua-10431	294	14	testosterone	testosterone	NOUN
aiua-10431	294	15	levels	level	NOUN
aiua-10431	294	16	and	and	CCONJ
aiua-10431	294	17	metabolic	metabolic	NOUN
aiua-10431	294	18	syndrome	syndrome	NOUN
aiua-10431	294	19	in	in	ADP
aiua-10431	294	20	aging	age	VERB
aiua-10431	294	21	male	male	NOUN
aiua-10431	294	22	.	.	PUNCT
aiua-10431	295	1	curr	curr	PROPN
aiua-10431	295	2	pharm	pharm	PROPN
aiua-10431	295	3	des	des	PROPN
aiua-10431	295	4	.	.	PROPN
aiua-10431	295	5	2017	2017	NUM
aiua-10431	295	6	;	;	PUNCT
aiua-10431	295	7	23:4470	23:4470	X
aiua-10431	295	8	-	-	SYM
aiua-10431	295	9	4474	4474	NUM
aiua-10431	295	10	.	.	PUNCT
aiua-10431	296	1	32	32	NUM
aiua-10431	296	2	.	.	PUNCT
aiua-10431	297	1	dandona	dandona	PROPN
aiua-10431	297	2	p	p	X
aiua-10431	297	3	,	,	PUNCT
aiua-10431	297	4	dhindsa	dhindsa	PROPN
aiua-10431	297	5	s.	s.	PROPN
aiua-10431	297	6	update	update	PROPN
aiua-10431	297	7	:	:	PUNCT
aiua-10431	297	8	hypogonadotropic	hypogonadotropic	ADJ
aiua-10431	297	9	hypogonadism	hypogonadism	NOUN
aiua-10431	297	10	in	in	ADP
aiua-10431	297	11	type	type	NOUN
aiua-10431	297	12	2	2	NUM
aiua-10431	297	13	diabetes	diabetes	NOUN
aiua-10431	297	14	and	and	CCONJ
aiua-10431	297	15	obesity	obesity	NOUN
aiua-10431	297	16	.	.	PUNCT
aiua-10431	298	1	j	j	PROPN
aiua-10431	298	2	clin	clin	PROPN
aiua-10431	298	3	endocrinol	endocrinol	PROPN
aiua-10431	298	4	metab	metab	NOUN
aiua-10431	298	5	.	.	PUNCT
aiua-10431	299	1	2011	2011	NUM
aiua-10431	299	2	;	;	PUNCT
aiua-10431	299	3	96:2643	96:2643	NOUN
aiua-10431	299	4	-	-	SYM
aiua-10431	299	5	2651	2651	NUM
aiua-10431	299	6	.	.	PUNCT
aiua-10431	300	1	33	33	NUM
aiua-10431	300	2	.	.	PUNCT
aiua-10431	301	1	watanobe	watanobe	PROPN
aiua-10431	301	2	h	h	PROPN
aiua-10431	301	3	,	,	PUNCT
aiua-10431	301	4	hayakawa	hayakawa	PROPN
aiua-10431	301	5	y.	y.	PROPN
aiua-10431	301	6	hypothalamic	hypothalamic	ADJ
aiua-10431	301	7	interleukin-1	interleukin-1	NOUN
aiua-10431	301	8	beta	beta	ADJ
aiua-10431	301	9	and	and	CCONJ
aiua-10431	301	10	tumor	tumor	NOUN
aiua-10431	301	11	necrosis	necrosis	NOUN
aiua-10431	301	12	factor	factor	NOUN
aiua-10431	301	13	-	-	PUNCT
aiua-10431	301	14	alpha	alpha	NOUN
aiua-10431	301	15	,	,	PUNCT
aiua-10431	301	16	but	but	CCONJ
aiua-10431	301	17	not	not	PART
aiua-10431	301	18	interleukin-6	interleukin-6	NUM
aiua-10431	301	19	,	,	PUNCT
aiua-10431	301	20	mediate	mediate	VERB
aiua-10431	301	21	the	the	DET
aiua-10431	301	22	endotoxin	endotoxin	ADV
aiua-10431	301	23	-	-	PUNCT
aiua-10431	301	24	induced	induce	VERB
aiua-10431	301	25	suppression	suppression	NOUN
aiua-10431	301	26	of	of	ADP
aiua-10431	301	27	the	the	DET
aiua-10431	301	28	reproductive	reproductive	ADJ
aiua-10431	301	29	axis	axis	NOUN
aiua-10431	301	30	in	in	ADP
aiua-10431	301	31	rats	rat	NOUN
aiua-10431	301	32	.	.	PUNCT
aiua-10431	302	1	endocrinology	endocrinology	NOUN
aiua-10431	302	2	.	.	PUNCT
aiua-10431	303	1	2003	2003	NUM
aiua-10431	303	2	;	;	PUNCT
aiua-10431	303	3	144:4868	144:4868	PROPN
aiua-10431	303	4	-	-	SYM
aiua-10431	303	5	4875	4875	NUM
aiua-10431	303	6	.	.	PUNCT
aiua-10431	304	1	34	34	NUM
aiua-10431	304	2	.	.	X
aiua-10431	304	3	brüning	brüne	VERB
aiua-10431	304	4	jc	jc	PROPN
aiua-10431	304	5	,	,	PUNCT
aiua-10431	304	6	gautam	gautam	PROPN
aiua-10431	304	7	d	d	PROPN
aiua-10431	304	8	,	,	PUNCT
aiua-10431	304	9	burks	burks	PROPN
aiua-10431	304	10	dj	dj	PROPN
aiua-10431	304	11	,	,	PUNCT
aiua-10431	304	12	et	et	PROPN
aiua-10431	304	13	al	al	PROPN
aiua-10431	304	14	.	.	PUNCT
aiua-10431	304	15	role	role	NOUN
aiua-10431	304	16	of	of	ADP
aiua-10431	304	17	brain	brain	NOUN
aiua-10431	304	18	insulin	insulin	NOUN
aiua-10431	304	19	receptor	receptor	NOUN
aiua-10431	304	20	in	in	ADP
aiua-10431	304	21	control	control	NOUN
aiua-10431	304	22	of	of	ADP
aiua-10431	304	23	body	body	NOUN
aiua-10431	304	24	weight	weight	NOUN
aiua-10431	304	25	and	and	CCONJ
aiua-10431	304	26	reproduction	reproduction	NOUN
aiua-10431	304	27	.	.	PUNCT
aiua-10431	305	1	science	science	NOUN
aiua-10431	305	2	.	.	PUNCT
aiua-10431	306	1	2000	2000	NUM
aiua-10431	306	2	;	;	PUNCT
aiua-10431	306	3	289:2122	289:2122	NUM
aiua-10431	306	4	-	-	SYM
aiua-10431	306	5	2125	2125	NUM
aiua-10431	306	6	.	.	PUNCT
aiua-10431	307	1	35	35	NUM
aiua-10431	307	2	.	.	NUM
aiua-10431	307	3	elsaied	elsaie	VERB
aiua-10431	307	4	ma	ma	PROPN
aiua-10431	307	5	,	,	PUNCT
aiua-10431	307	6	masallat	masallat	NOUN
aiua-10431	307	7	d	d	NOUN
aiua-10431	307	8	,	,	PUNCT
aiua-10431	307	9	abdel	abdel	PROPN
aiua-10431	307	10	-	-	PUNCT
aiua-10431	307	11	hamid	hamid	PROPN
aiua-10431	307	12	ia	ia	PROPN
aiua-10431	307	13	.	.	PROPN
aiua-10431	307	14	correlation	correlation	NOUN
aiua-10431	307	15	of	of	ADP
aiua-10431	307	16	adiponectin	adiponectin	NOUN
aiua-10431	307	17	with	with	ADP
aiua-10431	307	18	testosterone	testosterone	NOUN
aiua-10431	307	19	in	in	ADP
aiua-10431	307	20	patients	patient	NOUN
aiua-10431	307	21	with	with	ADP
aiua-10431	307	22	and	and	CCONJ
aiua-10431	307	23	without	without	ADP
aiua-10431	307	24	type	type	NOUN
aiua-10431	307	25	2	2	NUM
aiua-10431	307	26	diabetes	diabetes	NOUN
aiua-10431	307	27	and	and	CCONJ
aiua-10431	307	28	erectile	erectile	ADJ
aiua-10431	307	29	dysfunction	dysfunction	NOUN
aiua-10431	307	30	.	.	PUNCT
aiua-10431	308	1	am	be	AUX
aiua-10431	308	2	j	j	PROPN
aiua-10431	308	3	mens	mens	PROPN
aiua-10431	308	4	health	health	NOUN
aiua-10431	308	5	.	.	PUNCT
aiua-10431	309	1	2019	2019	NUM
aiua-10431	309	2	;	;	PUNCT
aiua-10431	310	1	13:1557988318807049	13:1557988318807049	X
aiua-10431	310	2	.	.	NOUN
aiua-10431	310	3	36	36	NUM
aiua-10431	310	4	.	.	PUNCT
aiua-10431	311	1	c.	c.	PROPN
aiua-10431	311	2	langer	langer	PROPN
aiua-10431	311	3	,	,	PUNCT
aiua-10431	311	4	b.	b.	PROPN
aiua-10431	311	5	gansz	gansz	PROPN
aiua-10431	311	6	,	,	PUNCT
aiua-10431	312	1	c.	c.	PROPN
aiua-10431	312	2	goepfert	goepfert	PROPN
aiua-10431	312	3	et	et	PROPN
aiua-10431	312	4	al	al	PROPN
aiua-10431	312	5	.	.	PROPN
aiua-10431	312	6	testosterone	testosterone	PROPN
aiua-10431	312	7	up	up	ADP
aiua-10431	312	8	-	-	PUNCT
aiua-10431	312	9	regulates	regulate	VERB
aiua-10431	312	10	scavenger	scavenger	NOUN
aiua-10431	312	11	receptor	receptor	NOUN
aiua-10431	312	12	bi	bi	NOUN
aiua-10431	312	13	and	and	CCONJ
aiua-10431	312	14	stimulates	stimulate	VERB
aiua-10431	312	15	cholesterol	cholesterol	NOUN
aiua-10431	312	16	efflux	efflux	NOUN
aiua-10431	312	17	from	from	ADP
aiua-10431	312	18	macrophages	macrophage	NOUN
aiua-10431	312	19	.	.	PUNCT
aiua-10431	313	1	biochemical	biochemical	ADJ
aiua-10431	313	2	and	and	CCONJ
aiua-10431	313	3	biophysical	biophysical	ADJ
aiua-10431	313	4	research	research	NOUN
aiua-10431	313	5	communications	communication	NOUN
aiua-10431	313	6	2002	2002	NUM
aiua-10431	313	7	;	;	PUNCT
aiua-10431	313	8	296:1051	296:1051	NUM
aiua-10431	313	9	-	-	SYM
aiua-10431	313	10	1057	1057	NUM
aiua-10431	313	11	37	37	NUM
aiua-10431	313	12	.	.	PUNCT
aiua-10431	314	1	feingold	feingold	PROPN
aiua-10431	314	2	kr	kr	PROPN
aiua-10431	314	3	,	,	PUNCT
aiua-10431	314	4	grunfeld	grunfeld	PROPN
aiua-10431	314	5	c.	c.	PROPN
aiua-10431	314	6	the	the	DET
aiua-10431	314	7	effect	effect	NOUN
aiua-10431	314	8	of	of	ADP
aiua-10431	314	9	inflammation	inflammation	NOUN
aiua-10431	314	10	and	and	CCONJ
aiua-10431	314	11	infection	infection	NOUN
aiua-10431	314	12	on	on	ADP
aiua-10431	314	13	lipids	lipid	NOUN
aiua-10431	314	14	and	and	CCONJ
aiua-10431	314	15	lipoproteins	lipoprotein	NOUN
aiua-10431	314	16	.	.	PUNCT
aiua-10431	315	1	in	in	ADP
aiua-10431	315	2	:	:	PUNCT
aiua-10431	315	3	feingold	feingold	PROPN
aiua-10431	315	4	kr	kr	PROPN
aiua-10431	315	5	,	,	PUNCT
aiua-10431	315	6	anawalt	anawalt	PROPN
aiua-10431	315	7	b	b	PROPN
aiua-10431	315	8	,	,	PUNCT
aiua-10431	315	9	boyce	boyce	PROPN
aiua-10431	315	10	a	a	PROPN
aiua-10431	315	11	,	,	PUNCT
aiua-10431	315	12	et	et	PROPN
aiua-10431	315	13	al	al	PROPN
aiua-10431	315	14	.	.	PROPN
aiua-10431	315	15	,	,	PUNCT
aiua-10431	315	16	eds	eds	PROPN
aiua-10431	315	17	.	.	PUNCT
aiua-10431	315	18	endotext	endotext	NOUN
aiua-10431	315	19	.	.	PUNCT
aiua-10431	316	1	south	south	PROPN
aiua-10431	316	2	dartmouth	dartmouth	PROPN
aiua-10431	316	3	(	(	PUNCT
aiua-10431	316	4	ma	ma	PROPN
aiua-10431	316	5	):	):	PUNCT
aiua-10431	316	6	mdtext.com	mdtext.com	PROPN
aiua-10431	316	7	,	,	PUNCT
aiua-10431	316	8	inc	inc	PROPN
aiua-10431	316	9	.	.	PROPN
aiua-10431	316	10	;	;	PUNCT
aiua-10431	316	11	january	january	PROPN
aiua-10431	316	12	8	8	NUM
aiua-10431	316	13	,	,	PUNCT
aiua-10431	316	14	2019	2019	NUM
aiua-10431	316	15	.	.	PUNCT
aiua-10431	317	1	38	38	NUM
aiua-10431	317	2	.	.	PUNCT
aiua-10431	318	1	ji	ji	PROPN
aiua-10431	318	2	b	b	PROPN
aiua-10431	318	3	,	,	PUNCT
aiua-10431	318	4	qu	qu	PROPN
aiua-10431	318	5	h	h	PROPN
aiua-10431	318	6	,	,	PUNCT
aiua-10431	318	7	wang	wang	PROPN
aiua-10431	318	8	h	h	PROPN
aiua-10431	318	9	,	,	PUNCT
aiua-10431	318	10	et	et	PROPN
aiua-10431	318	11	al	al	PROPN
aiua-10431	318	12	.	.	PROPN
aiua-10431	318	13	association	association	PROPN
aiua-10431	318	14	between	between	ADP
aiua-10431	318	15	the	the	DET
aiua-10431	318	16	visceral	visceral	ADJ
aiua-10431	318	17	adiposity	adiposity	NOUN
aiua-10431	318	18	index	index	NOUN
aiua-10431	318	19	and	and	CCONJ
aiua-10431	318	20	homeostatic	homeostatic	ADJ
aiua-10431	318	21	model	model	NOUN
aiua-10431	318	22	assessment	assessment	NOUN
aiua-10431	318	23	of	of	ADP
aiua-10431	318	24	insulin	insulin	NOUN
aiua-10431	318	25	resistance	resistance	NOUN
aiua-10431	318	26	in	in	ADP
aiua-10431	318	27	participants	participant	NOUN
aiua-10431	318	28	with	with	ADP
aiua-10431	318	29	normal	normal	ADJ
aiua-10431	318	30	waist	waist	NOUN
aiua-10431	318	31	circumference	circumference	NOUN
aiua-10431	318	32	.	.	PUNCT
aiua-10431	319	1	angiology	angiology	NOUN
aiua-10431	319	2	.	.	PUNCT
aiua-10431	320	1	2017	2017	NUM
aiua-10431	320	2	;	;	PUNCT
aiua-10431	320	3	68:716	68:716	PROPN
aiua-10431	320	4	-	-	SYM
aiua-10431	320	5	721	721	NUM
aiua-10431	320	6	.	.	NOUN
aiua-10431	320	7	39	39	NUM
aiua-10431	320	8	.	.	PUNCT
aiua-10431	321	1	štepánek	štepánek	ADJ
aiua-10431	321	2	l	l	NOUN
aiua-10431	321	3	,	,	PUNCT
aiua-10431	321	4	horáková	horáková	PROPN
aiua-10431	321	5	d	d	PROPN
aiua-10431	321	6	,	,	PUNCT
aiua-10431	321	7	cibicková	cibicková	X
aiua-10431	321	8	l	l	NOUN
aiua-10431	321	9	,	,	PUNCT
aiua-10431	321	10	et	et	PROPN
aiua-10431	321	11	al	al	PROPN
aiua-10431	321	12	.	.	PROPN
aiua-10431	322	1	can	can	AUX
aiua-10431	322	2	visceral	visceral	ADJ
aiua-10431	322	3	adiposity	adiposity	NOUN
aiua-10431	322	4	index	index	NOUN
aiua-10431	322	5	serve	serve	VERB
aiua-10431	322	6	as	as	ADP
aiua-10431	322	7	a	a	DET
aiua-10431	322	8	simple	simple	ADJ
aiua-10431	322	9	tool	tool	NOUN
aiua-10431	322	10	for	for	ADP
aiua-10431	322	11	identifying	identify	VERB
aiua-10431	322	12	individuals	individual	NOUN
aiua-10431	322	13	with	with	ADP
aiua-10431	322	14	insulin	insulin	NOUN
aiua-10431	322	15	resistance	resistance	NOUN
aiua-10431	322	16	in	in	ADP
aiua-10431	322	17	daily	daily	ADJ
aiua-10431	322	18	clinical	clinical	ADJ
aiua-10431	322	19	practice	practice	NOUN
aiua-10431	322	20	?	?	PUNCT
aiua-10431	322	21	.	.	PUNCT
aiua-10431	323	1	medicina	medicina	PROPN
aiua-10431	323	2	(	(	PUNCT
aiua-10431	323	3	kaunas	kaunas	PROPN
aiua-10431	323	4	)	)	PUNCT
aiua-10431	323	5	.	.	PUNCT
aiua-10431	324	1	2019	2019	NUM
aiua-10431	324	2	;	;	PUNCT
aiua-10431	324	3	55:545	55:545	NUM
aiua-10431	324	4	.	.	PUNCT
aiua-10431	325	1	40	40	NUM
aiua-10431	325	2	.	.	PUNCT
aiua-10431	326	1	amato	amato	PROPN
aiua-10431	326	2	mc	mc	PROPN
aiua-10431	326	3	,	,	PUNCT
aiua-10431	326	4	pizzolanti	pizzolanti	VERB
aiua-10431	326	5	g	g	PROPN
aiua-10431	326	6	,	,	PUNCT
aiua-10431	326	7	torregrossa	torregrossa	ADJ
aiua-10431	326	8	v	v	NOUN
aiua-10431	326	9	,	,	PUNCT
aiua-10431	326	10	et	et	PROPN
aiua-10431	326	11	al	al	PROPN
aiua-10431	326	12	.	.	PUNCT
aiua-10431	327	1	visceral	visceral	ADJ
aiua-10431	327	2	adiposity	adiposity	NOUN
aiua-10431	327	3	index	index	NOUN
aiua-10431	327	4	(	(	PUNCT
aiua-10431	327	5	vai	vai	NOUN
aiua-10431	327	6	)	)	PUNCT
aiua-10431	327	7	is	be	AUX
aiua-10431	327	8	predictive	predictive	ADJ
aiua-10431	327	9	of	of	ADP
aiua-10431	327	10	an	an	DET
aiua-10431	327	11	altered	alter	VERB
aiua-10431	327	12	adipokine	adipokine	ADJ
aiua-10431	327	13	profile	profile	NOUN
aiua-10431	327	14	in	in	ADP
aiua-10431	327	15	patients	patient	NOUN
aiua-10431	327	16	with	with	ADP
aiua-10431	327	17	type	type	NOUN
aiua-10431	327	18	2	2	NUM
aiua-10431	327	19	diabetes	diabetes	NOUN
aiua-10431	327	20	.	.	PUNCT
aiua-10431	328	1	plos	plos	PROPN
aiua-10431	328	2	one	one	NUM
aiua-10431	328	3	.	.	PUNCT
aiua-10431	328	4	2014	2014	NUM
aiua-10431	328	5	;	;	PUNCT
aiua-10431	328	6	9	9	NUM
aiua-10431	328	7	:	:	SYM
aiua-10431	328	8	e91969	e91969	NOUN
aiua-10431	328	9	.	.	PROPN
aiua-10431	328	10	41	41	NUM
aiua-10431	328	11	.	.	PUNCT
aiua-10431	329	1	al	al	PROPN
aiua-10431	329	2	-	-	PUNCT
aiua-10431	329	3	daghri	daghri	PROPN
aiua-10431	329	4	nm	nm	PROPN
aiua-10431	329	5	,	,	PUNCT
aiua-10431	329	6	al	al	PROPN
aiua-10431	329	7	-	-	PUNCT
aiua-10431	329	8	attas	attas	PROPN
aiua-10431	329	9	os	os	PROPN
aiua-10431	329	10	,	,	PUNCT
aiua-10431	329	11	alokail	alokail	PROPN
aiua-10431	329	12	ms	ms	PROPN
aiua-10431	329	13	,	,	PUNCT
aiua-10431	329	14	et	et	PROPN
aiua-10431	329	15	al	al	PROPN
aiua-10431	329	16	.	.	PUNCT
aiua-10431	330	1	visceral	visceral	ADJ
aiua-10431	330	2	adiposity	adiposity	NOUN
aiua-10431	330	3	index	index	NOUN
aiua-10431	330	4	is	be	AUX
aiua-10431	330	5	highly	highly	ADV
aiua-10431	330	6	associated	associate	VERB
aiua-10431	330	7	with	with	ADP
aiua-10431	330	8	adiponectin	adiponectin	NOUN
aiua-10431	330	9	values	value	NOUN
aiua-10431	330	10	and	and	CCONJ
aiua-10431	330	11	glycaemic	glycaemic	ADJ
aiua-10431	330	12	disturbances	disturbance	NOUN
aiua-10431	330	13	.	.	PUNCT
aiua-10431	331	1	eur	eur	PROPN
aiua-10431	331	2	j	j	PROPN
aiua-10431	331	3	clin	clin	PROPN
aiua-10431	331	4	invest	invest	PROPN
aiua-10431	331	5	.	.	PUNCT
aiua-10431	332	1	2013	2013	NUM
aiua-10431	332	2	;	;	PUNCT
aiua-10431	332	3	43:183	43:183	NUM
aiua-10431	332	4	-	-	SYM
aiua-10431	332	5	189	189	NUM
aiua-10431	332	6	.	.	PUNCT
aiua-10431	333	1	42	42	NUM
aiua-10431	333	2	.	.	PUNCT
aiua-10431	334	1	wang	wang	PROPN
aiua-10431	334	2	n	n	PROPN
aiua-10431	334	3	,	,	PUNCT
aiua-10431	334	4	zhai	zhai	PROPN
aiua-10431	334	5	h	h	PROPN
aiua-10431	334	6	,	,	PUNCT
aiua-10431	334	7	han	han	PROPN
aiua-10431	334	8	b	b	PROPN
aiua-10431	334	9	,	,	PUNCT
aiua-10431	334	10	et	et	PROPN
aiua-10431	334	11	al	al	PROPN
aiua-10431	334	12	.	.	PUNCT
aiua-10431	335	1	visceral	visceral	ADJ
aiua-10431	335	2	fat	fat	ADJ
aiua-10431	335	3	dysfunction	dysfunction	NOUN
aiua-10431	335	4	is	be	AUX
aiua-10431	335	5	positively	positively	ADV
aiua-10431	335	6	associated	associate	VERB
aiua-10431	335	7	with	with	ADP
aiua-10431	335	8	hypogonadism	hypogonadism	NOUN
aiua-10431	335	9	in	in	ADP
aiua-10431	335	10	chinese	chinese	ADJ
aiua-10431	335	11	men	man	NOUN
aiua-10431	335	12	.	.	PUNCT
aiua-10431	336	1	sci	sci	PROPN
aiua-10431	336	2	rep	rep	PROPN
aiua-10431	336	3	.	.	PROPN
aiua-10431	336	4	2016	2016	NUM
aiua-10431	336	5	;	;	PUNCT
aiua-10431	336	6	6:19844	6:19844	NUM
aiua-10431	336	7	.	.	NOUN
aiua-10431	336	8	43	43	NUM
aiua-10431	336	9	.	.	PUNCT
aiua-10431	337	1	blaya	blaya	NOUN
aiua-10431	337	2	r	r	PROPN
aiua-10431	337	3	,	,	PUNCT
aiua-10431	337	4	blaya	blaya	NOUN
aiua-10431	337	5	p	p	NOUN
aiua-10431	337	6	,	,	PUNCT
aiua-10431	337	7	rhoden	rhoden	ADJ
aiua-10431	337	8	l	l	NOUN
aiua-10431	337	9	,	,	PUNCT
aiua-10431	337	10	rhoden	rhoden	PROPN
aiua-10431	337	11	el	el	PROPN
aiua-10431	337	12	.	.	PROPN
aiua-10431	337	13	low	low	ADJ
aiua-10431	337	14	testosterone	testosterone	NOUN
aiua-10431	337	15	levels	level	NOUN
aiua-10431	337	16	and	and	CCONJ
aiua-10431	337	17	metabolic	metabolic	NOUN
aiua-10431	337	18	syndrome	syndrome	NOUN
aiua-10431	337	19	in	in	ADP
aiua-10431	337	20	aging	age	VERB
aiua-10431	337	21	male	male	NOUN
aiua-10431	337	22	.	.	PUNCT
aiua-10431	338	1	curr	curr	PROPN
aiua-10431	338	2	pharm	pharm	PROPN
aiua-10431	338	3	des	des	PROPN
aiua-10431	338	4	.	.	PROPN
aiua-10431	338	5	2017	2017	NUM
aiua-10431	338	6	;	;	PUNCT
aiua-10431	338	7	23:4470	23:4470	X
aiua-10431	338	8	-	-	SYM
aiua-10431	338	9	4474	4474	NUM
aiua-10431	338	10	.	.	PUNCT
aiua-10431	339	1	44	44	NUM
aiua-10431	339	2	.	.	PUNCT
aiua-10431	340	1	grossmann	grossmann	PROPN
aiua-10431	340	2	m	m	PROPN
aiua-10431	340	3	,	,	PUNCT
aiua-10431	340	4	hamilton	hamilton	PROPN
aiua-10431	340	5	ej	ej	PROPN
aiua-10431	340	6	,	,	PUNCT
aiua-10431	340	7	gilfillan	gilfillan	PROPN
aiua-10431	340	8	c	c	NOUN
aiua-10431	340	9	,	,	PUNCT
aiua-10431	340	10	et	et	PROPN
aiua-10431	340	11	al	al	PROPN
aiua-10431	340	12	.	.	PUNCT
aiua-10431	340	13	bone	bone	NOUN
aiua-10431	340	14	and	and	CCONJ
aiua-10431	340	15	metabolic	metabolic	NOUN
aiua-10431	340	16	health	health	NOUN
aiua-10431	340	17	in	in	ADP
aiua-10431	340	18	patients	patient	NOUN
aiua-10431	340	19	with	with	ADP
aiua-10431	340	20	non	non	ADJ
aiua-10431	340	21	-	-	ADJ
aiua-10431	340	22	metastatic	metastatic	ADJ
aiua-10431	340	23	prostate	prostate	NOUN
aiua-10431	340	24	cancer	cancer	NOUN
aiua-10431	340	25	who	who	PRON
aiua-10431	340	26	are	be	AUX
aiua-10431	340	27	receiving	receive	VERB
aiua-10431	340	28	androgen	androgen	NOUN
aiua-10431	340	29	deprivation	deprivation	NOUN
aiua-10431	340	30	therapy	therapy	NOUN
aiua-10431	340	31	.	.	PUNCT
aiua-10431	341	1	med	med	PROPN
aiua-10431	341	2	j	j	PROPN
aiua-10431	341	3	aust	aust	PROPN
aiua-10431	341	4	.	.	PUNCT
aiua-10431	342	1	2011	2011	NUM
aiua-10431	342	2	;	;	PUNCT
aiua-10431	342	3	194:301306	194:301306	NUM
aiua-10431	342	4	.	.	PUNCT
aiua-10431	343	1	45	45	NUM
aiua-10431	343	2	.	.	PUNCT
aiua-10431	343	3	pekgor	pekgor	PROPN
aiua-10431	343	4	s	s	PROPN
aiua-10431	343	5	,	,	PUNCT
aiua-10431	343	6	duran	duran	NOUN
aiua-10431	343	7	c	c	NOUN
aiua-10431	343	8	,	,	PUNCT
aiua-10431	343	9	berberoglu	berberoglu	NOUN
aiua-10431	343	10	u	u	NOUN
aiua-10431	343	11	,	,	PUNCT
aiua-10431	343	12	eryilmaz	eryilmaz	PROPN
aiua-10431	343	13	ma	ma	PROPN
aiua-10431	343	14	.	.	PUNCT
aiua-10431	344	1	the	the	DET
aiua-10431	344	2	role	role	NOUN
aiua-10431	344	3	of	of	ADP
aiua-10431	344	4	visceral	visceral	ADJ
aiua-10431	344	5	adiposity	adiposity	NOUN
aiua-10431	344	6	index	index	NOUN
aiua-10431	344	7	levels	level	NOUN
aiua-10431	344	8	in	in	ADP
aiua-10431	344	9	predicting	predict	VERB
aiua-10431	344	10	the	the	DET
aiua-10431	344	11	presence	presence	NOUN
aiua-10431	344	12	of	of	ADP
aiua-10431	344	13	metabolic	metabolic	NOUN
aiua-10431	344	14	syndrome	syndrome	NOUN
aiua-10431	344	15	and	and	CCONJ
aiua-10431	344	16	insulin	insulin	NOUN
aiua-10431	344	17	resistance	resistance	NOUN
aiua-10431	344	18	in	in	ADP
aiua-10431	344	19	overweight	overweight	ADJ
aiua-10431	344	20	and	and	CCONJ
aiua-10431	344	21	obese	obese	ADJ
aiua-10431	344	22	patients	patient	NOUN
aiua-10431	344	23	.	.	PUNCT
aiua-10431	345	1	metab	metab	ADJ
aiua-10431	345	2	syndr	syndr	PROPN
aiua-10431	345	3	relat	relat	PROPN
aiua-10431	345	4	disord	disord	NOUN
aiua-10431	345	5	.	.	PUNCT
aiua-10431	346	1	2019	2019	NUM
aiua-10431	346	2	;	;	PUNCT
aiua-10431	346	3	17:296	17:296	NUM
aiua-10431	346	4	-	-	SYM
aiua-10431	346	5	302	302	NUM
aiua-10431	346	6	.	.	PUNCT
aiua-10431	346	7	46	46	NUM
aiua-10431	346	8	.	.	PUNCT
aiua-10431	347	1	aboelnaga	aboelnaga	NOUN
aiua-10431	347	2	em	em	PRON
aiua-10431	347	3	,	,	PUNCT
aiua-10431	347	4	aboelnaga	aboelnaga	NOUN
aiua-10431	347	5	mm	mm	PROPN
aiua-10431	347	6	,	,	PUNCT
aiua-10431	347	7	elkalla	elkalla	PROPN
aiua-10431	347	8	hm	hm	INTJ
aiua-10431	347	9	.	.	PUNCT
aiua-10431	348	1	metformin	metformin	NOUN
aiua-10431	348	2	addition	addition	NOUN
aiua-10431	348	3	to	to	ADP
aiua-10431	348	4	androgen	androgen	NOUN
aiua-10431	348	5	deprivation	deprivation	NOUN
aiua-10431	348	6	therapy	therapy	NOUN
aiua-10431	348	7	effect	effect	NOUN
aiua-10431	348	8	on	on	ADP
aiua-10431	348	9	cancer	cancer	NOUN
aiua-10431	348	10	prostate	prostate	NOUN
aiua-10431	348	11	patients	patient	NOUN
aiua-10431	348	12	with	with	ADP
aiua-10431	348	13	type	type	NOUN
aiua-10431	348	14	2	2	NUM
aiua-10431	348	15	diabetes	diabetes	NOUN
aiua-10431	348	16	diabetes	diabete	VERB
aiua-10431	348	17	metab	metab	ADJ
aiua-10431	348	18	syndr	syndr	NOUN
aiua-10431	348	19	.	.	PUNCT
aiua-10431	348	20	2021	2021	NUM
aiua-10431	348	21	;	;	PUNCT
aiua-10431	348	22	15:102251	15:102251	NUM
aiua-10431	348	23	.	.	PUNCT
aiua-10431	349	1	correspondence	correspondence	NOUN
aiua-10431	349	2	sherihan	sherihan	PROPN
aiua-10431	349	3	i.	i.	PROPN
aiua-10431	349	4	gouda	gouda	PROPN
aiua-10431	349	5	,	,	PUNCT
aiua-10431	349	6	md	md	PROPN
aiua-10431	349	7	endocrinology	endocrinology	NOUN
aiua-10431	349	8	and	and	CCONJ
aiua-10431	349	9	diabetes	diabetes	NOUN
aiua-10431	349	10	unit	unit	NOUN
aiua-10431	349	11	,	,	PUNCT
aiua-10431	349	12	faculty	faculty	NOUN
aiua-10431	349	13	of	of	ADP
aiua-10431	349	14	medicine	medicine	NOUN
aiua-10431	349	15	,	,	PUNCT
aiua-10431	349	16	mansoura	mansoura	PROPN
aiua-10431	349	17	university	university	NOUN
aiua-10431	349	18	,	,	PUNCT
aiua-10431	349	19	mansoura	mansoura	PROPN
aiua-10431	349	20	(	(	PUNCT
aiua-10431	349	21	egypt	egypt	PROPN
aiua-10431	349	22	)	)	PUNCT
aiua-10431	349	23	mohamed	mohamed	PROPN
aiua-10431	349	24	mosaad	mosaad	PROPN
aiua-10431	349	25	aboelnaga	aboelnaga	PROPN
aiua-10431	349	26	,	,	PUNCT
aiua-10431	349	27	md	md	PROPN
aiua-10431	349	28	(	(	PUNCT
aiua-10431	349	29	corresponding	correspond	VERB
aiua-10431	349	30	author	author	NOUN
aiua-10431	349	31	)	)	PUNCT
aiua-10431	349	32	dr.mhd.endocrine@gmail.com	dr.mhd.endocrine@gmail.com	PROPN
aiua-10431	349	33	endocrinology	endocrinology	NOUN
aiua-10431	349	34	and	and	CCONJ
aiua-10431	349	35	diabetes	diabetes	NOUN
aiua-10431	349	36	unit	unit	NOUN
aiua-10431	349	37	,	,	PUNCT
aiua-10431	349	38	faculty	faculty	NOUN
aiua-10431	349	39	of	of	ADP
aiua-10431	349	40	medicine	medicine	NOUN
aiua-10431	349	41	,	,	PUNCT
aiua-10431	349	42	mansoura	mansoura	PROPN
aiua-10431	349	43	university	university	NOUN
aiua-10431	349	44	,	,	PUNCT
aiua-10431	349	45	2	2	NUM
aiua-10431	349	46	el	el	PROPN
aiua-10431	349	47	gomhouria	gomhouria	PROPN
aiua-10431	349	48	street	street	PROPN
aiua-10431	349	49	,	,	PUNCT
aiua-10431	349	50	zip	zip	NOUN
aiua-10431	349	51	code	code	NOUN
aiua-10431	349	52	:	:	PUNCT
aiua-10431	349	53	35516	35516	NUM
aiua-10431	349	54	,	,	PUNCT
aiua-10431	349	55	mansoura	mansoura	NOUN
aiua-10431	349	56	(	(	PUNCT
aiua-10431	349	57	egypt	egypt	PROPN
aiua-10431	349	58	)	)	PUNCT
aiua-10431	349	59	ahmed	ahme	VERB
aiua-10431	349	60	mg	mg	PROPN
aiua-10431	349	61	elbeltagy	elbeltagy	PROPN
aiua-10431	349	62	,	,	PUNCT
aiua-10431	349	63	md	md	PROPN
aiua-10431	349	64	clinical	clinical	ADJ
aiua-10431	349	65	pathology	pathology	PROPN
aiua-10431	349	66	department	department	NOUN
aiua-10431	349	67	,	,	PUNCT
aiua-10431	349	68	faculty	faculty	NOUN
aiua-10431	349	69	of	of	ADP
aiua-10431	349	70	medicine	medicine	NOUN
aiua-10431	349	71	,	,	PUNCT
aiua-10431	349	72	mansoura	mansoura	PROPN
aiua-10431	349	73	university	university	NOUN
aiua-10431	349	74	,	,	PUNCT
aiua-10431	349	75	mansoura	mansoura	PROPN
aiua-10431	349	76	(	(	PUNCT
aiua-10431	349	77	egypt	egypt	PROPN
aiua-10431	349	78	)	)	PUNCT
aiua-10431	349	79	amro	amro	PROPN
aiua-10431	349	80	elbaz	elbaz	PROPN
aiua-10431	349	81	,	,	PUNCT
aiua-10431	349	82	md	md	PROPN
aiua-10431	349	83	endocrinology	endocrinology	PROPN
aiua-10431	349	84	and	and	CCONJ
aiua-10431	349	85	diabetes	diabetes	NOUN
aiua-10431	349	86	unit	unit	NOUN
aiua-10431	349	87	,	,	PUNCT
aiua-10431	349	88	faculty	faculty	NOUN
aiua-10431	349	89	of	of	ADP
aiua-10431	349	90	medicine	medicine	NOUN
aiua-10431	349	91	,	,	PUNCT
aiua-10431	349	92	mansoura	mansoura	PROPN
aiua-10431	349	93	university	university	NOUN
aiua-10431	349	94	,	,	PUNCT
aiua-10431	349	95	mansoura	mansoura	PROPN
aiua-10431	349	96	(	(	PUNCT
aiua-10431	349	97	egypt	egypt	PROPN
aiua-10431	349	98	)	)	PUNCT